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An efficient route for the synthesis of a new highly selective and easily 
displaced chiral auxiliary 117 for the asymmetric boron-mediated aldol reaction has 







This novel chiral auxiliary has been shown to mediate anti and syn propionate 
and glycolate aldol reactions with a range of aldehydes in excellent yield (60-98%) and 
with good to excellent diastereoselectivity. Details of the methods which have been 












P = Me, Bn, TBDPS 
Propionate 	OH 0 Ph 
aldol reaction R__S__Me 
10 
 Bn N, S02Mes 
 
GIycoate 	 OH 0 Ph 
aldol reaction 
OP BnSO2Mes 
The facile displacement of auxiliary 117 with a range of nucleophiles under very 
mild conditions to give the corresponding phosphonate esters, alcohols, acids, SNAc 
thiolesters and methyl esters has been demonstrated. 
Iv 
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CHAPTER 1: INTRODUCTION 
1.1 ASYMMETRIC BORON-MEDIATED ALDOL REACTIONS 
The powerful aldol reaction involves the reaction of an enol or an enolate and an 
aldehyde or a ketone to form a new carbon-carbon bond. Intense and extensive studies 
on the reaction have covered a wide variety of reaction conditions and structural 
modifications for the development of efficient procedures, leading to high levels of 
stereo selection. "2 
In this regard, the use of chiral boron enolate reagents is notably successful and 
can give rise to the formation of the new carbon-carbon bond in a regio-, diastereo- and 
enantio selective manner. Up to two new stereocentres are created from two prochiral 
carbon atoms, producing four possible stereoisomers 1-4 (scheme 1). 
O OH 	 0 OH 
R1 (R3 	R1 R3 
syn-aldol 
0 	 0 	 R2 
R1!R 	
+ 	II 1 	 2 
HR 
O OH 	 0 OH 
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ant/-aldol 
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3 	 4 
Scheme 1: Four possible stereoisomers of the aldol reaction. 
1.1.1 Relative Stereocontrol 
The Z.E geometry of the enol borinate3'4 intermediate formed in the presence of 
a tertiary amine base determines the relative stereochemistry of the kinetically 
controlled boron aldol reaction. 
Boron-mediated aldol reactions are considered to go through a highly ordered 
cyclic transition state known as the Zimmerman-Traxler5  transition state. In the 
favoured transition states, the aldehyde substituent (R3) adopts a more stable equatorial 
position, avoiding unfavourable 1 ,3-diaxial interactions. 
j
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Scheme 2: Zimmerman-Traxler5 transition states for Z- and E-enolates. 
It can be seen from scheme 2 that the enolate geometry directly affects the 
stereochemistry of the products; (Z)-boron enolates give syn products, and (E)-boron 
enolates give anti products. 
3,4 Therefore, the ability to selectively obtain either enolate is 
of crucial importance. 
'I 
L2BX reagents with a variety of ligands and leaving groups 6-9 have been 
investigated to generate either E or Z enolates for a number of different substrates. 
Brown10'11  has studied the effects of varying the leaving groups of boron reagents with 
respect to stereochemical control of aldol adducts. The combination of small ligands on 
boron (e.g. n-butyl), a good leaving group (e.g. triflate) and a bulky amine base (e.g. 
diisopropylethylamine) usually leads to Zse1ective enolisation. However, the use of 
bulky ligands on boron (e.g. cyclohexyl), a poor leaving group (e.g. chloride) and a 
small amine base (e.g. triethylamine) usually promotes E-enolate formation. 
10-12 
Two hypotheses have been postulated to explain the stereochemical selectivity 
of the enolate formation. Molecular orbital calculations by Goodman and Paterson on 
R'R2CO•BH2X complexes (X = F, Cl) (used as a model for R'R2CO'BL2X complexes), 
have shown that an anomeric effect between the uncomplexed lone pair on the carbonyl 
and the B-X antibonding orbital (*) exists, causing the B-X bond to eclipse the C=O 
bond (scheme 3). 13 
n(0)— CY * (B-X) overlap 
short X --- H 	L L 
distance trans hydrogens 
X- 	o affected less 
by complexation 
H H  
partial negative 	
cis hydrogens less 
charge induced 
activated as X-B-0C 
on this carbon 	
angle increases 
Scheme 3: The effect of L2BX complexation on acetone. 
13 
3 
As shown in this acetone-boron complexed model (scheme 3) the halogen atom 
is directed towards one of the hydrogens on the cis alkyl group, inducing a partial 
negative charge on this a-carbon, thereby, activating the cis over the trans side for 
enolisation by an unhindered base such as Et3N via 7 (scheme 4). 
As the X-B-O=C dihedral angle increases, induced by sterically hindered triflate 
ligands, the electronic influence on the cis alkyl group decreases, and trans 
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Scheme 4: Paterson/Goodman model for deprotonation selectivity. 
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11 
Corey9 has proposed an alternative explanation in which the superior leaving 

















Scheme 5: Corey's model for deprotonation selectivity.9 
In this hypothesis a good leaving group allows deprotonation to give the Z-
enolate via 9, where the methyl group is able to eclipse the C=O-BL2 bond. In contrast, 
a poorer leaving group ensures that the bent complex 7 predominates, and deprotonation 
to give the E-enolate takes place preferentially. 
1.1.2 Absolute Stereocontrol 
To obtain absolute stereocontrol in a boron mediated aldol reaction the enolate 
must show a high level of pr-facial selectivity. 
3,4  One of the pr-faces of the enolate 
(scheme 6) must therefore be selective for either the si or re faces of the aldehyde, the 
E-enolate giving the anti isomers and the Z-enolate giving the syn isomers. 
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Scheme 6: Enantiofacial selectivity in boron aldol reactions.3'4 
Chiral aldehydes, enolates, boron reagents, and auxiliaries attached to an enolate 
which can be easily removed, are commonly used on their own or combined, to achieve 
n-facial selectivity. The use of chiral auxiliaries, which is central to this research, is 
described below in more detail. 
1.1.3 The Use of Chiral Auxiliaries to Obtain Absolute Stereocontrol 
Although asymmetric catalysis and biocatalytic methods increasingly allow for 
the efficient synthesis of many enantiomerically pure compounds, 
14-18  chiral auxiliaries 
remain as one of the principal means through which the aldol reaction finds its 
application in synthesis. '92' A wide range of auxiliaries have been developed, although, 
two auxiliaries have predominance in the field: the Evans' oxazolidinone 10 (figure 1) 
for syn aldol reactions, 
22-29 and the Abiko-Masamune auxiliary 11 for anti aldol 
reactions. 30-34 
0 	 Ph 
	
OANH 	 OH 
R 	 R2S02Rl 
10 11 
Figure 1: Evans' and Masamune's auxiliaries. 
The boron enolate chemistry pioneered by Evans utilising chiral N-
acyloxazolidin-2-ones derived from a-amino acids has become one of the most popular 
methods of generating aldol adducts because of the exceptionally high levels of 
diastereoselection that are possible. 
35-37 The original work by Evans involved the pair of 
chiral oxazolidin-2-one auxiliaries 12 and 13 derived from commercially available S-
valinol and (lS,2R)-norephedrine respectively (figure 2). 
Ph 
12 	 13 
Figure 2: Evans' auxiliaries. 
These oxazolidin-2-ones can be conveniently acylated to give a variety of useful 
chiral acyl equivalents, which undergo highly stereoselective enolisation to form almost 
exclusively Z-enolates, after reacting with a boron triflate and a base (scheme 7). 
7 
The corresponding Z-boron enolates, when reacted with achiral aldehydes, 
provide aldol adducts in which the a,J3-syn diastereoisorners are virtually the sole 
products. The absolute configuration of the two new chiral centres is controlled 
precisely by the chirality of the chiral auxiliary (scheme 7). 
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16 
Major syn aldol adduct 
Scheme 7: The Evans auxiliary absolute stereocontrol. Typical reagents and conditions: a) i. Bu2BOTf, 
Et3N, CH2Cl2, -78 °C; ii. RCHO, -78 °C to 0'C. 
In the above example (scheme 7) we have seen that a chiral enolate is able to 
control the stereochemistry of the newly formed chiral centres in the aldol reaction. It is 
able to do this by discriminating between each face of the aldehyde it attacks. 
If we analyse the transition state 15 which leads to aldol adduct 16 (scheme 7), 
we can see that the si face of the aldehyde and the si face of the enolate react to give the 
syn aldol adduct 16. We can also see from transition state 17 that the si face of the 
enolate prefers not to attack the re face of the aldehyde, due to unfavourable 1 ,3-diaxial 
interactions between the auxiliary and the R group on the aldehyde. Attack from the re 
face of the enolate to either face of the aldehyde is also disfavoured, due to steric 
crowding over the re face as a result of the substituent at the 4-position of the 
oxazolidin-2-one auxiliary. 
This high selectivity makes N-acyl oxazolidin-2-ones boron enolates extremely 
useful in asymmetric synthesis. The syn-selective aldol reaction using the Evans 
methodology has become the most reliable method for the direct synthesis of syn ,8-
hydroxycarbonyl systems, with many applications to natural product synthesis reported 
in recent years. 38-42 
Rizzacasa's formal total synthesis of (+)-zaragozic acid C (scheme 	a potent 
inhibitor of squalene synthase and farnesyl protein transferase, includes a highly 
selective Evans-controlled boron aldol reaction. 
0 
Ph O OH OAc 
HO2C — Jy Ph  
OH CO2H 
18 
Figure 3: (+)-Zaragozic acid C. 
The Evans aldol reaction between the boron enolate derived from oxazolidinone 
20 and aldehyde 21 proceeded in excellent yield (90%) and stereo selectivity (>97:3) to 
afford aldol adduct 22, a precursor to key fragment 19 in the synthesis of (+)-zaragozic 
39 
acid C by Rizzacasa (scheme 
AcO 	OAc 
OAc 	 BnO OBn 
















O 0 	 a)i. 
NAO 
ii. 
20 Bn 	TIPSO-CHO 
21 
OH 0 0 
TI PSO 	_L1)L. 
N'O 
22 	Bn 
Scheme 8: Retrosynthetic analysis of (+)-zaragozic acid C and Evans aldol reaction towards the synthesis 
of key fragment 19. Reagents and conditions: a) i. Bu2BOTf, 1Pr2EtN, -78 °C, CH202; ii. 21, -78 °C to 0 
°C (90%, ds >97:3). 
10 
Bu3SnW 
In White's total synthesis of polycavernoside A 23, a lethal toxin of the red algae 
Polycavernosa tsudai, a syn-selective boron-mediated aldol reaction was used to build 
fragment 24 (scheme 9)•41  Evans' methodology was used to generate the boron enolate 
derived from oxazolidinone 25. After addition of aldehyde 26, aldol adduct 27 was 
recovered in excellent yield (88%) and diastereoselectivity (>94:6) (scheme 
9),4 
Meo"q'oMe II 
BnO" - OMe 












N 0 	 30 
TBSO 
25 B  
TBSO CH0  
26 
TBSO OH 0 0 
TBSO'_' 	 N 
27 	Bn 
Scheme 9: Retrosynthetic analysis of Polycavernoside A and Evans aldol reaction towards the synthesis 
of key fragment 24. Reagents and conditions: a) i. Bu2B0Tf, Et3N, -78 °C, CH2Cl2; ii. 26, -78 °C to 0 °C 
(88%, ds >94:6). 
11 
Dias 42  approach to the asymmetric total synthesis of (-)-pironetin 28, a 
compound that shows plant growth regulatory activity and immunosuppression as well 
as a remarkable antitumoral activity, involves the use of three very efficient Evans' 
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Scheme 10: Retrosynthesis of (-)-pironetin.42  
As shown in scheme 10 these three high-yielding Evans' syn aldol reactions 
proceeded in high diastereo selectivities (>95:5) to set up six stereogenic centres in a 
very efficient manner. 
Thus, the asymmetric total synthesis of (-)-pironetin,42 polycavernoside A,4' and 
(+)-zaragozic acid C,39  can be shown as perfect examples of the high levels of 
diastereoselectivities that can be attained in oxazolidin-2-one-controlled aldo 1 reactions. 
12 
1.2 THE MASAMUNE AUXILIARY 
1.2.1 Propionate Aldol Reactions 
Numerous efforts have been devoted to the development of efficient procedures 
for the construction of /9-hydroxycarbonyl compounds in a stereodefined fashion. In 
many cases these methods provide aldol products with high enantio selectivities but 
appear to present problems in terms of the availability of reagents, the generality of 
reactions, or the conditions required for reactions. 
Studies by Abiko and Masamune 30-34  have shown that the Masamune chiral 
auxiliary (figure 4) can be used to achieve high stereo selectivities in the construction of 
anti and syn 3-hydroxycarbonyl systems. 
Ph o 	 Ph 0 
Mes = 246-trimethyiphenyl. 
OHA 	1 23467,89-octahydroa nth race nyl. 	Bn' N, S02Mes 	 ' SOOHA 
34 	 35 
ant/-aldol reagent 	syn-aldol reagent 
Figure 4: Optimum Masamune auxiliaries for anti- and syn aldol reactions.32'33  
Both enantiomers of the propionate esters 34 and 35 (figure 4) can be prepared 
from commercially available (+)- or (-)-norephedrine and (+)- or (-)-ephedrine 
respectively in three steps: selective sulfonylation of the amino group, selective N-
alkylation and acylation with propionyl chloride and pyridine (scheme 11). 
Ph OH 	a) 	Ph OH 	b) 	Ph OH 	C) 	
Ph 0 
C
NH2 	 NH 	 NBn 
SO2Mes 	 SO2Mes 	 Bn" SO
2Mes 
(-)-Norephedrine 36 	 37 	 38 	 34 
Ph OH 	d) 	Ph OH 	e) 	
Ph 0 
Iii 	 SO2OHA 	 "SO2OHA 
(-)-Ephedrine 39 	 40 
	
35 
Scheme 11: Synthesis of acylated Masamune chiral auxiliaries.3033 Reagents and conditions: a) 
MesS02C1, Et3N, CH2Cl2, 0 °C to RT, 100%. b) BnBr, K2CO3, MeCN, reflux, 95%. c) and e) EtCOCI, 
pyridine, CH2Cl2, 0°C to RT, 100%. d) OHASO2CI, Et3N, CH202, 0 °C to RT, 95%. 
13 
Abiko33  has shown that the aldol reaction of propionate chiral esters 34 and 35 
(figure 4) with a wide variety of aldehydes proceeds anti- or syn-selectively by the 
judicious selection of the enolisation reagents. Treatment of propionate esters with 
dicyclohexylboron triflate and triethylamine produces anti-aldol products, and with 
dibutylboron triflate and diisopropylethylamine gives syn-aldol products selectively 











Major anti aldol 
43 
Ph 0 




SO2OHA 	 L 	 I 
	
Z-enolate 	 Major syn aldol 
35 	 42 	 44 
Mes = 2,4,6-trimethyiphenyl. 
OHA = 1,2,3 ,4,6,7,8,9-octahydroanthracenyl. 
Scheme 12: Optimal conditions for anti and syn aldol reactions 
.33  Reagents and conditions: a) i. c-
FIex2BOTf(2.0 eq.), Et3N (2.4 eq.), CH202, -78 °C; ii. RCHO (1.2 eq.), -78°C to 0°C. b) i. Bu7BOTf 
(2.0 eq.), 'Pr2NEt (2.4 eq.), C142Cl2, -78 °C; ii. R'CHO (1.5 eq.), -78 °C to 0 °C. 
Many natural products often contain both anti- and syn-f3-hydroxy-a-
methylcarbonyl units in their structural framework. 
0 OH 	 OOH 
R1 	 R1  
R2 	 R2 	R2 =Me 
1 	 3 
Figure 5: Syn- and anti-j3-hydroxy-a-methylcarbonyl compounds. 
The anti-selective aldol reaction using chiral propionate esters derived from 
norephedrine represents one of the most reliable and practical methods for the direct 
construction of the anti-f3-hydroxy-ct-methylcarbonyl systems, 
30-34  which has challenged 
synthetic chemists in the aldol field for many years. Several applications to natural 









White43  has used the Masamune chiral auxiliary to produce an anti aldol 
fragment 47 in his synthesis of a major portion of (-)-kendomycin (scheme 13), which 
has been reported to posses antibacterial and cytostatic activity. 
51,52  The unique structure 
of (-)-kendomycin 45, in which an ansa macrocycle incorporating a fully-substituted 
tetrahydropyran, bridges a quinone methide core, presents a challenging target for 
synthesis. 3  Towards that goal, White has established a route to synthesise a major 





















Scheme 13: Use of the Masamune auxiliary towards the synthesis of (-)-kendomycin. 
43 Reagents and 
conditions: a) I. c-Hex2BOTf, Et3N, CH2Cl2, -78 °C; ii. 48, -78 °C to 0 °C (7 1%, ds >97:3). 
In the synthesis of 46 an anti-selective boron-mediated aldol reaction was used. 
Aldehyde 48 (scheme 13) was too sterically hindered for reactions intended to install a 
precursor to the tetrahydropyran segment of 46. These included asymmetric 
crotylation54 as well as Evans' anti-selective aldol process. 
55 Oppoizer's sultam 
methodology 56  was only slightly more successful, but the reaction of aldehyde 48 with 
the dicyclohexylborinate of propionate ent-34 led smoothly to hydroxy ester 47 in high 
diastereoselectivity (>97:3). 
15 
Leahy 4  has also used the Masamune methodology in his enantio selective total 
synthesis of the antitumor macrolide rhizoxin D 49. Leahy's retrosynthetic analysis 
(scheme 14) shows how the central core of rhizoxin D can be prepared via a chiral 












	51 	OHC 52 
[I! 
Ph 0 	 Ph 0 OH OTIPS 
a) i. 	 OTBS 
Bn S02Mes 	0 OTIPS 	 Bn 'SO2Mes 
54 	 H OTBS 	 53 
55  
Scheme 14: Use of the Masarnune auxiliary towards the synthesis of rhizoxin D.45 Reagents and 
conditions: a) i. c-Hex2BOTf, Et1N, CH202, -78 °C; ii. 55, -78°C to 0°C (8 1%, ds >95:5). 
During his work an efficient anti-selective aldol reaction was needed to install 
the natural stereochemistry. Synthesis of fragment 51 began from aldehyde 55 (scheme 
14), which was studied extensively as the substrate for an anti-aldol reaction. 
Paterson,57 Heathcock,58 Duthaler59 and Oppolzer56 protocols failed to give the desired 
aldol adduct 53 in good yield and/or diastereo selectivity. In particular, it was found that 
loss of the primary silyl protecting group or elimination of the protected hydroxyl 13  to 
the carbonyl were recurring problems. Fortunately during the course of Leahy and co-
workers studies Masamune and co-workers introduced the norephedrine-derived 
auxiliary methodology to give anti aldol products, 
30-33 which worked quite well on 
Leahy's substrate, giving excellent diastereo selectivity (ds> 95:5) and yield (81%). 
16 
Furstner carried out the total synthesis of glucolipsin A (figure 6), a complex 







Figure 6: Glucolipsin A. 
Furstner's retrosynthetic key strategy (based on the specific array of oxygen 
atoms in the core region of glucolipsin A) assumed the assembly of the target via a 
template-directed macro dil actoni sation reaction of a glycosylated aldol derivative 57 
preorganised around a suitable metal cation (scheme 15). In the preparation of building 
block 58, the norephedrine-derived auxiliary was employed to give the desired anti-


















Scheme 15: Use of the Masamune auxiliary towards the synthesis of glucolipsin A.46 Reagents and 
conditions: a) I. c-Hex2B0Tf, Et3N, CH2Cl2, -78 °C; ii. 60,-78 T to 0°C (71%, ds >99:1). 
17 
Panek47  has reported a convergent synthesis of the highly functionalised 
macrocyclic core of the cytotrienins 61, in which the synthesis of the C9-C 16 fragment 
proceeds via an anti-aldol reaction. Use of the Masamune3034 anti-selective 
methodology leads to the formation of 62 (scheme 16) as a single diastereoisomer (ds> 
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Scheme 16: Use of the Masamune auxiliary towards the synthesis of cytotrienins.47 Reagents and 
conditions: a) i. c-Hex2BOTf, Et3N, CH,02, -78 °C; ii. 63, -78 °C to 0 °C (94%, ds >98:2). 
18 
Shiori48  and co-workers have achieved the total synthesis of the ichthyotoxic 
cyclic lipopeptide (4R, 5R)-antillatoxin 64 (scheme 17) in an enantioselective 
convergent manner using the Abiko-Masamune3034 asymmetric aldol reaction. 
For the construction of the anti-C4, C5 configuration, the anti-selective boron-
mediated asymmetric aldol reaction developed by Abiko and Masamune was used 
(scheme 17). Aldehyde 66 was added to the E-enolate solution, which was generated 
from the propionate ester of norephedrine derivative 65 using dicyclohexylboron triflate 
and triethylamine. Subsequently, protection of the secondary alcohol gave the anti-aldol 
adduct 67, which was converted into the corresponding alcohol 68 using a DIBAL 
reduction. 
Bn _SO2Mes 
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Scheme 17: Use of the Masamune auxiliary for the synthesis of (4R-5R)-antillatoxin 
.48 Reagents and 
conditions: a) i. c-Hex2BOTf, Et3N, CH2C12, -78 °C; ii. 66, -78 °C to 0 °C b) TESOTf, 2,6-lutidine, CHC13 
(90%,2 steps). c) DIBAL, CH2Cl2, 100%- 
19 
Masamune49 has also used his own anti-selective aldol methodology in the 
synthesis of two key fragments 70 and 72 of miyakolide 69 (scheme 18) via asymmetric 
aldol reactions. The synthesis of fragment 70 starts from the chiral aldehyde 74 (scheme 
18) which reacts with the propionate chiral ester ent-34 derived from (1S,2R)-
norephedrine to give the aldol adduct 75 in high yield (90%) and good 
diastereoselectivity (>94:6). Construction of fragment 72 involves another anti-selective 
aldol reaction; aldehyde 76 was treated with the chiral ester 34 derived from (IR,25)-
norephedrine to give the aldol product 77 in 85% yield with good selectivity (>94:6). 
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Scheme 18: Use of the Masamune auxiliary towards the synthesis of miyakolide.49 Reagents and 
conditions: a) i. c-Hex2BOTf, Et-N, CH2CI7, -78 °C; ii. 74, -78 °C to 0 °C (90%, ds >94:6). b) i. c-
Hex7BOTf, Et3N, CH2C12, -78 °C; ii. 76, -78 °C to 0 °C (85%, ds >94:6). 
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All these examples show how the Masamune auxiliary can be effectively used in 
the construction of a variety of substrates, to obtain anti-aldol adducts with a wide range 
of aldehydes: from aromatic (e.g. scheme 13), to vinyl (e.g. scheme 17) or alkyl (e.g. 
scheme 15), achieving high yields and diastereoselectivities. 
1.2.2 Acetate Aldol Reactions 
An extension of the Masamune methodology includes an acetate aldol reaction 
utilising chiral ester 78. Treatment of 78 under the known conditions necessary to 
obtain mono-aldol propionate derivatives in high yield (scheme 12), provides bis-aldol 
products 80 via a double aldol reaction, along with the expected mono-aldol product 
79 60.62 
Ph o 	 Ph 0 OH 	 Ph 0 OH 
a) i. 
OPr 	+ 	 O 
11 	
'Pr 
Mes02SBn 	 Mes02S'Bn 	
Mes02SLBn Pr' OH 
78 	 79 	 80 
Scheme 19: Double aldol reaction. Reagents and conditions: a) i. c-Hex2BOTf (2.5 eq.), Et1N (3.0 eq.), 
CH202, -78 °C; ii. 'PrCHO (3.0 eq.), -78 °C to 0°C. 
Efforts to optimise the conditions for almost exclusive formation of bis-aldol 
products (scheme 19), led to the formation of 80 in over 95% yield with a 
diastereoisomer ratio of 80a : 80b : 80c = 90 : 8 : 2 (figure 7). The fourth possible 
isomer was not detected. 
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N, r Mes02SBn Pr' 	OH 
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Mes02S ' Bn Pr" OH 
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Figure 7: Bis-aldol stereo isomers. 
21 
These bis-aldol products serve as the starting material for the synthesis of chiral 
triols 81 of C3 symmetry (scheme 20). Compounds of C3 symmetry have attracted much 
attention as valuable ligands for asymmetric catalysts. 
63,64 
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HO 'Pr 	 HO O 
Pr1 OH 	 PrO 
Scheme 20: Bis-aldol products as starting material for chiral triols of C3 symmetry. Reagents and 
conditions: a) LiAIH4, THF (99%). b) PDC, CH2C12  (95%). c) RMgX, THF (65%, 97:3). d) TFA, MeOH, 
(96%). 
While double aldol reactions proceed with acetate esters, this double reaction 
does not occur with other carbonyl compounds such as methyl ketones, acetate 
thiolesters and propionate esters. There is the possibility that two kinds of boron species 
are involved in the boron-mediated aldol reaction. 
60-62  The first boron species exists 
with ketones and thiolesters and leads to the single aldol reaction, since boron can only 
chelate with the carbonyl group to form a 1:1 complex. The second boron species exists 
with acetate esters, in which coordination to the extra oxygen atom forms a 2:1 complex 
82 (scheme 21), which leads to the double aldol reaction. The failure of the double aldol 
reaction for propionate esters can probably be attributed to steric reasons. 
34 
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Scheme 21: Possible pathway in the formation ofbis-aldol products.61  
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1.2.3 Glycolate Aldol Reactions 
Aldol reactions have been extensively used in synthesis to produce differently 
protected 1,2-diol products. Various approaches have been undertaken, in most cases 
involving syn outcomes using a boron enolate of Evans' oxazolidin-2-one glycolate.2629 
There are also examples in the literature of highly selective syn glycolate aldol 
reactions with boron enolates of Masamune norephedrine esters. 
65-67  In contrast to the 
propionate series (scheme 12), in this case the optimal conditions to produce the syn 
product were dicyclohexylboron triflate and triethylamine (scheme 22). 
The glycolate syn aldol pathway begins with Z-enolate formation. The boron can 
chelate with two oxygen atoms forming a five-membered ring coordinated enolate 83, 
overcoming any steric effects imposed by the ligands on boron. After addition of 
aldehyde two options for product formation can be considered ,65 the reaction could 
proceed via a closed transition state 84 or an open arrangement 85 (scheme 22). 
c-Hex ,c-Hex 
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--l- r0 	 MeO H 	 HeX or 
	
+ O*R 
c-Hex 	 c-Hex' c-Hex 
84 	 85 
Ph 0 OH 
Major syn aldol adduct 
N.. 	OMe 
MesO2S Bn 
Scheme 22: Glycolate syn aldol pathway.65  Reagents and conditions: a) i. c-Hex2BOTf (3.0 eq.), Et3N 
(2.5 eq.), CH202, -78 °C; ii. RCHO (1.2 eq.), -78°C to 0 T. 
23 
Heathcock687° has reported that Evans' oxazolidinones can lead to the formation 
of anti-aldol adducts when an excess of triflate is present. Under these conditions the 
reaction occurs through an open transition state in which the triflate, acting as a Lewis 
acid, forms an activated complex with the aldehyde (scheme 23). 
Two possible open arrangements can be formed. Complex 86 is preferred with 
small Lewis acids (e.g. SnC14, TiC14) because it minimizes gauche interactions about the 
forming bond. In contrast, large Lewis acids (e.g. Et2AlC1, Bu2BOTf, c-Hex2BOTf) 
favour complex 87 due to the methyl-Lewis acid interaction in 86. In the absence of an 
excess of the triflate, the reaction takes place via a Zimmerman-Traxier transition state 
88, to afford the Evans syn aldol adduct as the major product (scheme 23). 
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Scheme 23: Open and close transition states with Evans' oxazolidinones.6869 
Under all conditions investigated with the glycolate-Masamune substrate, 
including various quantities of different boron compounds and bases, 
65 only syn 
products were obtained. Thus, the reaction proceeds through a close transition state, as 
partitioning to other diastereoisomers would be seen, if open arrangements with excess 
boron triflate Lewis acid activation were operative. 
24 
Andrus 65-67 and co-workers have applied their own methodology for the 
construction of syn-glycolate aldol units in the total synthesis of (+)-geldanamycin 89 
(scheme 24),6667 an antitumor I-Isp90 inhibitor that shows broad activity with the NCI 
60 cell-line panel (13 nM).71'72 
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Scheme 24: Syn glycolate aldol reaction using Masamune-based methodology .61,17 Reagents and 
conditions: a) i. c-Hex,BOTf, Et3N, CH7CI,, -78°C; ii. 93, -78°C to 0°C (90%, ds> 20:1). 
Synthesis of fragment 90 involved a syn-selective glycolate aldol reaction. The 
boron enolate 92 of the norephedrine-based glycolate 91 reacted with aldehyde 93 to 
generate 94 in greater than 20:1 diastereo selectivity and 90% isolated yield (scheme 
24). In contrast, asymmetric aldol reaction using the well-known methyiglycolate 
oxazolidinone boron enolate29 gave a much reduced 2:1 mixture of diastereomeric syn 
aldol products. 
III 
1.3 AN ALTERNATIVE STRATEGY: A NEW SULFUR MASAMUNE 
DERIVATIVE 
For an auxiliary-based strategy to be truly useful, the auxiliary must be 
removable under a range of conditions. Although this has been demonstrated to a 
certain extent for the Evans' oxazolidinone and the Abiko-Masamune auxiliary, there 
are still some nucleophilic displacement reactions which, though highly desirable 
synthetically, are unachievable or very low yielding with either of these auxiliaries, due 
to competitive retro-aldol or elimination reactions. 
Previous studies within the Hulme group 73,74  and several examples in the 
literature 75-80 have shown that thiolesters can be easily displaced using mild conditions. 
An efficient synthesis of ,B-ketophosphonates 97 from tert-butyl thiolesters 95 
using the lithium anion of either methane- or ethane-phosphonate has been described 
previously within the Hulme group (scheme 25). 73 





P(OMe)2 	 97 
96 
Scheme 25: Synthesis of fl-ketophosphonates from thiolesters 
.
73 Reagents and conditions: a) 96, BuLi, 
THF, -78 °C (73%). 
26 
This mild phosphonate displacement approach has been used in the studies 
towards the synthesis of marine metabolite octalactin A (scheme 26). 
74 In the synthesis 
of key target 101 a phosphonate displacement on aldol adduct 103 was carried out to 
give 105 in good yield. This could be converted via the HWE reaction to enone 101 
(scheme 26). 
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Scheme 26: Phosphonate displacement of a thiolester in the synthesis of octalactin A.74 Reagents and 
conditions: a) 104, BuLi, THF, -78 °C, (81%). b) 106, Ba(OH)2, THF (aq.) (81%). 
27 
As described above the displacement was readily undertaken onto the thiolester 
aldol adduct. In contrast, Evans' oxazolidinone aldol substrates are usually converted to 
the corresponding Weinreb amides, in order to achieve the desired phosphonate 
displacement prior to a HWE reaction (as shown in scheme 27).76 
OHO 0 	 a) 	 OHO 





TMSO 0 	 d) 	 TMSO 0 0 
TBSO l)l-P(OMe)2 
Scheme 27: Phosphonate displacement of Evans' oxazolidinones.76  Reagents and conditions: a) Me3AI, 
MeONHMeHCI, THF, 0 °C (75%). b) TMSCI, Imidazole, DMAP, CHI-C12.  c) 107, BuLi, THF, -78 T. 
d) 108, Ba(OH)2, THF (aq.), 0 °C (79% over three steps). 
There are many other examples in the literature where oxazolidinone aldol 
substrates are converted into thiolesters to carry out transformations not allowed directly 
on the aldol adduct. In the enantioselective synthesis of FRi 82877 by Sorensen, 
76  a 
Claisen condensation type displacement was attained under very mild conditions using a 
thiolester (scheme 28). 
0 
109U 
TESO 0 0 	a) 	TESO 0 	
OtBU  TESO 0 0 
YB 
0Bu o SEt 	b) 
Scheme 28: Mild displacement by Claisen condensation.76  Reagents and conditions: a) LiSEt, THF, -78 
°C. b) 109, LDA, THF, -78 °C to 0 °C (71% over two steps). 
28 
In the total synthesis of Leustroducsin B by Fukuyama,75 mild reduction 
























Scheme 29: Mild reduction to aldehyde 113.75  Reagents and conditions: a) Bu2BOTf, 'Pr2EtN, CH2CI7, - 
78°C. b) 110, -78°C to 0°C. c) TESCI, Imidazole, DMF. d) LiSEt, THF, 0°C (72% over three steps). e) 
DIBAL, toluene, -78 T. 
29 
It is also known that using sulfur derivatives of Evans' oxazolidinones the 
removal of the auxiliary proceeds under milder conditions. 
82-90 
SH 
114 	 115 	 116 
Figure 8: Evans' oxazolidinone and its sulfur counterparts. 
Both N-acyl oxazolidinethi ones 115 and thiazolidinethiones 116 can be 
reductively removed with either lithium or sodium borohydride in good yields, to 
produce primary alcohols and release the oxazolidinethione and thiazolidinethione 
auxiliaries (scheme 30).8289 
	
SO 	 a) 	
S 
XAN R 	 XANH + HOR 
X=OorS 
Scheme 30: Easy reductive cleavage of oxa- and thiazolidinethiones. Reagents and conditions: a) NaBH4 
or LiBH4, THF/EtOH, 0 °C. 
Most importantly, thiazolidinethiones 116 can be directly converted to the 
corresponding aldehydes, and release the chiral auxiliary, by reductive cleavage with 
diisobutylaluminum hydride (scheme 31). 
82-88 
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Scheme 31: Direct conversion to aldehydes. Reagents and conditions: a) DIBAL, CH,C12, -78 T. 
Many other transformations, such as: ester formation, 85-90 hydrolysis 
84-87  or 
aminolysis,8588  occur under milder conditions than those needed with oxazolidinones. 
Tiansamination to the Weinreb's amide can be achieved without using 
trimethy1aluminium.887  
30 
Studies carried out within the Hulme group have shown that using a thiol 
derivative of the Abiko-Masamune chiral auxiliary under the conditions for the anti-
selective propionate aldol reactions (scheme 32), good yields and diastereoselectivities 
can be achieved.91'92 





S02Mes 	 Bn" S02Mes 
Scheme 32: Results for the anti-aldols using a sulfur derivative of the Masamune's auxiliary."', 
92 
Reagents and conditions: a) c-Hex2BOTf, Et3N, CH2Cl2, -78 °C; then RCHO, -78 °C to 0 °C (> 81%, ds> 
91:9). 
Encouraged by these results we decided to investigate the use of the thiolester 
chiral auxiliary for syn-selective propionate aldol reactions and syn- and ant/-selective 
glycolate aldol reactions. 
We have also optimised the route towards the synthesis of the new thiol chiral 






Figure 9: New thiol chiral auxiliary. 
31 
CHAPTER 2: RESULTS AND DISCUSSION 1 
2.1 SYNTHESIS OF A SULFUR DERIVATIVE OF MASAMUNE'S AUXILIARY 
The initial synthetic strategy developed by John White within the Hulme group 
to synthesise a sulfur derivative of the Masamune auxiliary involved a six-step high-
yielding route (scheme 33), in which a double inversion was performed to achieve the 
desired stereochemistry (>44% over 6 steps). 
91 
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Scheme 33: Initial synthetic strategy to thiol auxiliary 117.' Reagents and conditions: a) MesS0
2Cl, 
Et3N, CH2Cl2, 2 h, 0 °C (95%). b) SOC12, 12 h, RT (97%). c) t
BuOK, DMF, 12 h, RT (91%). d) PhCOSH, 
PBu3 (10 mol%), MeCN/H20, 12 h, RT (93%). e) t
BuOK, BnBr, DMF, 18 h, RT (60% of 123, 30% of 
124). f) LiAIH4, THF, 2 h, RT (95%). 
32 
Starting from the commercially available (+)-(1S,2R)-norephedrine, selective 
sulfonylation of the amino group using mesitylenesulfonyl chloride and triethylamine in 
dichioromethane for 2 h at 0 °C, gave sulfonamide 119. 0 Chloride product 120 was 
obtained by treating the norephedrine sulfonamide with thionyl chloride at room 
temperature overnight. The reaction proceeds via an internal nucleophilic substitution 
(SNi), with retention of stereochemistry (scheme 34). 
0 
II 
Ph 	 0 Ph 	 Ph 
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120 NHS02Mes 
Scheme 34: Retention of stereochemistry via an SNi mechanism. 
The chloride product 120 was then treated with potassium tert-butoxide in 
dimethylformamide at room temperature for 12 h to generate the aziridine 121 via an 
SN2 type mechanism, with inversion of the stereochemistry at C3. The aziridine 121 was 
then opened 93-95 using thiolbenzoic acid as the nucleophile and a catalytic amount of 
PBu3 in acetonitrile-water at room temperature, to give the thiolester 122. The 
stereochemistry of 122 was confirmed by crystallographic analysis91 (figure 10). 
0 
, 0 
122 	5i: ~ 
Figure 10: Crystal structure ofthiolester 122.' 
33 
In the proposed mechanism 
93-95 (scheme 35) the phosphine attacks the ring of 
the aziridine to form the salt 125, which acts as a base to generate the anion of the 
nucleophile. Then the nucleophile reacts with aziridine to give the ring-opened 
intermediate 127, which reacts with another nucleophile to provide the product 122 and 
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Scheme 35: Proposed mechanism for the aziridine-opening reaction. 
93-95 
Benzylation of thiolester 122 was carried out using potassium tert-butoxide and 
benzyl bromide in dimethylformamide at room temperature. However, the desired 
benzylated thiolester 123 was not the only isolated product, since amide 124 generated 
as a result of benzyl group migration, was also detected (scheme 33). Finally, reduction 
of thiolester 123 using lithium aluminum hydride in tetrahydrofuran at room 
temperature generated the thiol 117 in good yield. 
These preliminary studies by John White highlighted the need to optimise 
several steps in this initial synthetic strategy; to this end aziridine 121 was generated 
directly from sulfonamide 119 via formation of a mesylate intermediate. Treatment of 
119 with methanesulfonylChlOride in triethylamine at room temperature overnight gave 
the desired aziridine 121 in good yield (scheme 36). In this manner the use of toxic 
thionyl chloride was avoided and the route towards thiol 117 decreased in length by one 
step 




NHS02Mes 	 121 SO2Mes 
119 
Scheme 36: Direct synthesis of aziridine 121 
from sulfonamide 119. Reagents and conditions: a) MsCI, 
Et3N, 0 °C for 10 min then RT for 14 h (85%). 
34 
Efforts to optimise the benzylation step were also carried out. Treatment of 
thiolester 122 with potassium carbonate and benzyl bromide in acetonitrile at room 
temperature was unsuccessful and only starting material was recovered. However, 
treatment of 122 with sodium hydride and benzyl bromide in dimethylformamide at 
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REAGENTS AND CONDITIONS 





K2CO3, BnBr, MeCN, 18 h, RT. --- 
99% FaH, BnBr, DMF, 18 h, RT. 
Table 1: Reagents and conditions to optimise the benzylation. 
While the use of potassium tert-butoxide gave a 30% of product 124, migration 
of the benzyl group was avoided by using sodium hydride as the base. The selectivity of 
the reaction was controlled due to the influence of the counter ion on the nucleophilicity 
of the anion. While potassium generates a more ionic/nucleophilic bond with the 
nitrogen allowing the migration to take place, sodium gives a more covalent/less 
nucleophilic type of bond making selective benzylation possible. Potassium carbonate 
failed to give the benzylated product; because of its weaker basicity compared to 
potassium teri-butoxide, it was not able to effect the deprotonation of the sulfonamide. 
35 
Alternative conditions to generate the thiol auxiliary 117 from benzylated 
thiolester 123 were also investigated. Saponification of 123 with sodium methoxide in 
methanol at room temperature gave thiol 117 in excellent yield, avoiding the need for 
tedious purification from aluminium salts when using LiAIH4 (scheme 37). 
After these results a new improved route to a thiol alternative of the Abiko-
Masamune auxiliary was achieved in five steps (> 70% overall yield) from 
norephedriiie (scheme 
37)•92 
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Scheme 37: Improved route towards the synthesis of the chiral auxiliary 117.92  Reagents and conditions: 
a) MesS02CI, Et3N, CH2Cl2, 2.5 h, 0 °C (95%). b) MsCI, Et3N, 0 °C 10 min then RT for 14 h (85%). c) 
PhCOSH, PBu3  (10 mol%), MeCN/H20, 18 h, RT (91%). d) NaH, BnBr, DMF, 18 h, RT (99%). e) 
NaOMe, MeOH, 1.5 h, RT (96%). 
No aerial oxidation of the new thiol auxiliary 117 was observed when left opened to air 
for months in the lab, which demonstrates its high stability and therefore its ready use in 
synthesis (scheme 38). 
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Scheme 38: No observed oxidation of thiol auxiliary 117. 
The new thiol-derivative 117 of the Abiko-Masamune auxiliary can be acylated 
using propionyl or acetyl chloride in the presence of pyridine, to give the chiral 
propionyl 131 or acetyl 128 thiolesters used as substrates for the study of propionate or 
acetate boron-mediated aldol reactions (scheme 39). 
a) 0 129 

















Scheme 39: Acylation of the chiral auxiliary 117. Reagents and Conditions: a) 129, py, CH7CI7, 18 h, RT 
(91%). b) 130, py, CH7C17, 18 h, RT (93%). 
The X-ray crystal structure 91  of 131 (figure 11), proved the overall net retention 
of stereochemistry from (1S,2R)-norephedrine of the synthetic sequence described in 
scheme 37. 
Figure 11: X-ray crystal structure of propionate derivative 131.' 
37 
An alternative strategy to generate acetyl thiolester 128 in just two steps was 
also investigated. Opening of aziridine 121 with thiolacetic acid in the presence of 
catalytic PBu3, as previously described in scheme 33, gave thiolester 132 in good 
yield.9395  However, use of the optimised conditions found to avoid benzoate migration 
(table 1) failed to generate the desired product 128. Treatment of 132 under these 
conditions (scheme 40) allowed acetyl group migration to a very high extent probably 
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Scheme 40: Failed strategy towards the synthesis of acetyl thiolester 128. 
Reagents and conditions: a) 
CH3COSH, PBu3 (10 rnol%) MeCN/H20, 18 h, RT (68%). d) NaH, BnBr, DMF, 18 h, RT (94% of 
133, 
4% of 128). 
2.2 ANTI PROPIONATE ALDOL REACTIONS 
2.2.1 Synthesis of Anti Propionate Aldols. 
Previous studies within the Hulme group 
91 proved that the new sulfur derivative 
117 of the Abiko-Masamune auxiliary could be effectively used for the anti-selective 
boron-mediated propionate aldol reaction, achieving high yields and 
di astereo selectivities with a range of aldehydes, when the optimised conditions 
developed by Abiko3334  were used. Enolisation of the chiral propionyl thiolester 131 
with dicyclohexylboron triflate and triethylamine at -78°C prior to addition of the 
aldehyde, produced anti aldol adducts in yields and diastereoselectivities comparable to 
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97 (96 : 4)33 90 (92 : 8)91 
b CHO 79 (98 : 2)
91  92 (93 : 7)91 
c 
)CHO 
95 (98: 2)33 94 (92 : 8)92 
d JCHO 
94 (94: 6)91 
e 
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Table 2: Synthesis of anti propionate aldols with the Abiko-Masamune auxiliary and its sulfur derivative. 
Reagents and conditions: a) c-Hex2BOTf (2.0 eq.), Et3N (2.4 eq.), CH2Cl2, -78 °C for 2 h; then RCHO 
(1.2 eq.), -78°C for I ii, 0°C for 1 h (anti:syn > 98:2). b) c-Hex2BOTf (2.0 eq.), Et3
N (3.0 eq.), CH,C11, - 
78 °C for 2 h; then RCHO (3.0 eq.), -78 °C for 2 h, 0 °C for I h (anti:syn> 98:2). 
C  by NMR and HPLC of 
diastereomeric mixture. 
39 
As shown above anti-aldol adducts were produced with a wide range of 
aldehydes (vinyl, alkyl and aromatic), with only a minor erosion of facial selectivity 
when switching from the ester to the thiolester.92 As with the classic auxiliary, 
30-34  the 
minor diastereoisomer has been assigned as the other anti isomer as discussed in the 
following section. 
2.2.2 Assignment of Relative Stereochemistry 
The relative stereochemistry of the four possible diastereoisomers was assigned 
on the basis of the coupling constant between C2 and C3 protons in the aldol adducts 
generated with a range of aldehydes. This coupling constant is smaller in syn-aldol 
adducts (typically 3-4 Hz) than in anti-aldol products (between 7-8 Hz) (figure 12).96 
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Figure 12: Coupling constants in syn- and anti-aldols. 
EN 
For example, NMR examination of the four diastereoisomers generated from 
benzaldehyde (scheme 41) allowed assignment of syn and anti stereochemistry of the 
aldol adducts. 
OH 0 Ph 
	













137e Major anti 





138e Minor anti 
OH 0 Ph 
Bn'SO2Mes 
141e Major syn 
	
142e Minor syn 
Scheme 41: Four possible diastereoisomers from benzaldehyde. Reagents and conditions: a) Bu2BOTf 
(2.0 eq.), 'Pr2NEt (3.0 eq.), CH2Cl2, -78 °C for 2 h; then benzaldehyde (3.0 eq.), -78 °C for 1.5 h, 0 °C for 
I h (88%, anti:syn = 98:2, anti:anti = 82:18). 
The anti stereochemistry of aldol adducts 137e and 138e was assigned by NMR 
analysis. The coupling constant between C2 and C3 protons was found to be 7.9 Hz in 
the aldol adduct 137e (figure 13) and 8.3 Hz in aldol adduct 138e (figure 14). Both are 
within the typical range for anti-vicinal protons. Similarly, the syn stereochemistry of 
aldol adducts 141e and 142e was assigned on the basis of their coupling constants, 
which were found to be 5.4 Hz in aldol adduct 141e (figure 15) and 3.7 Hz in aldol 
adduct 142e (figure 16). 
41 
OH 0 Ph 
BnSO2Mes 
137e Major anti 
7.95 	 7.89 
I 	 III I , IJIIIII 1 III 111 I 11hh I hhhh I 1Ih1 	I 





4.50 	 400 	 350 	 3.00 
PPM (t1 
Figure 13: The NMR of major anti-aldol adduct 137e and its expansion, showing the coupling constant 
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Figure 14: The NMR of minor anti-aldol adduct 138e and its expansion, showing the coupling constant 
between C2 and C3 protons. 
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Figure 15: The NMR of major syn-aldol adduct 141e and its expansion, showing the coupling constant 
between C2 and C3 protons. 
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Figure 16: The NMR of minor syn-aldol adduct 142e and its expansion, showing the coupling constant 














2.2.3 Proof of Absolute Stereochemistry 
The absolute stereochemistry was assigned based on optical rotations values 
calculated from different derivatives of the aldol adducts, and their comparison with 
known values in the literature. 
Aldol reaction between thiolester 131 and isobutyraldehyde was carried out 
under the two sets of optimised conditions developed by Abiko for anti- or syn-selective 
boron-mediated aldol reactions of esters. Surprisingly both sets of conditions afforded 
anti-aldol products 137c and 138c. 
O Ph 	 OH 0 Ph 	 OH 0 Ph 
or b) 
Bn S02Mes 	 Bn S02Mes 	 Bn S0
2Mes 
131 	 137c 	 138c 
	
Major 	 Minor 
Scheme 42: Synthesis of anti-aldol adducts from isobutyraldehyde. Reagents and conditions: a) c-
Hex2BOTf (2.2 eq.), Et3N (2.4 eq.), CH202, -78 °C for 2 h; then isobutyraldehyde (2.5 eq.), -78 °C for 2 
h, 0°C for 1 h (94%, anti:syn>99:I, anti:anti = 92:8). b) Bu2BOTf(2.0 eq.), 'Pr2NEt (3.0 eq.), CH207, - 
78 °C for 2 h; then isobutyraldehyde (3.0 eq.), -78 °C for 1.5 h, 0 °C for 1 h (94%, anti:syn> 99:1, 
anti:anti = 81:19). 
Assignment of the relative anti-stereochemistry was carried out by proton NMR 
analysis. Coupling constant between the C2 and C3 protons was found to be 6.9 Hz in 
aldol adduct 137c and 7.1 Hz in 138c. Both are typical values of coupling constants 
between vicinal anti protons in aldol substrates. 
96 
The absolute stereochemistry of both anti isomers was assigned by measurement 
of optical rotation values from acid derivatives 143 and 144 (obtained by hydrolysis of 
137c and 138c), and their comparison with the literature (scheme 43). 
96-98 
OH 0 Ph 	 OH 0 	 Ph 
OH 	+ H S( 
	
I a) 
BnSO2Mes 	 Bn ' SO2Mes 
137c 	 143 	 117 
Major 
lain = + 14.3 / Lit. 97 IaIn= + 14.1 
OH 0 Ph 	 OH 0 	 Ph 
a) 	
+ HS 
BnALSO2Mes 	 BnLSO2Mes 
138c 	 144 	 117 
Minor 
lain = - 16.0 / Lit-'8 IQin = - 15.3 
Scheme 43: Hydrolysis of anti-aldols and proof of absolute stereochemistry by optical rotation .1
6-11 
Reagents and conditions: a) L1OH (3.0 eq.), THF/H20 (2:1), RT, 30 mm (88% of 143; 117 recovered in 
99%) (86% of 144; 117 recovered in 88%). 
Following a similar procedure to that described in scheme 42, anti-aldol adducts 
137e and 138e were generated from benzaldehyde. Major product 137e was then 
hydrolysed to give acid 145 (scheme 44). 
O Ph 	 OH 0 Ph 	 OH 0 Ph 
a) 	
S-Y 	 SJ-T---- 
a--, ~I Bn N SO2Mes Bn S02Mes 	 Bn'SO2Mes 
131 	 137e Major 	 138e Minor 




Bn N S02Mes Bn SO2Mes 
137e Major 	 145 	 117 
lain = + 17.5 / Lit.97 laiD— + 17.8 
Scheme 44: Synthesis and hydrolysis of anti-aldols. Proof of absolute stereochemistry by optical 
rotation .97 Reagents and conditions: a) Bu2BOTf (2.0 eq.), 'Pr, Et (3.0 eq.), CH2Cl2, -78 °C for 2 h; then 
benzaldehyde (3.0 eq.), -78°C for 1.5 h, 0°C for I h (88%, anti:syn>99:l, anti:anti = 82:18). b) LiOH 
(20 eq.), THF/H20 (2:1), RT, 20 mm (98% of 145, 89% of 117). 
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The {ct]D obtained for acid 145 was in good agreement with the literature value, 97 
proving consistency in the stereochemical outcome of the aldol reaction (scheme 44). It 
also demonstrated achievement of the same absolute stereochemistry with the thiol 
auxiliary 117 with that reported with the Abiko-Masamune auxiliary. 
30-34 
Major aldol adduct 137e was also converted into its diol derivative 146 by 
reduction with NaBH4. The optical rotation of 146 was again in good agreement with 
the literature and the ester precedent (scheme 
45)•99100 
OH 0 Ph 	 OH 	 Ph y a) = 
HS(' S 	
CCOH + Bn Bn 
N 
 S02Mes 	 S02Mes 
137e Major 	 146 	 117 
(UID = + 32.0/ Lit.99  lUlD + 35.2 
Scheme 45: Synthesis and optical rotation value 
99,100 of 146. Reagents and conditions: a) NaBH4 (10 eq.), 
THF(aq.), RT, 14 h (99% of 146, 83% of 117). 
Having taken into account these results and that syn aldol adducts were 
generally present in less than 2% under all the conditions investigated, assignment of 




2.3 SYN-PROPIONATE ALDOL REACTIONS 
2.3.1 Attempted Synthesis of Syn-Propionate Aldols Using the Abiko-Masamune 
Optimised Conditions 
Studies reported by Abiko and Masamune have shown that through the 
appropriate choice of the enolisation reagents either anti- or syn-aldol adducts can be 
obtained. As described in table 2 the formation of anti aldols is controlled by the 
presence of bulky ligands on the boron (c-Hex2BOTf) and the addition of a non-bulky 
base (Et3N) to form the E-enolate. In contrast, the combination of small ligands on the 
boron (1311213OTf) and a larger base ('Pr2NEt) leads to the formation of the Z-enolate, 
and therefore the synthesis of syn-aldol adducts. 33,34 
Although both anti- and syn-selective aldol reaction conditions have been 
reported, only the anti-selective aldol reaction of esters has been widely used in 
synthesis, with no known examples of syn-selective propionate aldol reactions of the 
Abiko-Masarnune auxiliary in natural product synthesis. Thus, in our preliminary 
studies we decided to investigate both set of conditions with the Abiko-Masarnune 























Scheme 46: Synthesis of anti and syn Masarnune aldols using Abiko's optirnised conditions. Reagents 
and conditions: a) c-Hex2BOTf(2.2 eq.), Et3N (2.4 eq.), CH202, -78°C for 1.5 h; then PhCHO (1.5 eq.), - 
78 °C for 2 h, 0 °C for 1.5 h (anti:anti = 98:2). b) Bu2BOTf (2.0 eq.), 1Pr2NEt (3.0 eq.), CH2C12, -78 °C for 
2 h: then RCHO (1.5 eq.), -78 °C for I h, 0 °C for I h (isobutyraldehyde, syn:anti = 94:6; 
isovaleraldehyde, 83:17; benzaldehyde, 89:11). 
we 
Unfortunately, use of the optimised conditions to give syn-aldol adducts reported 
by Abiko,33'34  failed to produce syn-aldols when the sulfur derivative of the Abiko-
Masamune auxiliary was used. Treatment of thiolester 131 with Bu2BOTf and Pr2NEt 
gave only anti-aldol adducts in high yield with a range of aldehydes. In all cases an 
erosion of the facial selectivity was observed compared to the selectivities achieved 
when the anti conditions were used (table 3). 
o Ph 





OH 0 Ph 
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B N nSO2Mes 
137a-f 
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Yield (%) I ds (anti: anti)' 
87 (79: 21) 
Yield (%) / ds (anti: anti)' 








89 (76 : 24) 
94 (81:19) 
84 (77: 	23) 
88 (82 :18) 
80 (85:15) 
92 (93 : 7) 
94 (92: 8) 
94 (94: 6) 
85 (91 : 9) 
91 (97 :3) 
Table 3: Synthesis of anti propionate aldols using the syn conditions reported by Abiko.33'34 Reagents and 
conditions: a) Bu2 BOTf (2.0 eq.), 'Pr2NEt (3.0 eq.), C14202, -78 °C for 2 h; then RCHO (3.0 eq.), -78 °C 
for 1.5 h, 0°C for 1 h (anti:syn>99:l). b) c-Hex2 BOTf(2.0 eq.), Et3N (3.0 eq.), CH2Cl2, -78°C for  h; 
then RCHO (3.0 eq.), -78 °C for 2 h, 0 °C for 1 h (anti:syn > 98:2). 
C  by NMR and HPLC of 
diastereomeric mixture. 
50 
Although auxiliary 151 (derived from norephedrine) led to the formation of syn-
aldol adducts when B112BOTf and Pr2NEt were used as the enolisation reagents in the 
boron-mediated aldol reaction of Masamune esters, the diastereoselectivities syn to anti 
achieved (e.g. 87:13 syn:anti with isobutyraldehyde) were not comparable to those anti 
to syn obtained with c-Hex2BOTf and Et3N (e.g. > 98:2 anti:syn with isobutyraldehyde). 
Thus, Abiko and co-workers developed a different auxiliary 152 (derived from 
ephedrine) (figure 17) for the syn-selective propionate aldol reaction with esters, to 
achieve higher selectivities (e.g. > 95:5 with isobutyraldehyde). 
33 While the sulfur 
derivative of 151 and not that from 152 was used in our studies, the absence of syn-aldol 
adducts observed cannot be attributed to the selection of the wrong auxiliary, as high 
conversion to syn aldol adducts was possible in the case of the Abiko-Masamune 
auxiliary even when the non-optimum reagent 151 was used.33  
Ph 	 Ph 
Mes 	2,46-trim ethyl pheflyl. 	 HO'' 	 HO" 
OHA = 1 ,2346,7,8,9-octahydrOaflthraCeflYl. 	Bn 'LSO2Mes 	Me' 'SO2OHA 
151 	 152 
Figure 17: Optimum reagents for anti and syn boron-mediated propionate aldol reactions with esters. 
33,34 
At this point several attempts to try to synthesise syn-aldol adducts were 
investigated. 
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2.3.2 Investigation of the Effects of Different Bases and Triflates on Enolisation 
The effects of varying the base and the leaving groups on the boron reagents 
with respect to the stereochemical outcome of the aldol reaction have been widely 
investigated in the literature. It is known that the combination of small ligands on boron 
(e.g. n-butyl), a good leaving group (e.g. triflate) and a bulky amine base (e.g. 'Pr2NEt) 
usually leads to the formation of syn aldols by Z-selective enolisation.6 '3 This precedent 
is in agreement with the conditions reported by Abiko to generate syn-aldol adducts, 
33 
in which the variation of base and triflate used has been shown to have a great effect on 
the reaction outcome in the case of the Masamune auxiliary-mediated reaction. Thus, 
this formed the focus of our initial investigation (table 4). 
Although different combinations of triflates and bases were carried out in the 
first place, none of the conditions studied led to the formation of syn-aldols. In all cases, 
anti products were obtained to a very high extent (anti:syn> 91:9) (table 4). 
Switching from large ligands on the boron (c-Hex2BOTf) to smaller ones 
(Bu2BOTf, 9-BBNOTf, Et2BOTf) seems to lead to a decrease in facial selectivity (from 
90:10 to 80:20 anti:anti selectivity; entry 2 vs entries 4, 6 and 8); however, it fails to 
have a significant influence on the syn:anti selectivity. While c-Hex2BOTf and 
Bu2BOTf (entries 2 and 4) produce almost exclusively anti products (99:1), smaller 
ligands on the boron (9-BBNOTf and Et2BOTf; entries 6 and 8) seem to slightly 
increase the formation of syn-aldol adducts (92:8, 91:9 respectively) (table 4). 
Interestingly, in most cases the use of Et3N failed to induce the formation of 
aldol adducts (entries 3, 5 and 7). Only the combination of Et3N with c-FIex2BOTf 
(entry 1) allowed the reaction to take place. Similar results have been reported in the 
literature. 33 Boron-mediated aldol reactions of benzyl propionate did not occur when 
Et2BOTf and Et3N were used; in contrast, Et2BOTf and 'Pr2NEt produced aldol adducts 
in high yield (96%). The combination of Bu2BOTf and Et3N generated aldols in poor 
yield (10%); while Bu2BOTf and 'Pr2NEt gave a 97% yield. Finally, Et3N combined 
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OH 0 	Ph 
PhfS 
Entry F77Trifl ate / Base 
Bn 	SO2Mes 
Yield (%) / ds (anti: anti) lids (anti: syn)L 
1 (cHex)2BOTf I Et3N 85 (91 : 9)11(99 :1) 
2 (cHex)2BOTf I Pr2NEt 86 (90 :10)//(99 :1) 
3 Bu2BOTf I Et3N no reaction 
4 Bu2BOTf I 'Pr2 NEt 88 (82:18)//(99:1) 
5 9-BBN-OTf / Et3N no reaction 
6 'Pr2NEt 9-BBN-OTf I 81 (82 :18)//(92 : 8) 
7 
8 
Et2BOTf I Et3N 
Et2BOTf I 'Pr2NEt 
no reaction 
84 (80 : 20) //(91 :9) 
Table 4: Synthesis of anti aldols with different triflates and bases. Reagents and conditions: a) Triflate, 
Base, CH7C17, -78 °C; then PhCHO, from -78 °C to 0 C. bby NMR and HPLC of diastereomeric mixture. 
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2.3.3 Investigation of the Effects of Different Leaving Groups on Boron and 
Solvents on Enolisation 
It is known that the use of bulky ligands on boron (e.g. cyclohexyl), a poor 
leaving group (e.g. chloride) and a small amine base (e.g. triethylamine) usually 
promotes E-enolate formation. 6-13  When 131 was subjected to these conditions (entries 1 
and 3), the experimental results confirmed the predicted outcome of the reaction as anti-
products were recovered in high yield and with excellent diastereoselectivities. 
Dicyclohexylboron chloride and Et3N gave anti-aldol adducts in 92% yield, 90:10 
anti:anti diasterofacial selectivity and 97:3 anti:syn diastereoselectivity (entry 1, table 
5). In contrast, when 1Pr2NEt was used as the base the reaction did not take place (entry 











OH 0 Ph 
Bn ' SO2Mes 
1 38e 
Minor 
OH 0 	Ph 
Ph 	S -Y 
Entry Base / Solvent 7F 
Bn 	SO2Mes 
Yield (%) I ds (anti: anti) II ds (anti: syn)b 
1 Et3N I CH2Cl2 92 (90 :10)//(97 : 3) 
2 
3 
'Pr2NEt / CH202 
Et3N I Ether 
no reaction 
82 (85 :15)/I (98 : 2) 
Table 5: Synthesis of anti-aldol adducts with c-Hex2BCI. Reagents and conditions: a) c-Hex2BCI, Base, 
Solvent, -78 °C; then PhCHO, from -78 °C to 0 
C. b by NMR and HPLC of diastereomeric mixture. 
The experimental results described in table 5 also proved the comparatively 
minor influence of the solvent on the stereochemical outcome of the aldol reaction. Use 
of either CH2C12  or ether did not appear to have a major impact on the stereo selectivity 
of the reaction, and only a slight erosion of the facial selectivity was observed when 
ether was used (entry 1 cf 3). 
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2.3.4 Investigation of the Effects of Enolisation Temperature 
The effect of the temperature in the enolisation process was also investigated. 
Abiko has reported isomerisation of the E-enolate (kinetic) to the Z-enolate 
(thermodynamic) by heating. An aldol reaction performed on EtCOOBn at -95 °C using 
c-Hex2BOTf/Et3N afforded the anti-aldol product in 97:3 ratio. 
33  When the enolate 
solution was warmed to 0 °C before addition of aldehyde, the syn-aldol adduct was 
obtained as a major product (anti:syn = 33:67 after 30 min and 10:90 after 1 h). In our 
case, when the enolisation was carried out at 0 °C, with either c-Hex2BOTf/Et3N or 
Bu2BOTf/Pr2NEt, no significant Z-enolate formation was observed compared with the 
results obtained at -78 °C. However, some erosion of selectivity occurred with Bu2BOTf 
and Pr2NEt when the enolisation was performed at room temperature (anti:syn from 
99:1 at -78°C to 87:13 at RT) (table 6). 
0 Ph 
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(CHex)BOTf I Et3N Bu2BOTf I 'Pr2NEt 




85 (91 : 9)/I (99 :1)91  
82 (82 :18)//(95 : 5) 
71 (49 : 51) //(96 : 4) 
88 (82 : 18) //(99  :1) 
80 (81 : 19) /1(94 : 6) 
82 (52 : 48) //(87 :13) 
Table 6: Propionate aldol enolisations carried out at different temperatures. Reagents and conditions: a) 
TriflateiBase in CH2Cl2, at -78 °C (2 h), 0 °C (1 h) or room temperature (1 h); then PhCHO. b by NMR 
and HPLC of diastereomeric mixture. 
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Although changes in the temperature did not afford extensive formation of the 
Z-enolate, it did have an effect on the facial selectivity. Significant loss of 
diastereofacial selectivity was observed at higher enolisation temperatures (anti:anti 
from 91:9 at -78 °C to around 50:50 at RT) (table 6). 
2.3.5 Investigation of the Number of Equivalents of Lewis Acid 
Assuming that the reaction takes place through a Zimmerman-Traxier transition 
state, generation of Z-enolates would lead to the formation of syn-aldol adducts, while 
the production of E-enolates would afford anti-aldol products (scheme 47). However, as 
reported with Evans' oxazolidinones (scheme 23),6870  in the presence of an excess of 
Lewis acid (e.g. triflate) the aldol reaction could proceed through an open transition 
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Scheme 47: Closed and open transition states leading to syn or anti aldol adducts. 
For this reason, the influence of the number of equivalents of triflate used in the 
aldol reaction was investigated. When only 1.0 equivalent of Bu2BOTf was used for the 
aldol reaction with isobutyraldehyde in the presence of 1.5 equivalents of 'Pr2NEt at -78 
°C, anti-aldol products were obtained in 46% yield and 80:20 anti:anti diastereofacial 
selectivity, while none of the syn-products were detected. These results are similar to 
those achieved when 2.0 equivalents of Bu2BOTf were used in the presence of 3.0 
equivalents of base under the same reaction times and temperatures (88%, anti:anti = 
82:18), demonstrating that when the triflate:base ratio is maintained, but the overall 
number of equivalents of triflate is increased, only the extent of the conversion and not 
the stereochemistry was affected. In contrast, Heathcock68 has reported a reversal of 
stereochemistry with Evans' oxazolidinones when an excess of triflate and no 
significant changes in the triflate:base ratio were investigated. Treatment of Evans' 
auxiliary propionate derivative with 1.1 equivalents of Bu2BOTf in the presence of 1.3 
equivalents of 'Pr2NEt afforded excellent syn:anti selectivity (> 98:2). However, use of 
an excess of Lewis acid promoted a reversal of the stereochemical outcome of the 
reaction, affording anti aldol adducts in high selectivities (syn:anti = 23:77 with 1.5 eq. 
of Bu2BOTf and 2.0 eq. of 'Pr2NEt; syn:anti = 5:95 with 2.0 eq. of Bu2BOTf and 2.2 
eq. of Pr2NEt).68  
Changes in the enolisation time (45min-2.5 h), reaction time (3-8 h) and number 
of equivalents of base (1.5-4.0 eq.) and aldehyde (1.2-4.0 eq.) were also shown to only 
affect the yield and not the diastereo selectivity of the reaction. 
2.4 RATIONALISATION STUDIES 
2.4.1 Literature Precedent 
While the Masamune auxiliary appears to allow access to both the E-enolate (c-
Hex2BOTf, Et3N, -78 °C, 2 h, then isobutyraldehyde gives >98:2 anti:syn and 98:2 
selectivity anti:anti) and the Z-enolate (Bu2BOTf, 'Pr2NEt, -78 °C, 2 h, then 
isobutyraldehyde gives 87:13 syn:anti and 96:4 selectivity syn:syn), it is only possible to 
access the E-enolate with reasonable selectivity for the thiol analogue. This suggests 
that there could be a significant difference in the ground state energies of the Z- and F-
enolates for the thiol derivative and not for the Abiko-Masamune auxiliary, and 
therefore that the Z-enolate of the thiol analogue would not be accessible. 
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Previous reports of boron enolisation for thiolesters have shown that bulky 
thiolesters, such as tBusc(o)cH2cH3, typically produce E-enolates under the 
enolisation conditions, to give anti-aldol adducts in high anti:syn diastereo selectivity 
(table 7, entries 16)73 b 01106. The oxygenated counterpart has also been successfully 









156 	 157 	
R)(XJ< 
syn 
Entry X Enolisation Conditions Solvent ds (anti: syn) Ref. 
1 S (cPen)2BOTf/ 'Pr2NEt R20 > 95:5 101 L 1 
2 S Bu2BOTf/ 'Pr2NEt Et20 
> 95:5a 102 
3 S (CHex)BOTf / Et3N Et20 or pentane > 97:3 103 
4 S R2BBrb / Et3N Et20 or C 20 > 98:2a 104,105 
5 S ('Hex)2BCl I Et3N CH202 > 95:5 106 
6 S (cHex)2BBr I Et3N Et20 > 95:5 73 
7 0 R2BBrC I Et3N CH202 > 94:6 
8 0 (CHex)BOTf I Et3N 
I
107 
CH2Cl2 > 97:3 33 
Table 7: Anti-selective enolisation of bulky thiolesters. E:Z enolisation. 
b R2BBr = 
cRBBr _ 
CF3 	 CF3 
Ph, 	Ph 
F3C) LS r* N" 2'CF3 
O 	02 
Br 
However, smaller thiolesters, such us PhSC(0)CH2CH3, allow Z-selective 
enolisation to generate syn-aldol products (table 8, entries 14).b081 I Although there 
are no boron enolisation examples previously reported in the literature for the 
oxygenated counterpart, Z-selective enolisation with titanium (table 8, entry 5) gives 
cyn-aldol adducts with good diastereo selectivities (syn:anti> 89:11).h12h13 
OH 0 
R )X anti 




Ph 	 or 
X, I 
Ph 	 OHO 
158 	 159 	
syn 
M 	B or Ti Y1 
Ph 
Entry X Enolisation Conditions Solvent ds (syn: anti) Ref. 
1 S 9-BBN-OTf/ Pr2NEt Et20 > 95:5 108 
2 S 9-BBN-OTf/ 'Pr2 NEt Et20 > 95:5 109 
3 S R2BBra I 'Pr2NEt CH202 > 96:4 110 
4 S 9-BBN-OTf/ 'Pr2NEt Et20 > 95:5 111 
5 0 T1CI4  I EtN CH202 > 89:11 112,113 
02 N 	Ph Ph j NO2 
s N 
Table 8: Syn-selective enolisation of less hindered thiolesters. 
a R2BBr 
= 	 O 	02 
Thus, considering our sulfur analogue of the Abiko-Masarnune auxiliary as a 
bulky thiolester, the literature precedent for E-selective enolisation of bulky thiolesters, 
could explain the absence of syn aldol adducts observed in our experimental results. 
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2.4.2 Enolisation Studies 
In order to prove the geometry of the enolate, enolisation studies were carried 
out under both the anti and syn-selective conditions reported by Abiko.33  
A method reported to be effective for the assignment of Z- and E-enolate 
geometry of silyl enol ethers was initially investigated. 
102,114-116 Thiolester 131 was 
treated with triflate and base at -78 °C to generate boron enolates 160. Transmetalation 
with butyl-lithium followed by derivatisation with trimethylsilyl chloride was carried 
out in an attempt to isolate trimethylsilyl enol ethers 161 (scheme 48). It has been 
reported that the vinyl proton in an E-diastereoisomer generally resonates downfield of 
the corresponding proton in the Zdiastereoisomer.hlSH 6  However, this method is not 
always possible due to the narrow difference in the resonances of the stereoisomeric 
pair (0.06-0.07 ppm). Although analysis by proton NMR is not always possible, 
assignment of enolate geometry by carbon NMR is straightforward and unambiguous. It 
is well established that the vinyl carbons in cis-alkenes resonate at higher field than 
those in trans-alkenes. The shift is typically 5-6 ppm. The same effect can be observed 
in stereoisomeric silyl enol ethers."'-"' Thus, isolation and subsequent NMR analysis 
















Scheme 48: Study of enolate geometry by silyl enol ether formation. Reagents and conditions: a) i. c-
Hex7BOTf/Et3N or Bu2BOTf/Pr2NEt, CH-,Cl,, 2 h, -78 °C; ii. BuLi, 5 h, -78 °C; iii. TMSCI, 14 h, RT. 
Although different attempts to isolate silyl enol ethers 161 were undertaken, 
including the use of TBDMSC1 to generate more stable silyl enol ethers, only thiolester 
131 was observed by NMR analysis in all cases. 
When an aliquot of a solution of thiolester 131, Bu2BOTf and 'Pr2NEt in 
deuteriated chloroform at -78 °C was taken for NMR analysis, again only thiolester 131 
was observed, suggesting the high instability of the boron enolate. 
M. 
2.5 CONCLUSION 
2.5.1 Improvement of the Route towards the Synthesis of Sulfur Auxiliary 117 
An improved route to a thiol derivative 117 of the Abiko-Masamune auxiliary 


















Figure IS: New thiol chiral auxiliary 117 and Abiko-Masamune auxiliary 162. 
2.5.2 Anti-Propionate Aldols and Proof of Relative and Absolute Stereochemistry 
Anti propionate aldol adducts 137a-f and 138a-f were synthesised in excellent 
anti:syn diastereo selectivity (> 98:2) and anti:anti diastereofacial selectivity (> 91:9; 
table 2).9192 
O Ph 	 OH 0 Ph 	 OH 0 Ph 
RS( + R S( 




131 	 137a-f Major 	 138a-f Minor 
Scheme 49: Synthesis of anti propionate aldols using sulfur auxiliary 117.9192 
The relative stereochemistry of anti aldols 137a-f and 138a-f was assigned by 
NMR analysis of coupling constants between vicinal protons. The absolute 
stereochemistry was proved by optical rotation values of acid and diol derivatives and 
their agreement with the literature. 
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2.5.3 Syn-Propionate Aldols 
A number of attempts were pursued in order to synthesise syn-propionate aldol 
adducts, including the investigation of changes in enolisation reagents and reaction 
conditions. Unfortunately, all the conditions studied failed to produce significant 
amounts of syn aldol adducts and only an erosion of the anti:anti facial selectivity was 
observed in all cases. 
2.5.4 Rationalisation Studies 
Based on our experimental results, in which only anti propionate aldol adducts 
were obtained to a high extension under a range of different enolisation conditions, it 
appears that while both the E-enolate and the Z-enolate are accessible with the 
Masamune auxiliary, only E-enolisation can be achieved with the sulfur auxiliary. 
Considering our sulfur auxiliary as a bulky thiolester, our experimental results would be 
in good agreement with previous reports of boron enolisation for thiolesters in the 
literature, in which E-selective enolisation is achieved with bulky thiolesters such as 
tBusC(o)cH2cH3 73101 '°6 while Z-selective enolisation is accessible with less 
hindered thiolesters such as PhSC(0)CH2CH3 .10811 ' However, we were unable to show 
this directly from E-selective enolisation studies. 
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CHAPTER 3: RESULTS AND DISCUSSION 2 
3.1 CLYCOLATE ALDOL REACTION IN SYNTHESIS 
Glycolate aldol reactions have been extensively used in synthesis to produce 
1 ,2-diol products as an alternative method to double bond dihydroxylation. 
r 
enolisation 	






OP] 	 op 
Scheme 50: Use of glycolate aldols to afford 1,2-diols. 
Various auxiliary-based approaches have been reported to successfully obtain 
the desired products. In the majority of cases a boron enolate of the Evans 
oxazolidinone glycolate is used to generate the syn aldol adducts. 
26-29,120-123  In addition, 
the titanium enolates of Evans' oxazolidinones and oxazolidinethiones have also 
demonstrated to give high syn selectivities. 
121,121  Other successful auxiliary-based 
strategies include the use of Abiko-Masamune norephedrine esters, which have been 
effectively used in the synthesis of syn glycolate aldols by Andrus. 
65,66 
Effective methods to obtain anti-aldol adducts from glycolate enolates are less 
prevalent. Moderately selective anti-aldol reactions of tin(II) enolates of oxazolidinones 
and thiazolidinethiones have been observed by Mukayama-Kobayashi'26 '28 and 
Evans. 129  However, Crimmins 130"3 ' has reported a highly anti-selective aldol reaction 
with titanium enolates of oxazolidinethiones. The reaction proceeds via an open 
transition state similar to the one described for their propionate counterparts by 
Heathcock (scheme 23),6870  due to aldehyde activation by an excess of Lewis acid. 
Alternative auxiliary-based approaches include the use of oxapyrone boron- 
enolates' 32,133 	titanium enolates of oxazolidin-2-sel ones. '34 
Catalytic approaches to glycolate aldol reactions have also been investigated in 
recent years; 135,136 Kobayashi's tin glycolates, with good selectivity for either the syn or 
anti diols, remain among the prime examples. 
137,138 
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3.2 SYNTHESIS OF SYN GLYCOLATE ALDOLS 
3.2.1 Use of the Optimised Conditions for the Abiko-Masamune Auxiliary 
Andrus has reported the use of Abiko-Masamune norephedrine glycolate esters 
to produce syn-aldol adducts with a range of aldehydes in high yields ( >75%) and 
variable diastereo selectivities (syn:syn from 67:33 to 97:3).65  Interestingly, the 
optimised conditions found by Andrus to give syn glycolate aldols were coincident with 
those reported by Abiko to afford anti propionate products (c-Hex2BOTf/Et3N).33'65  
In our initial investigations we decided to test the optimised conditions 
developed by Andrus with our sulfur analogue of the Abiko-Masamune auxiliary. 
Preparation of glycolate thiolesters 163 and 166 was performed following an analogous 
procedure to the one described by Andrus. 65  Coupling of thiol auxiliary 117 with 
methoxyacetic acid 164 using catalytic DMAP and the coupling reagent EDCI in 
CI-12C12 afforded glycolate thiolester 163 in good yield. A slight variation on the 
conditions reported by Andrus (use of coupling reagent DIC instead of EDCI), also 
gave 166 in comparable yield (scheme 51). 
a) 0 164 
















Scheme 51: Synthesis of glycolate thiolesters. Reagents and conditions: a) methoxyacetic acid 164 (1.1 
eq.), DMAP (10 mol%), EDCI (1.1 eq.), CH2Cl2, 2 h at 0 °C then 14 h at RT (71%). b) benzyloxyacetic 
acid 165 (1.2 eq.), DMAP (10 mol%), DIC (1.2 eq.), CH2C12, 2 h at 0°C then 14 hat RT (69%). 
rii 
Treatment of glycolate thiolester 163 under Andrus' optimised conditions 
afforded syn glycolate aldol adducts with a range of aldehydes in good yields and 
excellent syn:anti diastereoseleCtivities (>98:2). In contrast, we found lower 
syn:syn 
selectivities (around 65:35) showing an erosion in the facial selectivity compared to its 
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OH 0 	Ph 
RS( 
OMe 	BnSO2Mes 
OH 	0 	Ph 
R(O 
OMe 	Bn_NSO2MeS 
Aldehyde Yield (%)! ds (syn: sy0 
Yield (%) I ds (syn: syn) 
Lc JCHO 67(65:35) 88(96:4) 
d CHO 90 (66 : 34) 
92 (93 : 7)65 
e 
aCHO 
95 (66: 34) 	
-E 87 (97 : 3)65 
Table 9: Synthesis of syn-glycolate 
aldols under the optimised conditions for Abiko-Masamune 
norephedrine glycolate esters. 
65 Reagents and conditions: a) c-Hex2BOTf (3.0 eq.), Et3N (2.5 eq.), 
CH2Cl2, -78 °C for 2 h; then aldehyde (3.0 eq.), -78 °C for 2 h, 0 °C for I h. 
b  by NMR and HPLC of 
d.iastereomeric mixture. 
65 
3.2.2 Assignment of Relative StereochemistrY 
As described before for the propionate aldols (figure 12), the relative 
stereochemistry of the four possible diastereoisolTlerS was assigned on the basis of the 
coupling constant value between C2 and C3 protons in the aldol adducts generated. 
For example, NMR analysis of the four glycolate diastereoisomers generated 
from isobutyraldehyde (scheme 52) allowed assignment of syn and 
anti stereochemistry 
of the aldol adducts. 
OH 0 Ph 
	









167c Major syn 




168c Minor syn 
OH 0 Ph 
bMe Bn N S02Mes 
169c Major anti 
	 170c Minor anti 
Scheme 52: Four possible glycolate diastereoiSornerS from isobutyraldehyde. Reagents and conditions: a) 
cHex2BOTf(3.0 eq.), Et3N (2.5 eq.), CH2Cl2
, -78 °C for I h; then isobutyraldehyde (3.0 eq.), -78°C for 4 
h, 0°C for 1 h (67%, syn:syn = 65:35, syn:anti 
= 98:2; by NMR and HPLC of diastereomeric mixture). 
Analysis of NMR coupling constants between the C2 and C3 protons, allowed 
assignment of the syn stereochemistry of aldol adduct 167c 
(3.3 Hz in figure 19) and 
168c (4.0 Hz in figure 20). In both NMR spectra a small amount of 
anti diastereoisomer 
was also detected (minor anti aldol 170c with coupling constant 6.1 Hz and major 
anti 
product 169c with coupling constant 6.6 Hz respectively). NMR of major 
anti aldol 
adduct 169c (figure 21) 
showed a coupling constant value of 6.6 Hz and the same for 
minor anti aldol product 170c (figure 
22) gave a 6.1 Hz coupling constant (here, a small 
amount of major syn aldol 167c was also detected). 
66 
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Figure 19: The NMR of major syn-aldol adduct 167c and its expansion, showing the coupling constant 
between C2 and C3 protons. 
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Figure 20: The NMR of minor syn-aldol adduct 168c and its expansion, showing the coupling constant 
between C2 and C3 protons. 
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Figure 21: The NIMR of major anti-aldol adduct 169c and its expansion, showing the coupling constant 
between C2 and C3 protons. 
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Figure 22: The NMR of minor anti-aldol adduct 170c and its expansion, showing the coupling constant 
between C2 and C3 protons. 
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3.2.3 Proof of Absolute Stereochemistry 
The absolute stereochemistry of major syn-glycolate aldol 167e was proved by 
X-ray crystal structure, demonstrating agreement with the stereochemistry previously 
reported with the Abiko-Masamune auxiliary. 65 
Figure 23: X-ray crystal structure of major syn-adol adduct 167e. 
The absolute stereochemistry of the minor syn-glycolate aldol adducts 168a-c 
was assigned as the other possible syn-diastereoisomer. 
71 
3.2.4 Investigation of the effects of Different Bases and Triflates on Enolisation 
Disappointed with the level of facial selectivity achieved using the optimised 
conditions reported for the Abiko-Masamune auxiliary, we decided to investigate the 
use of different protecting groups (Me- and Bn-groups) and various combinations of 
triflates and bases, to study their potential influence on the stereochernical outcome of 
the reaction. All these reactions were carried out with benzaldehyde as it was the 
aldehyde reported to give the best selectivities by Andrus. 
65 Under all the conditions 
investigated excellent syn:anti diastereoselectivitieS were obtained (>91:9). 
Interestingly, although there was not significant improvement in the syn:syn 
diastereofacial selectivity, inversion of facial selectivity was observed depending on the 
ligand involved. While the major aldol adducts produced with c-Hex213OTf were those 
with the same stereochemistry of the glycolate ester precedent syn 1 (table 10, entries 1 
and 2),65  Bu213OTf and 9-1313NOTf afforded the other syn-aldol adduct 
syn 2 as the 
major diastereoisomer (table 10, entries 3-6). 
Andrus 65 also investigated the influence that different ligands could have on the 
stereochemistry of the aldol products, but no switch in the facial selectivity was 
reported with the Abiko-Masamufle auxiliary. The use of c-Hex2BOTf with either Et3N 
or 'Pr2NEt afforded syn-aldol adducts with isobutyraldehyde in high 
syn:syn selectivity 
(96:4 synl:syn2 for the Me-protected ester, entries 1 and 2, table 11; 
95:5 synl:syn2 
with the Bn-protected substrate, entries 1 and 2, table 11). In contrast, 
Bu2BOTf/Pr2NEt gave a lower yield and diastereoselectivitY (30%, 75:25 
synl :syn2, 
entry 4, table 11), while only traces of products were recovered with Bu
2BOTf/Et3N 
(entry 3, table 11) (both with Bn-protected glycolate ester, isobutyraldehyde). 
72 
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P = Me, 167e 
	
P = Me, 168e 
P = Bn, 171e 
	
P = Bn, 172e 
	
OH 0 	Ph 
Ph ) S( 
OMe 	_N. 
Bn 	SO2Mes 




try Trifiate / Base Yield (%) / ds (synl : syn2) // ds (syn: anti )b Yield (%) / ds (synl : syn2) II ds (syn: ant/)b 
1 L(Hex)2BOTf I Et3N 90 (66 : 34) /7(91: 9) 90 (74 : 26) /7(99 :1) 
21 
(CHex)BOTf I 'Pr2NEt 85 (68 : 32) /1(95 : 5) 84 (65 : 35) //(99 :1) 
3 9-BBN-OTf / Et3N 73 (21 : 79) //(99 :1) 80 (31 : 69) //(93 : 7) 
41 
9-BBN-OTf / 'Pr2NEt 80 (47 	53) /7(96 : 4) 79 (43 	57) /7(97 : 3) 
5 Bu2BOTf I Et3N 84 (26 	74) /7(91: 9) 82 (36 : 64)17(99 :1) 
-13 
Bu2BOTf I PrNEt 78 (31 : 69) //(98 : 2) 74 (28 : 72) //(94 : 6) 
Table 10: Synthesis of syn-glycolate aldols with different bases and trifiates. Reagents and conditions: a) 
Boron Triflate (3.0 eq.), Base (2.5 eq.), CH7Cl2, -78 °C for 1 h; then benzaldehyde (3.0 eq.), -78 °C for 2 
h, 0 °C for 1.5 h. b by NMR and HPLC of diastereomeric mixture 
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	 synl 173 
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Entry Triflate I Base Yield (°h) I ds (synl : 
syn2) Yield (%) / ds (synl : syn2) 
1 (cHex)2BOTf I Et3N 88 (96: 4)65 
98 (95: 5)55 
2 (CHex)BOTf I 'Pr2NEt 88 (96 	




Bu2BOTf I Et3N 
Bu2BOTf I Pr2NEt 
3 (Not determined)65 
30 (75 : 25)65 
Table 11: Synthesis of Masamune syn-glycolate 
aldols with different bases and triflates.65  Reagents and 
conditions: a) Boron Triflate (3.0 eq), Base (2.5 eq.), CH2Cl2, -
78 °C; then isobutyraldehyde (1.2 eq.), 
from -78 °C to 0 °C. 
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3.2.5 Investigation of the Effects of Enolisation Temperature 
We also studied the influence that the temperature could have on the enolisation 
process. When the reaction was carried out at 0 °C under Bu2BOTf/'Pr2NEt no 
significant change in the syn:anti selectivity was detected (94:6 at -78 °C and 93:7 at 0 
°C). In contrast, some erosion in the syn:syn facial selectivity was observed (28:72 at - 
78 °C and 42:58 at 0 °C). When cHex2BOTf/Et3N was used at 0 °C a significant increase 
in the amount of anti-aldol products was detected (syn:anti 99:1 at -78 °C and 68:32 at 0 
°C), suggesting possible isomerisation between the Z- and E-enolate at higher 
temperatures (although these were results obtained after a single attempt). In order to 
prove this, the enolisation was carried out at room temperature. Surprisingly, the results 
obtained in this case were similar to those detected at -78 °C (syn:anti 99:1 at -78 °C, 
68:32 at 0 °C and 93:7 at RT). Erosion in the facial selectivity was also observed at 
higher temperatures (syn:syn 74:26 at -78 °C, 55:45 at 0 °C and 62:38 at RT) 
(table 12). 
	
o Ph 	 OH 0 Ph 	 OH 0 Ph a) 	
Ph S 	 + Ph S 
OBnBn 
IN, 
S02Mes 	 OBn BnSO2Mes 	
OBn BnSO2MeS 
166 	
syni 171e 	 syn2 172e 
(CHex)BOTf I Et3N Bu2BOTf I 'Pr2EtN 
Temperature 
-78 OC 
Yield (%) / ds (synl : syn2) // ds (syn: 
antl)b 
90 (74: 26) 11(99:1) 
Yield (%) / ds (synl : syn2) II ds (syn: ant,)b 
74 (28 : 72) //(94: 6) 
0 °C 
RT 
60 (55 : 45) //(68 : 32) 
88 (62 : 38) //(93  : 7) 
68 (42 : 58) //(93 : 7) 
Table 12: Syn glycolate aldol enolisations carried out at different temperatures. Reagents and conditions: 
a) Boron Triflate/Base in CH202, at -78 °C, 0 °C or room temperature for I h; then PhCHO at the same 
temperature. b by NMR and HPLC of diastereomeric mixture. 
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3.3 SYNTHESIS OF ANTI GLYCOLATE ALDOLS 
3.3.1 Auxiliary-Controlled Anti Glycolate Aldol Reactions in Synthesis 
Very few examples of auxiliary-based anti-glycolate aldols have been 
previously reported in the literature. The selective anti-aldol reaction of titanium 
enolates of oxazolidinethiones developed by Crimmins 130 has been successfully used in 
the stereoselective synthesis of the BCDE fragment of Brevetoxin A,'3 ' where a good 
yield (64%) and selectivity (87:2:11, anti:anti:syn) were achieved (scheme 53). 
a) 
H 







Scheme 53: Use of Crimmins' anti-glycolate methodology in the synthesis of the BCDE fragment of 
Brevetoxin A.'3 ' Reagents and conditions: a) TiC14, (-)-sparteine, CH2C12, -78 °C, 1 h, then 176 and TiCI
4, 
15 mm (64%, 87:2:11, anti:anti:syn). 
The anti-selective boron-mediated glycolate aldol reaction using a 
diaryldioxanone auxiliary 178 developed by Andrus 132 has been used in the synthesis of 
(+)-geldanamycin, affording a good yield (70%) and excellent diastereoselectivity 













MeO 	 05_y 
~OM  
OH 0 
NO2 	 180 
66 ' Scheme 54: Use of Andrus' anti-g!yco!ate methodology in the synthesis of (+)-geIdanamycin.  
Reagents and conditions: a) c-Hex2BOTf, Et3N, CH2C12, -78 °C, 2 h, then 179, -78 °C, 2 h (70%, ds 
>91:9). 
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3.3.2 Synthesis of Anti Glycolate aldols 
As 	described before, Andrus 65  has reported the use of Abiko-Masamune 
norephedrine glycolate esters to produce syn-aldol adducts with a range of aldehydes in 
high yields and diastereoselectivities. However, there are no examples in the literature 
of anti-selective glycolate aldol reactions involving the Abiko-Masamune auxiliary. 
When thiolester 166 was treated with dicyclohexylboron chloride and a base, 
anti-aldol adducts were produced in very high anti:syn diastereoselectivities (>94:6), 
suggesting E-enolate formation, in contrast to the ester precedent. Use of these well-
known conditions for E-enolisation (and also TiC14 and tin (II) triflate) were reported to 
be ineffective with the ester analogue by Andrus. 65  However, use of dicyclohexylboron 
chloride with different bases and solvents proved to be highly effective in the synthesis 
of anti-aldol adducts in excellent anti:syn diastereoselectivities, with the sulfur analogue 
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Base / Solvent Yield (%) / ds (anti: anti) /7 ds (anti: syn)b 
Et3N I CH2Cl2 98 (77 : 23) //(98 : 2) 
'Pr2NEt I CH202 49 (71 : 29) /1(94 : 6) 
Et3N I Ether 92 (77 : 23) /1(99 :1) 
Table 13: Synthesis of anti-glycolate aldols. Reagents and conditions: a) c-Hex2BCI (3.0 eq.), Base (2.5 
eq.), Solvent, -78 °C, 1 h, then benzaldehyde (3.0 eq.), -78 °C, 2 h, 0 °C, 1.5 h. b  by NMR and HPLC of 
diastereomeric mixture. 
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As shown in table 13 anti-aldol products were obtained in very high 
anti:syn 
selectivities (from 94:6 to 99:1) independent of the base (Et3N, Pr2EtN) or solvent 
(ether, CH2C12) used. In contrast, the anti:anti 
facial selectivity was found to be lower 
(from 71:29 to 77:23) although this ratio was not significantly dependent on either the 
base or solvent. 
3.3.3 Assignment of Relative Stereochemistry 
As described previously for the propionate and syn-glycolate aldols, the 
assignment of the relative stereochemistry was made on the basis of the coupling 
constant value between C2 and C3 protons in the aldol adducts generated (figure 12). 
NMR analysis of the mixture of diastereoisomers 181e-182e (figure 24) and the 
isolated major aldol-adduct 181e (figure 25) allowed assignment of their 
anti 
stereochemistry. The coupling constant between the C2 and C3 protons of the major 
anti aldol 181e was found to be around 6.4 Hz (figures 24 
and 25) while it was 6.0 Hz 
for minor anti aldol adduct 182e (figure 24), both higher values than those found for the 
Bn-protected synl (171e) and syn2 (172e) 
aldol adducts from benzaldehyde generated 
as described in tables 10 and 12 (5.2 and 3.8 Hz respectively). 
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Figure 24: The NMR mixture of anti-aldol adducts 181e and 182e and its expansion, showing the 
coupling constants between C2 and C3 protons. 
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Figure 25: The NMR of major anti-aldol adduct 181e and its expansion, showing the coupling constant 
between C2 and C3 protons. 
RIK 
3.3.4 Proof of Absolute Stereochemistry 
The absolute stereochemistry of major anti aldol-adduct 181e was proved by 
measurement of optical rotation value of derivative 184 (obtained by reduction of 181e 
to diol 183 and subsequent benzoylation of 183 to give 184), and its comparison with 
the literature (scheme 55). 





Bn S02Mes  
181e Major 	 183 	 117 
b) 
OBz 
Gc OBz 184 
laiD = -30.4 I Lit. 139 Jul, - 31.6 
Scheme 55: Synthesis and optical rotation value of 184. 139 Reagents and conditions: a) NaBH4 (10 eq.), 
THF(aq.), RT, 1 h (78% of 183, 83% of 117). b) Benzoyl chloride (4 eq.), DMAP (10 mol%), Py, RT, 14 
h (96% of 184). 
The [U]D obtained for 184 was in good agreement with the literature value,' 39 
demonstrating achievement of the same absolute stereochemistry with the thiol 
auxiliary 117 to that reported for the anti propionate aldol reaction with the Abiko-
Masamune auxiliary. 30-34 
Having taken into account this result and that syn aldol adducts were generally 
present in less than 6% under all the conditions investigated, assignment of the absolute 
stereochemistry for the minor anti diastereoisomer and the syn aldol adducts was made 
on the basis of the Abiko-Masamune precedent. 30
-34 
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3.4 SYNTHESIS OF SYN SILYL ALDOLS 
3.4.1 Preliminary Computational Studies 
As described before, syn-glycolate aldols were synthesised in excellent syn:anti 
diastercoselectivities but in low syn:syn diastereofacialselectivity (table 10). In order to 
investigate ways to improve this moderate facial selectivity, modelling of the ground 
state conformations of the thiolester was performed using Gaussian at a semi-empirical 
level (AM1) in vacuo. 
These preliminary computational studies of the ground state conformations of E-
and Z-enolates of the glycolate thiolester using different ligands and protecting groups 
(figure 26), suggested that by using TBDPS as the protecting group rather than either 
Me or Bn, an increase in the facial selectivity could be possible by means of blocking 
one of the two faces of the enolate for the aldehyde approach (E-enolates formed with c-
Hex2BC1, have tetrahedral geometry and negatively charged B atom, Z-enolates formed 
with c-Hex2BOTf, Bu2BOTf or Et2BOTf, are fully dissociated and have a trigonal 
planar neutral B atom) (figure 26).12140141 
L 
L B 	
L = 'Hex, Bu, Et 
	 Ph 







Figure 26: Z- and E-enolates modelled using Gaussian AM  in vacuo. 
Based on the results of these preliminary computational studies, we decided to 
investigate the selective glycolate aldol reaction of TBDPS-protected thiolesters. 
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3.4.2 Synthesis of TBDPS-Protected Thiolesters 
Several attempts to synthesise the TBDPS-protected thiolester 189 via the 
unprotected precursor 188 were undertaken. The initial approach involved coupling of 
glycolic acid 187 and thiol auxiliary 117 using coupling reagent DIC (N,N-
diisopropylcarbodiimide) in the presence of catalytic DMAP in CH2C12, conditions 
previously used in the formation of Me- and Bn-protected thiolesters (scheme 51). The 
coupling reaction was also carried out using DSC (N,NdisuccinimidY1carboflate) in an 
attempt to avoid the urea side product generated with DIC. Unfortunately, under both 
sets of conditions only thiol auxiliary 117 was recovered and just traces of desired 
product 188 were observed. Failure in the production of thiolester 188, probably due to 
polymerisation of glycolic acid under the coupling conditions, made the synthesis of 
TBDPS-protected 189 by this route impossible (scheme 56). 
	
o 	 Ph 	 0 Ph 
	 0 Ph 
HS( 
a) or b) 	r ~'S Y ........... J._ 
0H + 	
. 
OH 	 Bn 	es 
N _ OH 	N 	 OTBDPS NBn 
Bn SO2Mes SO2Mes 
187 	 117 	 188 	
189 
Scheme 56: Attempted coupling of glycolic acid and thiol auxiliary 117. Reagents and conditions: a) 187 
(1.0 eq.), 117 (1.1 eq.), DMAP (10 mol%), DIC (1.5 eq.), CH2C12, 10 min at 0°C, overnight RT. b) 187 
(1.0 eq.), Et3N (1.1 eq.), DSC (1.5 eq.), DMF, 2 h, RT, then 117 (1.2 eq.), overnight RT. 
We also investigated the synthesis of 189 through unprotected thiolester 188, via 
hydrogenolysis of benzyl-protected thiolester 166, readily prepared by coupling of 
commercially available benzyloxyacetic acid and thiol 117 with coupling reagent DIC 
as described in scheme 51. Unfortunately, catalytic hydrogenolysis of 166 
did not take 
place after 3 days and only traces of the desired product 188 were detected (scheme 57). 
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OTBOPS NBn 
Bn S02Mes 	 Bn S02Mes 	 I SO2Mes 
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Scheme 57: Attempted synthesis of thiolester 188 via hydrogenolysis of 166. Reagents and conditions: a) 
Pd/C, H-,, MeOH. 
Gennari '42  has reported the synthesis of protected glycolate thiolesters from 
unprotected methyl glycolate by using the Lewis acid AlMe3. Thus, we decided to 
investigate a different route towards 189 under Gen nan's Lewis acidic conditions. 
Unfortunately, repetition of the conditions used by Gennari failed to generate thiolester 
188 from thiol auxiliary 117, and only starting materials were recovered probably due to 
the use of a bulkier thiol (scheme 58). 
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Scheme 58: Attempted synthesis of thiolester 188 from methyl glycolate 190. 
Reagents and conditions: a) 
117 (1.2 eq.), AIMe3 (1.2 eq.), CH2Cl2, 30 min at 0 °C, then 190 (1.0 eq.), 1 h at 0 °C, overnight RT. 
Although Gennari has reported the synthesis of protected glycolate thiolesters, 
through thiol addition to methyl glycolate and subsequent glycolate protection, prior 
TBDMS-protection of methyl glycolate followed by thiol addition proved to be more 
effective (53% of tBuSH addition to methyl glycolate with A1Me3 in CH202, 79% of 
PhSH addition to TBDMS-protected methyl glycolate with A1Me3 in CH202) (scheme 
59), 142 
O 	 0 	 0 
?- OMe 	
a) 	 StBU 	 11 SBu 
OH 190 	
OH 	 OBz 
0 	 0 	 0 





Scheme 59: Gennari's synthesis of protected glycolate thiolesters. Reagents and conditions: a) 'BUSH 
AIMe3, CH2Cl2  (53%). b) PhSH, AIMe3, CH2C12 (79%). 
Thus, we decided to repeat these conditions with our thiol auxiliary 117. 
Treatment of methyl glycolate with either TBDMSC1 or TBDPSC1 and imidazole in 
DMF, afforded TBDMS- and TBDPS-protected methyl glycolates in excellent yields. 
However, addition of thiol 117 to TBDPS-protected methyl glycolate 192 under 
Gennari's conditions, 142  failed to generate thiolester 189 and again only thiol auxiliary 
117 was recovered (scheme 60). 

















Scheme 60: Attempted synthesis of thiolester 189 from TBDPS-protected methyl glycolate 192. Reagents 
and conditions: a) 190 (1.0 eq.), imidazole (2.5 eq.), TBDMSCI (1.2 eq.), DMF, RT, 4 h (100%). b) 190 
(1.0 eq.), imidazole (2.5 eq.), TBDPSCI (1.2 eq.), DMF, RT, 4 h (98%). c) 117 (2.0 eq.), AIMe3 (2.0 eq.), 
MCI,, 30 min at 0°C, then 192 (1.0 eq.), 1 h at 0°C, overnight RT. 
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However, a three-step high yielding route (81% overall yield) proved to be 
successful in the synthesis of TBDP S-protected glycolate thiolester 189. Hydrolysis of 
TBDPS-ester 193 (derived from glycolic acid 187) with K2CO3 in THF/MeOHIH20 
afforded acid 194 in very good yield in just 30 min. 
143 Glycolate acid 194 was 
immediately coupled with thiol auxiliary 117 using coupling reagent DIC in the 
presence of catalytic DMAP, in excellent yield (scheme 61). Although some instability 
of glycolate acid 194 was detected, its immediate use after flash chromatography 
purification proved to be successful in the synthesis of thiolester 189 (98% when used 
inmediately, no reaction when acid 194 was used after one day). 
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Scheme 61: Synthesis of thiolester 189. Reagents and conditions: a) 187 (1.0 eq.), TBDPSCI (4.0 eq.), 
py. 3.5 h, RT (95%). b) 193 (1.0 eq.), K2CO3 (3.0 eq.), THF/MeOH/H2
0 1:2:1, 30 mm, RT (86%).'
43 
 c) 
117 (1.0 eq.), 194 (2.3 eq.), DMAP (10 mol%), DIC (2.0 eq.), CH2C12, 30 
min at 0 °C, overnight RT 
(98%). d) 117 (1.2 eq.), NaH (1.2 eq.), DMF, 30 min at 0 °C, then 193 (1.0 eq.), 1 h at 0 °C, I h RT. e) 
117 (1.2 eq.), K7CO3  (1.2 eq.), THF, 30 min at 0 °C, then 193 (1.0 eq.), 1 hat 0 °C, overnight RT. f) 117 
(1.2 eq.), AIMe3 (1.2 eq.), CH2Cl2, 30 min at 0°C, then 193 (1.0 eq.), 1 h at 0 °C, overnight RT. 
A more direct route towards the synthesis of 189 involved the addition of thiol 
auxiliary 117 to TBDPS-ester 193. Although three different sets of conditions were 
investigated, none of them afforded the desired product. Use of NaH in DMF produced 
degradation of the thiol, suggesting the instability of 117 under basic conditions. Use of 
a milder base, such as K2CO3, failed to afford the addition and mainly thiol auxiliary 
117 was recovered together with some traces of decomposed thiol. Finally, AlMe3 was 
also inefficient and only starting material was recovered (scheme 61). 
me 
3.4.3 Synthesis of TBDPS-Protected Syn Glycolate Aldols 
With an efficient synthetic strategy towards the TBDPS-protected glycolate 
thiolester 190 in hand (scheme 56), we decided to investigate the potential influence 
that the TBDPS group could have in the improvement of the diastereofacial selectivity 
of the syn glycolate aldol reaction. Thus, initial studies involving the aldol reaction 
between thiolester 190 and benzaldehyde, in the presence of different combinations of 
boron-triflate/chloride and bases were undertaken (table 14). As described previously 
for the Me- and Bn-protected glycolate esters (table 10), the use of boron-triflate/base 
always afforded syn-glycolate products whilst the use of c-Hex2BC1/base gave anti-
glycolate aldols. Interestingly, use of either trifiate (entries 1 and 4, table 14) or 
chloride (entry 2, table 14) in the silyl aldol reaction always afforded syn-glycolate 
products. Additionally, the use of different ligand sizes on the triflate (entry I vs entry 
4, table 14) did not result in inversion of the facial selectivity as previously observed 
with the Me- and Bn-protected glycolate aldols (table 10). In contrast, the 
stereochemistry of the major and minor aldol adducts was constant, independent of the 
conditions used (table 14). 




.- 	OTBDPS NBn 	 ,- 	OTBDPS NBn 
SO2Mes 	 S02Mes 	 S02Mes 
190 	 Major 195e 	 Minor 196e 
OH 0 	Ph 







Trifiate / Base 
(cHex)2BOTf I Et3N 
(CHex)BCI I Et3N 
Bu2BOTf/ Et3N 
Bu2BOTf I 'Pr2EtN 
Yield (%) I ds (syn: syn) II ds (syn: antl)b 
82 (92 : 8)11(99 : 1) 
95 (90:10)//(99:1) 
no reaction 
77 (61 :39) /1(99 :1) 
Table 14: Synthesis of syn-silyl glycolate aldols under different conditions. Reagents and conditions: a) 
boron-triflate or chloride (3 eq.), base (2.5 eq.), CH202, I h, -78 °C; then benzaldehyde (3.0 eq.), 2 h, -78 
°C, 1 .5 h, 0 
C. b by NMR and HPLC of diastereomeric mixture. 
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Analysis of the results described in table 14 showed an important improvement 
in the facial selectivity due to the presence of bulky TBDPS-group. Although 
Bu2B0Tf/Et3N (entry 3, table 14) failed to produce aldol adducts and Bu2BOTf/'Pr2NEt 
(entry 4, table 14) gave low facial selectivity (similar results have been reported by 
Andrus 65  in the syn-selective aldol reaction with Bn-protected esters, where 
Bu2B0Tf/Et3N failed to give aldols and Bu2BOTf/'Pr2NEt only produced 75:25 syn:syn 
selectivity). In contrast, Hex2BC1 and c-Hex2BOTf with Et3N afforded syn-aldol 
adducts in high yields and excellent diastereoselectivities (syn:anti > 99:1, syn:syn > 
90:10, entries 1 and 2, table 14). Encouraged by these results, we decided to investigate 
the use of our optimised conditions (c-Hex2BOTf/Et3N, entry 1, table 14) with a range 
of aldehydes, in order to prove the generality of the reaction conditions (table 15). 
o Ph 	 OH 0 Ph 	 OH 0 Ph 
- R S 	 + R S 
OTBDPS NBn 	 OTBDPS NBn 	 OTBDPS NBn 
S02Mes 	 SO2Mes 	
SO21vles 
190 	 Major 195a,c-e 	 Minor 196a,c-e 










Aldehyde Yield (%) / ds (syn: syn)5  Yield (%) I ds (syn: syn) 	
] 
a)CHO 
76 (92: 8) 76 (96 : 4)65 
c 
)CHO 
73 (95: 5) 
64 	5) 
88 (96 : 4)65 
92 (93 : 7)65 d ).CHO (95 : 
e 82 
CHO 
(92 : 8) 87 (97 : 3)65 
Table 15: Synthesis of syn-silyl glycolate aldols with a range of aldehydes in high yields and excellent 
diastereoselectivities. Reagents and conditions: a) c-Hex2BOTf (3 eq.), Et3N (3.0 eq.), CH2Cl2, I h, -78 
°C, then aldehyde (3.0 eq.), 2 h, -78 °C, 1.5 h, 0 0c 
b  by NMR and HPLC of diastereomeric mixture. 
As shown in table 15 excellent diastereoselectivities were obtained with a range 
of aldehydes (syn:anti > 99:1, syn:syn > 92:8), demonstrating the generality of the 
retction conditions. The results obtained for our syn-silyl glycolate aldols were 
comparable to those reported by Andrus 65  for the syn-selective glycolate aldol reaction 
of Abiko-Masamune esters (syn:syn> 93:7) (table 15). Interestingly, TBDPS-protected 
Abiko-Masume esters failed to generate aldol products even when c-Hex2BOTf7 Et3N 
were used over extended times and at warmer temperatures. 65  
3.4.4 Assignment of Relative and Absolute Stereochemistry 
As described in sections 2.2.2, 3.2.2 and 3.3.3 with the propionate and Me- and 
Bn-protected glycolate aldol adducts, assignment of the syn relative stereochemistry of 
the TBDPS-protected glycolate products was made on the basis of coupling constant 
value between C2 and C3 protons in the aldol adducts generated (figure 12). 
Major and minor aldol adducts 195e and 196e from benzaldehyde were shown 
to have typical syn coupling constant values by NMR analysis of the crude mixture of 
diastereoisomers (4.4 and 3.9 Hz, respectively). 
Similarly, NMR analysis of major aldol adducts 195a from methacrolein (figure 
27), 195c from isobutyraldehyde (figure 28), and 195d from isovaleraldehyde, also 
showed syn coupling constant values (4.0, 3.5 and 3.2 Hz, respectively). 
Assignment of the absolute stereochemistry was made on the basis of the 
stereochemical outcome of the reaction previously proved in sections 3.2.3 and 3.3.4 for 
the syn Me-protected and the anti Bn-protected glycolate aldol adducts, which was also 
shown to be in good agreement with the absolute stereochemistry reported for the 
Masamune oxygenated version. 65 
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Figure 27: The NMR of syn-aldol adduct 195a and its expansion, showing the coupling constant between 
C2 and C3 protons. 
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Figure 28: The NMR of syn-aldol adduct 195c and its expansion, showing the coupling constant between 
C2 and C3 protons. 
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3.5 CONCLUSION 
3.5.1 Synthesis of Syn Glycolate Aldols 
Me- and Bn-protected syn glycolate aldol adducts (scheme 62) were synthesised 
in excellent syn:anti di astereo selectivity (> 91:9) and moderate syn:syn diastereofacial 
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Scheme 62: Synthesis of Me- and Bn-protected syn glycolate aldols. 
Improvement of the diastereofacial selectivity was achieved using the TBDPS 
protecting group. In this manner, TBDPS-protected syn glycolate aldol adducts (scheme 
63) were synthesised in excellent syn:anti diastereoselectivity (> 98:2) and high syn.syn 















Scheme 63: Synthesis of TBDPS-protected syn glycolate aldols. 
92 
3.5.2 Synthesis of Anti Glycolate Aldols 
Anti glycolate aldol adducts (scheme 64) were synthesised in excellent anti:syn 
diastereoselectivity (> 94:6) and moderate anti: anti diastereofacial selectivity (from 
71:29 to 77:23; table 13). 
O Ph 	 OH 0 Ph 	 OH 0 Ph 
Ph S 	+ Ph) S( 
OBn 





166 	 Major 181e 	 Minor 182e 
Scheme 64: Synthesis of anti glycolate aldols. 
3.5.3 Proof of Relative and Absolute Stereochemistry 
The relative stereochemistry of syn and anti aldol adducts was assigned by NMR 
analysis of coupling constants between vicinal protons. 
The absolute stereochemistry was proved by X-ray analysis or optical rotation 
values of different derivatives, and their agreement with the literature precedent. 
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CHAPTER 4: RESULTS AND DISCUSSION 3 
4.1 DEVELOPMENT OF MILD DISPLACEMENT CONDITIONS 
As discussed in chapter 1, the main focus for the development of the thiol 
auxiliary 117 was its potentially facile displacement with a range of nucleophiles under 
very mild conditions. Thus, we decided to investigate the auxiliary removal under a 
variety of useful reaction conditions in synthesis. 
4.1.1 Phosphonate Displacement Precedent 
Previous studies carried out within the Hulme group 
91 proved the efficient 
displacement of the auxiliary by phosphonate nucleophiles, which could then allow 
direct extension of the aldol adduct using a Horner-Wadsworth-Emmons reaction 
144 
(HWE) (table 16). 
a) 0 198 
II 
TBSO 0 Ph 	 P(OEt)2 TBSO 0 0 	 b) 	
TBSO 0 
RS(' 	































Table 16: Phosphonate displacement. Reagents and conditions: a) 198, BuLi, THF, -78 °C. b) RCHO, 
Ba(OH)2, THF (aq), 0 0•9 
MAI 
As shown in table 16 treatment of protected aldol adducts 197 with the lithium 
anion of diethyl ethane phosphonate 198 afforded the desired phosphonate esters 199 in 
high yields (> 8 1%). In all cases the thiol auxiliary 117 was also recovered in good yield 
(> 79%). Phosphonate esters 199 were then treated under standard conditions for the 
Horner-Wadsworth-Emmons reaction to generate alkenes 200. 
After the successful displacement of auxiliary 117 was achieved with a 
phosphonate anion, we decided to investigate the displacement reaction with other mild 
nucleophiles.92 
4.1.2 Hydrolysis Reaction 
Initially we decided to investigate the hydrolysis reaction of our thiolester aldol 
adducts; corresponding reactions of ester aldol adducts have been shown to be quite 
sluggish with the Masamune auxiliary. 
	
OH 0 Ph 	 OH 0 	 Ph 
S 	 10 
a) 	
f(oH + HS( 
BnSO2Mes 	 Bn1'SO2MeS 
137c 	 143 	 117 




-- Y Y Z LOH + HS( 
BnSO2Mes 	 Bn'LSO2MeS 
138c 	 144 	 117 
OH 0 Ph 	 OH 0 	 Ph 
b) 
S 	 OH + HS 
Bn 'LSO2Mes 	 Bn ' SO2Mes 
137e 	 145 	 117 
Scheme 65: Hydrolysis of anti-propionate aldol adducts. Reagents and conditions: a) LiOH (3.0 eq.), 
THF/H20 (2:1), RT, 30 mm (88% of 143; 117 recovered in 99%), (86% of 144; 117 recovered in 88%). 
b) LiOH (20 eq.), THF/H20 (2:1), RT, 20 mm (98% of 145,89% of 117). 
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As shown in scheme 65 treatment of anti-propionate aldol adducts 137c and 
138c with LiOH in THF/1-120 (2:1), afforded acids 143 and 144 after just 30 minutes in 
excellent yield (> 86%). When the reaction was carried out with aldol-adduct 137e in a 
smaller scale, an increase in the number of equivalents of LiOH was used (20 eq. 
instead of 3.0 eq.), producing acid 145 after just 20 minutes in 98%. 
In contrast, LiOH-mediated hydrolysis of the Abiko-Masamune auxiliary has 
been reported to require much longer reaction times, 
66,145 typically between 24-48 h. 
Thus, the results described above demonstrate the facile hydrolysis of the thiol auxiliary 
117 compared to its Abiko-Masarnune oxygenated counterpart. Furthermore, in all 
cases the thiol auxiliary 117 was recovered in high yield (> 88%), allowing its 
subsequent use in other reactions. 
The synthesis of acids 143, 144 and 145 permitted assignment of absolute 
stereochemistry of the propionate aldol adducts by optical rotation analysis. The [cL]D 
calculated were in good agreement with the literature values, as previously shown in 
schemes 43 and 44. 
When the hydrolysis reactions were left for extended time periods (1-14 h), 
partial degradation of the chiral auxiliary 117 was observed, suggesting instability of the 
thiol under strong basic conditions, as previously observed in schemes 56 and 59 in the 
presence of NaH. 
The attempted hydrolysis of aldol adducts under extremely mild conditions 
using K2CO3 in aqueous THF, failed to produce acid products and only starting material 
was recovered after 14 h. 
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4.1.3 Reduction to Alcohol 
After the successful hydrolysis reaction, we examined the reduction of aldol 
adducts to alcohols, a reaction which typically requires rather harsh conditions (LiA1H4, 
DIBAL) with the Abiko-Masamune auxiliary. 45,146-148  In contrast, we found that upon 
treatment of aldol-adduct 137e with NaBH4, diol 146 and chiral auxiliary 117 were 
obtained in excellent yield after just 1 h (99% and 83% respectively) (scheme 66). 















Scheme 66: Synthesis of diol 146 under mild reduction conditions. Reagents and conditions: a) NaBH4 
(10 eq.), THF(aq.), RT, I h (99% of 146, 83% of 117). 
Synthesis of diol 146 allowed the absolute stereochemistry of aldol-adduct 137e 
to be proved by optical rotation analysis, as previously shown in scheme 45. 
Similar conditions to those used with aldol-adduct 137e were employed with 
anti-propionate aldol adduct 137f, to generate its diol product 201 in 94% (auxiliary 
recovered in 88%) (scheme 67), confirming the efficiency of the mild reduction 
conditions for the removal of thiol auxiliary 117. 
OH 0 Ph 	 OH 	 Ph 
a) 	
ru(yOH + HSf' 
0 / 	
Bn'LSO2Mes 	 o"'f 	 Bn'SO2Mes 
137f 	 201 	 117 
Scheme 67: Synthesis of diol 201 under mild reduction conditions. Reagents and conditions: a) NaBH4 
(50 eq.), THF(aq.), RT, 14 h (94% of 201, 88% of 117). 
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Glycolate anti aldol-adduct 181e was also reduced to diol 183 in excellent yield 
(78%, auxiliary recovered in 83%) under the same conditions previously used with 
propionate aldol adducts 137e and 137f (scheme 68). 
OH 0 Ph 	 OH 	 Ph 
a) 
OH + HS 
OBn Bn'SO2Mes 	 Bn N S02MeS  
181e 	 183 	 117 
Scheme 68: Synthesis of diol 183. Reagents and conditions: a) NaBH4 (10 eq.), THF(aq.), RT, I h (78/o 
of 183, 83% of 117). 
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4.1.4 Reduction to Aldehyde 
The direct reduction of aldol adducts to aldehydes using mild reductive 
conditions was achieved in moderate yield. Initial treatment of different unprotected 
aldol adducts with DIBAL at -78 °C failed to produce aldehydes, instead unreacted aldol 
adduct (46%) and a complex mixture of products (34%) were detected. Similar 
problems have been reported for the direct cleavage of Evan's oxazolidinones,'49 
suggesting that protection of the free hydroxyl group was required. 
Thus, protection of aldol adduct 137e with TBSOTf and 2,6-lutidine followed by 
DIBAL reduction, afforded a crude mixture of thiol auxiliary 117 and aldehyde 203. 
Unfortunately, the desired aldehyde 203 appeared to decompose when subjected to flash 
chromatography and only 13% was recovered probably due to a competing elimination 
reaction. Chiral auxiliary 117 was obtained in 84% and only traces of the alcohol 
product 204 were observed (scheme 69). 
OH 0 Ph 	 TBSO 0 Ph 
&)ASJ"~ a) Cr 
Bn N S02MeS Bn N SO2Mes 
137e 	 1 	202 
b) 




LJ 	 Bn'LSO2Mes 
203 	 204 	 117 
la1D = + 40.0 / Lit. enant.'5° IUI D = - 60.0 
Scheme 69: Reduction of TBS-protected aldol 200 to aldehyde 201. Reagents and conditions: a) TBSOTf 
(2.3 eq.), 2,6-lutidine (3.1 eq.), CH202, 0 °C, 2 h (88% brsm). b) DIBAL (2.0 eq.), CH2C12, -78 °C, 2 h 
(13% of 203, 84% of 117). 
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To avoid the undesired elimination reaction, the saturated TBS-protected aldol 
adduct 205 was treated under the same reductive conditions, to afford a 1:1 crude 
mixture of thiol auxiliary 117 and aldehyde 206, which after flash chromatography 
purification gave aldehyde 206 in 53%. Despite the moderate yield only traces of 
unreacted aldol adduct and alcohol product 207 were observed, suggesting degradation 
of the aldehyde during the purification process (scheme 70). 
OH 0 Ph 	 TBSO 0 Ph  
a) __~S_y 
OMe BnSO2Mes 	 OMe BnLSO2Mes 





H + ) 	
JOH + HS(" 
206 	 207 	 117 
OMe 	 OMe 	 Bn'SO2Mes 
Scheme 70: Reduction of TBS-protected aldol 205 to aldehyde 206. Reagents and conditions: a) TBSOTf 
(2.6 eq.), 2,6-lutidine (3.0 eq.), CH7Cl2, 0 °C, 2 h (90% brsrn). b) DIBAL (4.4 eq.), MCI?, -78 °C, 2 h 
(53% of 206, 71% of 117). 
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4.1.5 Transthiolesterification Reaction 
It is known that N-acetylcysteamine (SNAc) thiolester derivatives are accepted 
as substrates by some polyketide' 53 and nonribosomal peptide 
154  synthases. When 
SNAc derivatives are used for feeding experiments, these unusual precursors are 
recognised as Acyl-S-CoA substitutes. Thus, the transthio lesterifi cation reaction takes 
place next, and the desired precursor is loaded into the biosynthetic machinery. Having 
this in consideration the direct construction of SNAc thiolesters could be of high interest 
in synthesis. Therefore, transthiolesterification of aldol adduct 137c was carried out 
under the extremely mild conditions reported by Raines (scheme 71).l5 





B'L n SO2Mes  
1 37c 
OHO 	 Ph 
+ HS-Y  
0 	
Bn'SO2Mes 
209 	 117 
Scheme 71: Transthiolesterification of aldol 137c to SNAc thiolester 209. Reagents and conditions: a) N-
acetylcystearnine 208 (15 eq.), Pr2NEt (15 eq.), DMF, RT, I h (88% of 209, 93% of 117). 
Treatment of propionate aldol adduct 137c with N-acetylcysteamine (SNAc) 208 
in the presence of 'Pr2EtN, gave SNAc thiolester 209 in only 1 h and in excellent yield 
(88%) (scheme 71). Treatment of aldol adduct 137f under the same conditions afforded 
SNAc thiolester 210 in high yield, demonstrating the generality of the reaction 
conditions. This procedure is notable as it avoids the need for a two-step hydrolysis-
thiolesterification process, which is typically used in the case of polyketide starter units 
derived from the Evans oxazolidinone (scheme 72).15658 
a) 	
0 208 
OH 0 Ph 	HS N 	 OH 0 H 
H 
J7 	0 0 / 	 BnSO2Mes 	 0 
137f 	 —o 210 
Ph 
+ HS( 
Bn N S02Mes 
117 








S N 1( 
B 	211 
Scheme 72: SNAc thiolester formation from aldol adduct 137f and Evans' aldol adduct 211. Reagents 
and conditions: a) 208 (15 eq.), 'Pr2NEt (15 eq.), DMF, RT, I h (86% of 210,77% of 117). 
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Attempted transthiolesterification under the conditions reported by Willis 
159  (N-
acetylcysteamine, Me3A1, THF, 0°C) failed to produce the desired product and only 
complex mixtures were obtained, including the products of elimination and retroaldol 
reaction 
4.1.6 Transesterification Reaction 
Finally, transesterifi cation '6°  of aldol adduct 137f was readily achieved by 
treatment with sodium methoxide in methanol, giving methyl ester 212 in 94% after just 
30 minutes. Auxiliary 117 was also recovered in excellent yield (99%) (scheme 73). 
	




I  -Y )  o	 BnSO2Mes 	 0 	 BnSO2Mes 137f 	 \—o 	212 	 117 
Scheme 73: Transesterification reaction of aldol adduct 137f to give methyl ester 212. Reagents and 
conditions: a) NaOMe (2.0 eq.), MeOH, RT, 30 mm (94% of 212,99% of 117). 
4.2 CONCLUSION 
We have demonstrated the facile displacement of chiral auxiliary 117 with a 
range of nucleophiles under very mild conditions, to give the corresponding 
phosphonate esters, acids, alcohols, aldehydes, methyl esters and SNAC thiolesters 
(scheme 74). 
OH OH 	TBSO 0 
R* RH 
OHO 	 OHO 
RfOH 	 R1OMe 
/ 
OHO 0 	 OHO 	 OHO 
R (( 0Et)2 	 R(SAux . R(SNY 
Scheme 74: Removal of thiol auxiliary 117 under a range of mild reaction conditions. 
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CHAPTER 5: FUTURE WORK 
5.1 FUTURE WORK 
5.1.1 Use of Thiol Auxiliary 117 in Natural Product Synthesis 
The new thiol auxiliary 117 has been successfully used in the Hulme group for 
an anti-selective boron-mediated propionate aldol reaction, in the route towards the 
synthesis of marine metabolite octalactin A 98, achieving high yield (92%) and 
diastereoselectivity (anti:anti = 93:7) (scheme 
75)74  These results confirmed the high 
levels of diastereoselectivity showed by the auxiliary with a range of aldehydes for the 
anti-selective propionate aldol reaction (table 2),' making it an attractive alternative in 



















Scheme 75: Use of the sulfur analogue of the Abiko-Masamune auxiliary in an anti-selective propionate 
aldol reaction towards the synthesis of octalactin A. Reagents and conditions: a) i. c-Hex2B0Tf, Et3N, 
C142CI7, -78 °C; U. 213, -78°C to 0°C (92%, ds = 93:7). b) TBSOTf, 2,6-lutidine, CH202 (94%).74 
The selective glycolate aldol reaction using thiol auxiliary 117 has also been of 
high interest in our research. As described before, several studies were undertaken 
leading to the development of the optimised conditions to afford syn glycolate aldols in 
excellent diastereoselectivity (table 15). Thus, an extension of this investigation will 
include the use of this new glycolate-aldol methodology in natural product synthesis. 
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Investigations towards the synthesis of the arninopolyol antibiotic zwittermicin 
A 214 have been previously carried out in the Hulme group.' 
61 In these studies, a 
synthetic route involving a syn-selective glycolate aldol reaction followed by peptide 
bond formation was considered (scheme 76). 
Glycolate aldol 
Peptide coupling 
0 	H OH NH2 	NH2 
H2N 
NH2 OH OH OH 
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Scheme 76: Retrosynthetic analysis of zwittermicin A.'6 ' 
In the proposed synthetic route described above, our new aldol methodology 
could be used in the glycolate aldol reaction between TBDPS-protected thiolester 216 
and aldehyde 217 (scheme 77). 
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217 
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Scheme 77: Proposed syn-selective glycolate aldol reaction towards zwittermicin A. Reagents and 
conditions: a) I. c-Hex2BOTt Et3N, CH2Cl2; ii. 217. b) LiOH, THF/H10, RT. 
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In this manner, fragment 218 could be generated in expected high yield and 
diastereoselectivity, and then used in the synthesis of zwittermicin A by hydrolysis 
(using the optimised hydrolysis conditions previously described in scheme 65) and 
subsequent peptide bond formation between acid 219 and nitrogen-rich fragment 215.162 
The peptide bond formation 161-16'  between fragments 219 and 215 could be 
achieved using well-known coupling reagents such us: EDCI, DCC or DIC, in a similar 
way to that described in scheme 51. Alternatively, peptide bond formation could also be 
obtained via Native Chemical Ligation (NCL).166"67 The method of NCL was first 
introduced by Kent 168  and is based on the reaction between a thiolester and the 
sidechain of a Cys residue. In this reaction, two fully unprotected peptides react to form 
an amide bond in aqueous conditions at neutral pH. The first step of this process 
involves the reversible chemoselective transthiolesterification of an unprotected 
peptide-a-thiolester 220, with another unprotected peptide segment 221 containing an 
N-terminal Cys residue. The thio lester- linked intermediate 222 formed in this first step, 
spontaneously undergoes a rapid S—*N-acyl transfer to form a native peptide bond at the 
ligation site (scheme 78).166177 
NH2 
NH2 [_Peptide 2 j + 	ry Peptide 2 -RSH 	 II 
0 	SHO 	 0 	0 
220 	 221 	 222 
de1 
223 
Scheme 78: Principle of Native Chemical Ligation. 
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The NCL of unprotected peptide segments has been demonstrated to be uniquely 
effective for the rapid and efficient synthesis of numerous proteins. However, the 
necessity of an N-terminal Cys residue at the ligation site is not always compatible with 
the synthetic target, limiting the use of the NCL in synthesis. For this reason, numerous 
examples of auxiliary-assisted peptide ligation have been investigated. 
170-177 The 
development of these cleavable thiol auxiliaries enlarges the applicability of NCL to 
non-Cys targets. For example, the TFA-removable Macmillan auxiliary has been 
successfully used for Cys-free NCL (scheme 
79)• 177 









0 	 Macmillan-Aux 
NCL 	 N 	
fide2 
225 
Scheme 79: Use of Macmillan's auxiliary in peptide synthesis. 
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Thus, the NCL methodology could be used in the synthesis of zwitterrnicin A, 
leading to peptide bond formation between the unprotected glycolate aldol fragment 226 





MeO 	OMe 	 NCL 
+ 
lycoIate aldol X. 
226 
Macmillan-Aux 
0 	 OH NH2 	NH2 
H2NA N  
0 OH OH OH 
NH2 	 228 
TFA 
0 	 OH NH2 	NH2 
H2N N
HI 	0 OH OH OH 
	0H  
Zwittermicin A 214 	
0 NH2 
Scheme 80: Use of NCL in the synthesis of zwittermicin A. 
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Initial studies were undertaken to optimise the conditions of the original NCL in 
the reaction between a simple glycolate aldol-adduct and Cys methyl ester. The first 
attempt was carried out between glycolate aldol 167e and Cys methyl ester 229 in 
aqueous buffer at pH 7.5; in the presence of 4-mercaptophenyl acetic acid (MPAA) as a 
reducing reagent to prevent the thiol of the Cys from oxidation, and also to increase the 
reactivity by forming new thiolester intermediates through transthiolesterification 
(scheme 81). Unfortunately, this first attempt was unsuccessful and only starting 
materials were recovered after 4 days. In spite of all the efforts to conduct the reaction 
in an inert atmosphere (the reaction was carried out under argon and the buffer solution 
was degassed under vacuum and flushed with argon prior to use), and the careful 
selection of the reagents (MPAA was chosen as catalyst based on reports of its high 
efficiency 172  in the NCL) the reaction failed to work, maybe due to the low solubility of 
aldol-adduct 168e in aqueous conditions. Thus, a second attempt was conducted in 
DMF (scheme 81). However, the expected NCL did not occur and again only starting 
materials were recovered. 
OHO Ph 	 OHO HS 
	 Ph 
Cr1_y
JA -- 	 + HS Me 
OMe Bn 'LSO2Mes 	 0 	
-' OMe 	0 	 BnSO2Mes 
Major 167e 	 HS OMe 	 230 	 117 
NH2• HCI 229 
OHO Ph 	 OHO 
HS 
i1 : ii_OMe + HS 
Ph 
 Me 
' OMe Bn'LSO2Mes 	 0 L) OMe 	0 	 BnSO2Mes 
Minor 168e 	 HS OMe 	 231 	 117 
NH2•HCI 229 
Scheme 81: Attempted NCL between glycolate aldol adducts and Cys methyl ester. Reagents and 
conditions: a) 229 (2.0 eq.), MPAA (250 mM), 6 M guanidineHCl, 0.1 M Na2HPO4 buffer, pH 7.5, RT. 
b) 229 (2.0 eq.), MPAA (250 mM), DMF, RI. 
Although our initial NCL studies were not successful, further investigations 
could be undertaken to optimise the solubility conditions and investigate a range of thiol 
additives; this could allow the peptide bond formation to take place, and therefore the 
possibility of using the optimised NCL conditions in the synthesis of zwittermicin A. 
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5.1.2 Development of Alternative Thiol Auxiliaries 
An extension of our studies would include the development of alternative thiol 
auxiliaries to be used in selective propionate and glycolate boron-mediated aldol 
reactions. In our studies, we have proved the high selectivity and easy cleavage of the 
new thiol auxiliary 117. However, the longer length of its synthetic route (five or six 
steps) compared with the Abiko-Masamune auxiliary (2 steps), together with its failure 
to give syn-propionate aldols, could be a limitation for its use in synthesis. Therefore, 
the development of alternative highly selective auxiliaries for syn and anti propionate 
and glycolate aldol reactions, that could be prepared in fewer steps, would be of high 
interest. Different auxiliaries derived from norephedrine or ephedrine (R' = Me) have 
been investigated by Abiko33 leading to the development of the Abiko-Masamune 
auxiliary 232, and therefore similar studies could also be undertaken with its thiol 
derivative 117 (figure 29). 
Ph 	 Ph 	 Ph 
Me HX 	,Me 	R1  Me, Bn. 
HO 	 HS 	 R2 = Bn, S02T0I, S02Mes, S02TIP, S020HA. 
BnSO2Mes 	Bn' 'SO2Mes 	R1R2 
232 	 117 	 233 
X =0, S 
Figure 29: Abiko-Masamune auxiliary 232, thiol auxiliary 117 and their possible alternatives (233, X = 
0,S). 
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CHAPTER 6: EXPERIMENTAL PROCEDURES 
6.1 GENERAL EXPERIMENTAL 
'H nuclear magnetic resonance (NMR) spectra were recorded using an internal 
deuterium lock for the indicated reference at ambient probe temperatures on Varian 
Gemini 200 (200 MHz), Bruker AC250 (250MHz), Bruker DPX360 (360MHz) Fourier 
transform instruments. The data are presented as follows: chemical shift (in ppm on the 
(5 scale relative to 6TMS = 0), integration, multiplicity, (s = singlet, d = doublet, t = triplet, 
q = quartet, in = multiplet, br = broad), coupling constant and the interpretation. 1 3  C 
NMR spectra were recorded using an internal deuterium lock for the indicated reference 
at ambient probe temperatures on Varian Gemini 200 (50.3 MHz), Bruker AC250 (62.9 
MHz) or Bruker AM360 (90.6 MHz) instruments and are reported in ppm on the 6 
scale. Where Distortionless Enhancement Polarisation Transfer (DEPT) spectra have 
been reported, the carbon signals due to methyl (CH3), methylene (CH2), methine (CH) 
and quaternary carbon (C) are assigned. 
Infra-red spectra were recorded on a Perkin Elmer Paragon 1000 FT-JR 
instrument using 5 mm sodium chloride plates, or 0.1 mm sodium chloride solution 
cells. The wavelengths of maximum absorbance (Vmax) are quoted in cm 1 . 
Electron impact (El) and electrospray mass spectrometries were carried out on a 
Thermo MAT 900 XP mass spectrometer. Fast atom bombardment was performed on a 
Kratos MS50TC. The parent ion or fragment of highest mass is quoted, followed by 
significant fragments with relative intensities. Fast atom bombardment (FAB) mass 
spectra were performed on a Kratos MS50TC mass spectrometer. The parent ion or 
relevant fragments are quoted, followed by significant fragments and their relative 
intensities. Elemental analysis was carried out on a Perkin Elmer 2400 C1-[N Elemental 
analyser by the service at the University of St. Andrews. 
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Optical rotations were measured on an AA-1000 polarimeter with a path length 
of 1.0 dm at the sodium D line (589 nm) and are reported as follows: [a]D,  concentration 
(c in g/100 ml), and solvent. All optical rotations were measured at room temperature. 
Melting points were determined on a Gallenkamp Electrothermal melting point 
apparatus and are uncorrected. TLC was performed on Merck 60F254 (0.25 mm) glass 
silica plates and visualised by ultraviolet (UV) light and/or ammonium molybdate stain. 
Flash column chromatography was carried out on Merck Kieselgel 60 (Merck 9385) 
under positive pressure by means of an air line or hand pump. Eluent compositions are 
quoted as v/v ratios. High performance liquid chromatography (HPLC) was carried out 
on a Gilson instrument using a Spherisorb column (internal diameter: 20 mm) and 
equipped with a Gilson refractive index detector. All solvents to be used for HPLC 
analysis were vacuum filtered and degassed prior to use. All HPLC samples were 
filtered through 0.45 pm nylon syringe filters prior to analysis. 
Reagents were purified by standard means. Dichioromethane (CH2C12), toluene, 
hexane, triethylamine (Et3N), diisopropylethylamine (DIPEA), pyridine and 2,6-lutidine 
were distilled from calcium hydride and stored over calcium hydride under a nitrogen 
atmosphere. The aldehydes acrolein, methacrolein, isobutyraldehyde and 
isovaleraldehyde were freshly distilled from calcium chloride immediately prior to use. 
Benzaldehyde was distilled from calcium hydride. Tetrahydrofuran (THF) was distilled 
from sodium metal/benzophenone ketyl and stored under nitrogen atmosphere. All other 
reagents were used as supplied except where otherwise stated in the experimental text. 
Saturated aqueous solutions of inorganic salts are represented as: (volume, sat.). 
All experiments were performed in an inert atmosphere of nitrogen or argon 
under anhydrous conditions using oven dried apparatus cooled in a desiccator or flame 
dried under nitrogen prior to use. Standard techniques for the handling of air-sensitive 
materials were employed. 
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An oven-dried, 100 ml, round-bottomed flask capped with septum was charged with 
freshly distilled cyclohexene (7.0 ml, 0.07 mmol) and dry Et20 (20 ml), and kept at 0 
°C under nitrogen. Borane-dimethyl sulfide complex (3.2 ml, 0.03 mmol) was added 
dropwise over 10 min with stirring. The reaction mixture was stirred for 3 h at 0 °C and 
then the solid was allowed to settle without stirring. The supernatant organic solution 
was removed as much as possible by syringe, and the residual solid was dried under 
reduced pressure (vacuum line) to give dicyclohexylborane as a colourless solid. 
The solid was suspended in dry hexane (20 ml) and trifluoromethanesulfonic acid (5.0 
g, 0.03 mmol) was added dropwise via syringe over 20 min with constant stirring, 
during which time vigorous gas evolution occurred and the solid gradually dissolved. 
Stirring was continued at RT for 1 h and then the reaction mixture was left for 2 h 
without stirring. A semi-solid phase separated and the upper liquid was transferred via 
syringe into a dry, 100 ml, round-bottomed storage flask. 
The solution was cooled to - 20 °C overnight, the hexane layer removed from the 
crystalline triflate and a stock solution 1.0 M of dicyclohexylboron 
trifluoromethanesulfonate in hexane was prepared. 
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Synthesis of Dicyclohexylboron Chloride 
To a cooled (20 °C, water bath) stirred solution of freshly distilled cyclohexene (10.6 
ml, 105 mmol) in dry Et20 (20 ml) was added monochioroborane-methyl sulfide 
complex (5.2 ml, 50 rnmol) dropwise. The reaction mixture was stirred for 2 h at 20 °C, 
and then the solvent was removed under reduced pressure (vacuum line), to give the 
chloroborane-methyl sulfide complex as a white solid. Distillation under reduced 
pressure gave dicyclohexylboron chloride as a colourless oil. The chioroborane could be 
stored in the freezer (- 20 °C) for several weeks without significant loss in activity. (Bp 
98-104 °C, 1.0 mmHg). 
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33 
(lS,2R)2(N_MeSitY1enesthf0nY1amih0)4 -phenylpropafl-1 -ol 119 
To a stirred solution of (is, 2R)(+)-norephedrifle (21.0 g, 139 mmol) and Et3
N (20.0 
ml, 143 mmol) in dry CI-12
C12 (300 ml) was added mesitylenesulfonYl chloride (31.0 g, 
142 mmol) at 0 °C. The reaction was stirred at 0 °C for 2 h. The reaction mixture was 
diluted with Et20 (400 ml) and was washed with H
20 (2 x 200 ml), HC1 (2 x 200 ml, 1 
N aq), H2
0 (2 x 200 ml), NaHCO3 (2 x 200 ml, sat aq) and NaCI (2 x 200 ml, sat aq). 
The organics were dried (MgSO4) and the volatiles removed under reduced pressure to 
give the sulfonamide 119 as a colourless solid which was recrystallised from 
CH202/hexane (44.0 g, 95%); Rf 
 (25% EtOAc in hexane) = 0.24; mp 120-121 °C 
(CH2C17/heXafle), lit.33  120.5-121.5 °C; [UID 
= 12.7 (c 1.10, CHC13), lit- 33 12.8 (c 2.12, 
CHC13); Vmax (nujol)/cm' 3500 (OH), 3295 	
H), 1377 (SO2N), 1155 (SO2N); 'H 
NMR 6 (250 MHz, CDC13) 7.30-7.12 (514, in, Arm, 6.90 (2H, s, Arm, 4.90 (11-1, hr d, 
J 
= 9.1 Hz, Ch), 4.70 (1H, d, J = 3.2 Hz, N, 3.45 (1H, dqd, 
J = 9.1, 6.8 & 3.2 Hz, 
CHCH3), 2.60 (614, s, o-CH3), 2.24 (3H, s, p-CH3), 
0.80 (3H, d, J = 6.8 Hz, CH3CH); 
'3C NMR 6 (62.9 MHz, CDCI3
) 141.66 (C), 139.66 (C), 138.26 (2 x C), 133.68 (C), 
131.40 (2 x CH), 127.72 (2 x CH), 127.05 (CH), 125.37 (2 x CH), 75.01 (CH), 53.94 
(CH), 22.35 (2 x CH3), 20.30 (CH3), 14.02 (CH3); nilz 
(FAB, THIOG) 334 ([M+H], 56 
%), 316 (87), 183 (64), 134 (75), 119 (100), 91(80), 77 (67); HRMS 
(FAB, THIOG) 
[M+H] found 334.1472, C18H24NO3
S requires 334.1476. Found: C, 64.4; H, 7.18; N, 
4.04. C,8H23NO3S requires: C, 64.8; H, 6.95; N, 4.20. 
spectroscopic data in good agreement with the literature. 33 
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(1S,2R)-1 	
f0nytamifl0)-1 pheny1prOpafle 120 
To sulfonamide 119 
(42.0 g, 126 mmol) was added thionyl chloride (30.0 ml, 411 
mmol) and the reaction was stirred at RT for 15 h. The excess thionyl chloride was 
removed under reduced pressure to give the crude chloride as a brown oil. Trituration 
using Et20/hexane gave chioropropane 120 as a colourless solid (42.1 g, 95%); 
R1 (20% 
EtOAc in hexane) = 0.44; mp 137-138 °C; [c10 = 27.2 (c 1.10, CHC1
3); Vrnax (nujol)/cni 
3295 H), 1377 (SON, 1151 (S02N), 723 (CC!); 1 H NMR 
ö (360 MHz, CDC13) 
7.43-7.27 (5H, m, Arm, 7.04 (2H, s, Arm, 5.05 (1H, d, J = 
3.2 Hz, N, 4.96 (1H, br 
d, J = 9.5 Hz, CIh), 3.77 (1H, dqd, J = 
9.5, 6.6 & 3.2 Hz, CHCH3), 2.74 (6H, s, 2 x  o-
CH3), 2.37 (3H, s,p-CH3), 1.14 (3H, d, J = 6.6 Hz, 
CHCH3); '3C NMR 6 (90.5 MHz, 
CDC13) 142.29 (C), 138.78 (2 x C), 137.38 (C), 134.31 (C), 131.96 (2 x CH). 128.37 (2 
x CH), 128.18 (CH), 126.97 (2 x CH), 67.89 (CH), 54.94 (CH), 22.86 (2 x CH3), 20.81 
(CH3), 15.01 (CH3); m/z (FAB, THIOG) 352 ([M+H]
+, 80%), 316 (73), 183 (68), 119 
(100), 91 (84), 77 (71); HRMS (FAB, THIOG) [M+H]
+  found 352.1136, 
C18H23C1NO2S requires 352.1138. Found: C, 61.2; H, 6.30; N, 3.73. C
18H22CIN02S 




Method A: To a solution of chloride 120 (35.0 g, 100 mmol) in DMF (150 ml) was 
added potassium tert-butoxide (13.5 g, 120 mmol) at 0 °C. The reaction mixture was 
stirred at 0 °C for 30 min and the reaction was stirred for a further 18 h at RT. NaCl 
(300 ml, sat aq) was added and the mixture was extracted with Et20 (3 
x 200 ml). The 
organics were combined and dried (MgSO4) and volatiles were removed under reduced 
pressure to give a solid residue which was recrystallised from hexane to give the 
aziridine 121 as a colourless solid (29.0 g, 92%). 
Method B: To (N
ylpropan-1-Ol 119 (2.0 g, 
6.0 mmol) was added Et3N (20 ml) at 0 °C. Methanesulfoflyl chloride (1.0 ml, 13 mmol) 
was added dropwise with vigorous stirring. A pale yellow precipitate resulted upon 
addition. The reaction mixture was stirred at 0 °C for 10 min and then at RT for 14 h. 
NaCl (20 ml, sat aq) was added and the mixture was extracted with EtOAc (3 
x 20 ml) 
and washed with NaCI (3 x 20 ml, sat aq). The organics were combined and dried 
(MgSO4) and the volatiles removed under reduced pressure to give the aziridine 121 as 
a colourless solid which was recrystallised from hexane (1.60 g, 85%); Rf (20% EtOAc 
in hexane) = 0.65; mp 77-78 °C (hexane); LUID 
= - 31.8 (c 1.10, CHC13), Vmax (nujol) / 
cm-' 1234 (SO2N); 1H NMR 6 (360 MHz, CDC13) 
7.58-7.46 (3H, in, An]), 7.45-7.35 
(2H, in, Arm, 7.17 (2H, s, Arm, 4.07 (1H, d, J = 4.2 Hz, CHPh), 3.13 (1H, qd, 
J= 5.9 
& 4.2 Hz, CHCH3), 2.97 (6H, s, o-CH3), 2.52 (3H, s, 
p-CH3), 2.10 (3H, d, J = 5.9 Hz, 
CHCH3); 13C NMR 6 (90.5 MHz, CDC13) 142.40 (C), 139.31 (2 
x C), 136.03 (C), 
134.92 (C), 131.58 (2 x CH), 128.36 (2 x 
CH), 127.80 (CH), 126.07 (2 x CH), 48.82 
(CH), 48.63 (CH), 22.86 (2 x  CH3), 20.82 (CH3), 14.21 (CH3
); m/z (FAB, THIOG) 316 
([M+H] , 93%), 314 (13), 183 (22), 167 (10), 165 (7); HRMS (FAB, THIOG) [M+H] 
found 316.1372, C18H22NO2S requires 316.1371. Found: C, 68.4; H, 6.62; N, 4.17. 
C18H21NO2S requires: C, 68.5; H, 6.71; N, 4.44. 
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To a stirred solution of aziridine 121 (25.0 g, 79.4 mmol) and thiolbenzoic acid (11.6 g, 
84.0 mmol) in MeCN (60 ml) was added tributyiphosphine (2.10 ml, 8.40 mmol) 
followed by H20 (50 ml) under nitrogen, and the resulting mixture was stirred at RT for 
18 h. The mixture was extracted with CH202 (3 x  50 ml), washed with NaCl (2 x  50 
ml, sat aq) and dried (MgSO4). The organics were removed under reduced pressure to 
give the crude thiolbenzoate. Purification by flash chromatography (20% EtOAc in 
hexane) gave the thiolbenzoate ester 122 as a colourless solid (32.7 g, 91%); Rf (20% 
EtOAc in hexane) = 0.42; mp 101-102 °C; [aID 113 (c 1.10, CHC13); Vmax (nujol) / cm1  
3288 (NH), 1659 (C=O), 1234 (SO2N), 1159 (S02N); 1H NMR 6 (360 MHz, CDC13) 
7.94 (2H, d, J = 7.2 Hz, ArIf), 7.70 (1H, t, J = 7.4 Hz, ArH), 7.55 (2H, t, .1= 6.5 Hz, 
ArH), 7.48-7.35 (5H, in , ArH), 6.97 (2H, s, ArH), 4.87 (1H, d, J = 4.2 Hz, NH), 4.75 
(1H, d. I = 9.6 Hz, CHPh), 3.97 (1H, dqd, Jr  9.6, 6.6 & 4.2 Hz, CHCH3), 2.76 (6H, s, 
2 x  o-CH3), 2.29 (3H, s, p-CH3), 1.37 (3H, d, J = 6.6 Hz, CHCH3); '3C NMR 6 (90.5 
MHz, CDC13) 189.75 (C), 143.04 (C), 139.01 (2 x  C), 136.92 (C), 136.25 (C), 133.73 
(C), 133.41 (CH), 131.78 (2 >< CH), 128.53 (4 >< CH), 128.37 (2 x  CH), 127.84 (CH), 
127.11 (2 x  CH), 53.36 (2 x  CH), 22.96 (2 x  CH3), 20.72 (CH3), 20.08 (CH3); m./z 
(FAB, THIOG) 455 ([M+H]+  , 47%), 316 (29), 255 (38), 226 (31), 183 (29); HRMS 







To a solution of thiolbenzoate ester 122 (20.0 g, 44.1 mmol) in DMF (250 ml) was 
added NaH (1.97 g, 60% dispersion in mineral oil, 49.2 mmol) at 0 °C. The reaction 
was stirred for 30 mm, benzyl bromide was added (5.66 ml, 47.6 mmol) and the 
reaction was stirred for a further 18 h at RT. NaCI (200 ml, sat aq) was added and the 
mixture was extracted with Et20 (2 x  200 ml). The organics were combined and dried 
(MgSO4) and volatiles were removed under reduced pressure to give the crude 
thiobenzoate. Recrystallisation from hexanes gave benzyl protected sulfonamide 123 as 
a colourless solid (23.7 g, 99%); Rf  (20% EtOAc in hexane) = 0.47; 
mp 60-61 °C; IUID 
71.3 (c 1.15, CHC13); Vmax (nujol) I cm-'1665 (C0), 1234 (SO
2N), 1155 (S02N); 'H 
NMR 6 (360 MHz, CDC13) 8.07 (211, d, J = 
7.1 Hz, Arm, 7.80-7.30 (9H, m, Arm, 
7.25 (211, t, J = 8.5 Hz, ArH), 7.05 (2H, s, Arm, 7.01 (2H, d, 
J = 7.0 Hz, Arm, 5.26 
(I H, d, J = 9.0 Hz, Ch), 5.07 (IH, d, J = 
16.2 Hz, CHAHBPh), 4.75 (1H, d, J = 16.2 
Hz, CHAHBPh), 4.50 (1H, qn, J 9.0 & 6.8 Hz, 
CHCH3), 2.55 (6H, s, 2 x o-CH3), 2.51 
(3H, s, p-CH3), 1.57 (311, d, J = 6.8 Hz, CHCH3); 
13C NMR 8 (90.5 MHz, CDC13) 
189.58 (C), 142.78 (C), 141.03 (2 x 
C), 140.54 (C), 138.96 (C), 136.88 (C), 134.00 
(CH), 133.31 (C), 132.59 (2 x CH), 129.17 (2 x CH), 129.02 (2 
x CH), 128.87 (2 x 
CH), 128.83 (2 x CH), 128.14 (2 x CH), 127.83 (2 
x CH), 127.75 (CH), 127.66 (CH), 
57.18 (CH), 51.93 (CH), 47.93 (CH2), 23.34 (2 x CH3), 21.35 (CH
3), 17.97 (CH3); n17z 
(FAB, NOBA) 544 ([M+H], 11%), 406 (16), 362 (10), 317 (20), 316 (51); IIRMS 






Method A: To a solution of thiolbenzoate ester 123 (15.0 g, 27.6 mrnol) in THF (100 
ml) at 0 °C was added LiA1H4  (1.20 g, 31.6 rnmol). The reaction mixture was warmed 
to RT and stirred for 2.5 h. The reaction mixture was cooled to 0 °C, Na2SO4•1OH20 
was added slowly and the reaction mixture was stirred for 1 h. The reaction mixture was 
filtered through celite and the organics removed under reduced pressure to give the 
crude thiol as an oil. Purification by flash chromatography (20% EtOAc in hexane) gave 
thiol 117 as a colourless solid (11.3 g, 93%). 
Method B: To a stirred suspension of thiolbenzoate ester 123 (1.8 g, 3.3 mmol) in 
MeOH (20 ml) was added NaOMe (5.1 ml, 1 M in MeOH, 5.1 mrnol) at RT. The 
reaction mixture was stirred at RT for 1.5 h. Cation exchange resin AG 50W-X8 in its 
hydrogen form was added and the mixture stirred for 20 min until a neutral pH was 
reached. The reaction mixture was filtered to recover the resin and the filtrate was 
concentrated under reduced pressure. Purification by flash chromatography (10% 
EtOAc in hexane) gave thiol 117 as a colourless solid (1.39 g, 96%); Rf  (10% EtOAc in 
hexane) = 0.41; Rf  (20% EtOAc in hexane) = 0.60; mp 57-58 °C; [aID 
-10.9 (c 1.10, 
CHC13); Vmax (nujol) / cm '  2558 (SH), 1376 (SO2
N), 1152 (SO2N); 'H NMR 6 (360 
MHz, CDC13) 7.60-7.25 (811, in, Arm, 7.10-7.00 (4H, in, 
	4.95 (1H, d, J= 16.2 
Hz, CHAHBPh), 4.70 (111, d, J = 16.2 Hz, CHA
HBPh), 4.45 - 4.30 (2H, in, CHCH3 & 
Ch), 2.57 (6H, s, 2 x o-CH3), 2.51 (3H, s,p-CH3), 1.97 (1H, d, 
J = 4.2 Hz, S, 1.53 
(3H, d, J = 6.6 Hz, CHCH3); '3C NMR 
6 (90.5 MHz, CDC13) 142.80 (C), 142.58 (C), 
140.93 (2 x  C), 138.93 (C), 133.40 (C), 132.56 (2 
x CH), 128.93 (2 x CH), 128.85 (2 x 
CH), 128.77 (2 x CH), 127.84 (CH), 127.62 (CH), 127.48 (2 x CH), 58.58 (CH), 48.83 
(CH), 48.28 (CH2), 23.34 (2 x CH3), 21.33 (CH3), 17.51 (CH
3); nilz (FAB, THIOG) 440 
([M+H], 15%), 406 (13), 317 (30), 316 (81), 91(100); HRMS (FAB, THIOG) [M+H]
+  
found 440.1725, C25H30NO2S2 requires 440.1718. 
119 
(lS,2R)2(N_BeflZY1N_mesY1e11esu1f0nY1amuhb0)4 -phenyipropyl thiolacetate 128 
0 Ph 
Bn'SO2 
To a solution of thiol 117 (200 mg, 0.456 mmol) in CH2C12  (10 ml) was added pyridine 
(89 l, 1.1 mmol) followed by acetyl chloride (80 l, 0.91 mmol) at 0 °C. The reaction 
mixture was warmed to RT and stirred for 18 h. The reaction mixture was diluted with 
Et20 (20 ml) and was washed with H2
0 (20 ml), HC1 (20 ml, I N aq), H20 (20 ml), 
NaHCO3  (20 ml, sat aq) and NaCl (20 ml, sat aq). The organics were dried (MgSO
4) 
and volatiles were removed under reduced pressure to give the crude thiolester as a 
colourless oil. Purification by flash chromatography (10% EtOAc in hexane) gave the 
thiolacetate ester 128 as a colourless oil (199 mg, 91%); Rf  10% EtOAc in hexane) = 
0.25; [aID 65.7 (c 8.05, CHCI3); V-al (neat) / cm-1 
 1696 (C0), 1603 (Ar), 1495 (Ar), 
1154 (SON; 1H NMR 6 (250 MHz, CDC13) 7.64 (2H, d, 
J = 7.6 Hz, An]), 7.49-
7.43 (311, m, Arm, 7.33 (1H, d, J = 7.3 Hz, Arm, 7.22 (2H, t, J = 
6.3 Hz, ArR), 7.01 
(2H, s, An]), 6.88 (2H, d, J = 7.1 Hz, ArH), 4.98 (1H, d, J = 
16.2 Hz, CHAHBPh), 4.97 
(1H, d, J = 9.3 Hz, CHPh), 4.65 (1H, d, J = 16.2 Hz, CH
AHBPh), 4.36 (1H, dq, J = 9.3 
& 6.8 Hz, CHCH3), 2.49 (9H, s, 2 x o-CH3 & p-CH3), 
2.39 (3H, s, CH3CO), 1.46 (3H, 
d, J = 6.8 Hz, CHCH3); 13C NMR ö (62.9 MHz, CDC13
) 193.37 (C), 142.74 (C), 140.99 
(2 x  C), 140.46 (C), 138.91 (C), 133.22 (C), 132.56 (2 
x CH), 129.19 (2 x CH), 128.87 
(2 x CH), 128.80 (2 x CH), 127.96 (2 
x CH), 127.85 (CH), 127.64 (CH), 56.87 (CH), 
52.00 (CH), 47.81 (CH2), 30.76 (CH3), 23.29 (2 
x CH3), 21.32 (CH3), 17.91 (CH3); m1z 
(FAB, THIOG) 482 ([M+H], 16%), 316 (30), 183 (15), 119 (73), 91(100), 77 (48), 75 








To a solution of thiol 117 (9.00 g, 20.5 mmol) in CH2C12 (100 ml) was added pyridine 
(2.18 ml, 27.0 mmol) followed by propionyl chloride (2.19 ml, 36.0 mmol) at 0 °C. The 
reaction mixture was warmed to RT and stirred for 18 h. The reaction mixture was 
diluted with Et20 (300 ml) and was washed with H20 (200 ml), HC1 (200 ml, 1 N aq), 
H20 (200 ml), NaHCO3 (200 ml, sat aq) and NaCl (200 ml, sat aq). The organics were 
dried (MgSO4) and volatiles were removed under reduced pressure to give the crude 
thiolester as a colourless oil. Purification by flash chromatography (20% EtOAc in 
hexane) gave the thiolpropionate ester 131 as a colourless solid (9.39 g, 93%); Rf (20% 
EtOAc in hexane) = 0.56; mp 60-61 °C; Ia]D 71.3 (c 1.15, CHCI3); Vflax (neat) / cm 1  
1697 (C=O), 1375 (S02N), 1147 (S02N); 'H NMR 6 (360 MHz, CDC13) 7.30 (2H, d, J 
= 7.6 Hz, An]), 7.20 - 7.06 (3H, m, ArT]'), 7.00 (1H, t, J = 7.4 Hz, ArIf), 6.87 (2H, t, J 
= 6.3 Hz, An]), 6.69 (2H, s, ArIf), 6.55 (2H, d, J = 7.0 Hz, An]), 4.65 (1H, d, J= 16.2 
i-Iz, CHAHBPh), 4.64 (1H, d, J- 9.2 Hz, CHPh), 4.31 (1H, d, J = 16.2 Hz, CH AHBPh), 
4.01 (1H, dq, J = 9.2 & 6.8 Hz, CHCH3), 2.32 (2H, q, J= 7.5 Hz, CH2CH3), 2.16 (3H, 
s,p-CH3), 2.15 (6H, s, 2 x  o-CH3), 1.14 (3H, d, J = 6.8 Hz, CHCH3), 0.95 (3H, t, J 
7.5 Hz, CH2CH3); '3C NMR 6 (90.5 MHz, CDC13) 197.83 (C), 142.72 (C), 141.00 (2 
C), 140.56 (C), 138.93 (C), 133.21 (C), 132.54 (2 x  CH), 129.15 (2 x  CH), 128.85 (4 x 
CH), 127.94 (2 x  CH), 127.81 (CH), 127.58 (CH), 56.96 (CH), 51.51 (CH), 47.79 
(CH2), 37.63 (CH2), 23.29 (2 >< CH3), 21.32 (CH3), 17.86 (CH3), 9.82 (CH3); m/z (FAB, 
THIOG) 496 ([M+H]', 8%), 406 (24), 316 (54), 207 (53), 91(100); HR1VIS (FAB, 
NOBA) [M+H]" found 496.1985, C28H34NO3S2 requires 496.1980. Found: C, 67.9; H, 





To a stirred solution of aziridine 121 (2.0 g, 6.3 mmol) and thiolacetic acid (0.52 ml, 6.9 
mmol) in MeCN (15 ml) was added tributyiphosphifle (0.16 ml, 0.63 mmol) followed 
by H20 (10 ml) under nitrogen, and the resulting mixture was stirred at RT for 18 h. 
The mixture was extracted with EtOAc (3 x 30 ml), washed with NaCl (2 
x 30 ml, sat 
aq) and dried (MgSO4). The organics were removed under reduced pressure to give the 
crude thiolacetate. Purification by flash chromatography (20% EtOAc in hexane) gave 
the thiolacetate ester 132 as a colourless oil (1.7 g, 68%); Rf  (20% EtOAc in hexane) = 
0.38; [aID 195 (c 1.0, CHC13); VmaX (neat) I cm-
'3270 (NH), 1693 (C0), 1603 (Ar), 
1493 (Ar), 1155 (SON; 'HNMR 6 (250 MHz, CDCI3
) 7.21-7.11 (314, m, ArII), 7.10-
7.02 (2H, m, Arm, 6.85 (2H, s, Arm, 4.72 (1H, d, J= 
9.4 Hz, Ch), 4.46 (111, d, J= 
4.9 Hz, N, 3.60 (1 H, dqd, J— 9.4, 6.6 & 4.9 Hz, CHCH3), 
2.51 (6H, s, o-CH3), 2.21 
(3H, s,p-CH3), 2.19 (3H, s, CH3CO), 1.07 (3H, d, 
J = 6.6 Hz, CH3CH); '3C NMR 
(62.9 MHz, CDC13) 194.30 (C), 142.49 (C), 139.56 (2 
x C), 137.77 (C), 134.44 (C), 
132.31 (2 x CH), 128.98 (2 x CH), 128.80 (2 
x CH), 128.19 (CH), 53.93 (CH), 53.70 
(CH), 30.74 (CH3), 23.41 (2 x CH3), 21.28 (CH3), 20.11 (CH
3); m/z (FAB, THIOG) 392 
([M+H]t 39%), 316 (33), 183 (48), 119 (100), 77 (35), 43 (81); HRMS (FAB, 3-









To a solution of thiolacetate ester 132 (1.36 g. 3.48 mmol) in DMF (20 ml) was added 
NaH (153 mg, 60% dispersion in mineral oil, 3.83 mmol) at 0 °C. The reaction was 
stirred for 30 mm, benzyl bromide was added (0.46 ml, 3.8 mmol) and the reaction was 
stirred for a further 18 h at RT. NaCI (30 ml, sat aq) was added and the mixture was 
extracted with Et20 (3 x 30 ml). The organics were combined and dried (MgSO
4) and 
volatiles were removed under reduced pressure to give a crude oil. Purification by flash 
chromatography (10% EtOAc in hexane) gave 133 as a colourless oil (1.57 g, 94%); Ri 
(10% EtOAc in hexane) = 0.33; Ialü 5.6 (c 2.3, CHC13); Vmax (neat) / cm-1 
 1691 (C0), 
1602 (Ar), 1493 (Ar); 'H NMR ö (250 MHz, CDCI3
) 7.25-7.06 (IOH, in, ArII), 7.05 
(2H, s, Arm, 4.47 (1H, d, J = 10.2 Hz, Ch), 3.75 (1H, dq, 
J = 10.2 & 6.6 Hz, 
CHCH3), 3.43 (1H, d, J = 13.0 Hz, CHAHBPh), 3.35 (1H, d, 
J = 13.0 Hz, CHAHBPh), 
2.43 (6H, s, o-CH3), 2.35 (3H, s, CH3CO), 2.19 (3H, 
s, p-CH3), 1.41 (3H, d, J= 6.6 Hz, 
CH3CH); '3C NMR ö (62.9 MHz, CDC13
) 172.13 (C), 144.39 (C), 140.47 (2 x C), 
139.51 (C), 137.99 (C), 132.97 (2 x CH), 132.54 (C), 129.70 (2 x CH), 129.49 (2 x 
CH), 129.30 (2 x CH), 128.55 (2 x CH), 127.95 (CH), 127.44 (CH), 59.91 (CH), 53.68 
(CH), 36.71 (CH2), 28.33 (CH3), 23.13 (2 x CH3), 21.34 (CH
3), 17.64 (CH3); m/z (FAB, 
THIOG) 482 ([M+H], 6%), 119 (90), 91(100), 79 (70), 77 (67), 43 (85); HRMS 
(FAB, 3-NOBA) [M+Hf found 482.1823, C27H32NO3S2 requires 482.1824. 
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General procedure A: Synthesis of Anti Propionate Aldol Adducts 
To a stirred solution of thiolpropionate ester 131 (200 mg, 0.404 mmol) in solvent (20 
ml) at - 78 °C was added boron triflate or chloride (0.81 mmol) then amine base (1,2 
mmol). The reaction mixture was stirred at - 78 °C for 2 h, then aldehyde was added 
(1.2 mmol). The reaction was stirred at —78 °C for 1.5 h and warmed to 0 °C for 1 h. 
The mixture was quenched by the addition of pH 7 buffer and methanol (1:1, 4 ml) and 
diluted with methanol (6 ml) to make a homogeneous solution. After careful addition of 
H202  (30% aq, 2 ml) the mixture was stirred at RT for 1 h. 
NaCl (30 ml, sat aq) was added and the mixture was extracted with CH202 (3 x 20 ml). 
The combined organics were washed with NaHCO3 (30 ml, sat aq) and NaCl (30 ml, sat 
aq), dried (MgSO4) and concentrated under reduced pressure to give the crude aldol 
product. Purification by flash chromatography (20% EtOAc in hexane) gave a mixture 
Of diastereoisomerS that was separated by HPLC. 
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2' -(N-Benzyl-N-mesitylenesulfonylamino)-1 '-phenylpropyl (1 'S,2S,2 'R,3R)-2,4-
dimethyl-3-hydroxythiolpent-4-eneoate 137a 








General procedure A was followed with thiolpropionate ester 131 (200 mg, 0.404 
rnmol), dibutylboron triflate (1.0 M in hexane, 0.81 ml, 0.81 mmol), 
diisopropylethylamine (0.21 ml, 1.2 mmol) and methacrolein (0.11 ml, 1.2 mmol). 
Purification by flash chromatography (20% EtOAc in hexane) gave a mixture of 
di astereo isomers 137a and 138a that was separated by HPLC (199 mg, 87%)(ds cwt,:anhi 
79 :21, ds anli:syn = 99: 1). 
(2S,3R)-Major diastereoisomer 137a: HPLC R (10% EtOAc in hexane, flow rate: 5 
ml/min) = 71 mm; Rf (20% EtOAc in hexane) = 0.35; Ialn= + 77 (c 5.0, CHC13); Vmax 
(neat)/cm' 3512 (OH), 1683 (C=O), 1153 (S02N), 958 (CH2CH); 'H NMR 6 (250 
MHz, CDC13) 7.65 (2H, d, J= 7.5 Hz, ArII), 7.55 - 7.42 (3H, in, An]), 7.35 (1H, t, J= 
7.4 Hz, Ar!]), 7.23 (2H, t, J = 7.7 Hz, An]), 7.03 (2H, s, An]), 6.85 (2H, d, J= 7.1 Hz, 
AnTI), 5.12 (1H, br s, CCH3=CHC HD), 5.09 (1H, br s, CCH3=CHC HD), 5.02 (1H, d, 1= 
8.9 Hz, CHPh), 4.99 (IH, d, I = 16.3 Hz, CHAHBPh), 4.68 (1H, d, I = 16.3 Hz, 
CHAHBPh), 4.42 - 4.30 (2H, in, CHOH & C(2')HCH3), 2.96 (1H, dq qn, I = 7. 1, 
CHCH3), 2.51 (6H, s, 2 x  o-CH3), 2.50 (3H, s,p-CH3), 1.89 (3H, s, CCH3=CH2), 1.49 
(3H, d, J= 6.8 Hz, CHCH3), 1.17 (3H, d, J = 7.1 Hz, CHCH3); '3C NMR 6 (90.5 MHz, 
CDC13) 200.99 (C), 144.49 (C), 142.70 (C), 140.97 (2 x  C), 140.15 (C), 138.90 (C), 
133.25 (C), 132.51 (2 x  CH), 129.11 (2 x  CH), 128.83 (2 x  CH), 128.73 (2 x  CH), 
127.91 (2 x  CH), 127.74 (CH), 127.60 (CH), 114.74 (CH2), 78.73 (CH), 57.26 (CH), 
51.77 (CH), 51.58 (CH), 47.69 (CH2), 23.28 (2 x  CH3), 21.29 (CH3), 17.58 (CH3), 
17.19 (CH3), 15.24 (CH3); m/z (FAB, THIOG) 566 ([M+H], 99%), 492 (12), 406 (57), 
384 (52), 316 (75), 183 (56), 91 (100); HRMS (FAB, THIOG) [M+H] found 
566.2410, C32H40NO4S2 requires 566.2399. 
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(2R,3S)-Minor diastereoisomer 138a: HPLC R (10% EtOAc in hexane, flow rate: 5 
ml/min) = 84 mm; R f (20% EtOAc in hexane) = 0.31; IQ] D= + 21 (c 0.65, CHC1
3 ); Vma 
(neat)/cm-1  3511 (OH), 1687 (C0), 1153 (SON, 958 (CH2CH); 
'H NMR S (250 
MHz, CDC13) 7.53, (2H, d, J = 7.6 Hz, ArH), 7.43 - 7.30 (3H, m, ArH), 7.23 (IH, t, 
J= 
7.4 Hz, ArH), 7.11 (2H, t, J = 6.3 Hz, ArH), 6.92 (2H, s, ArH), 6.79 (2H, d, 
J 7.1 Hz, 
ArH), 4.96 (IH, br s, CHCHD), 4.93 (1H, br s, =CHCHD), 4.90 (IH, d, J = 9.0 Hz, 
CHPh), 4.89 (1H, d, J = 16.3 Hz, CHAHBPh), 4.55 (1H, d, J = 
16.3 Hz, CHAHBPh), 4.34 
-4.18 (2H, rn, CHOH & CHCH3), 2.83 (1H, dq qn, J = 7. 1, CHCH3), 
2.40 (9H, s, 2 x 
o-CH3 &p-CH3), 2.22 (IH, d,J4.8 Hz, OH) 1.70 (3H, s, CCH3 CH2), 
1.37 (3H, d,J 
6.8 Hz, CHCH3), 1.14 (3H, d, J = 7.1 Hz, CHCH3 ); ' 3C NMR 
5 (90.5 MHz, CDC13 ) 
200.79 (C), 144.03 (C), 142.51 (C), 140.73 (2 x C), 139.80 (C), 138.62 (C), 133.01 (C), 
32.30 (2 x CH), 128.80 (2 x CH), 128.56 (2 x CH), 128.54 (2 
x CH), 127.78 (2 x  CH), 
127.55 (CH), 127.36 (CH), 114.55 (CH2), 78.39 (CH), 56.84 (CH), 51.66 (CH), 
51.49 
(CH), 47.65 (CH2), 23.05 (2 x  CH3), 21.06 (CH3), 17.42 (CH3
), 16.85 (CH3), 15.24 
(CH3); m/z (FAB, THIOG) 566 
([M+H]', 42%), 406 (45), 316 (60), 289 (14), 183 (44), 
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General procedure A was followed with thiolpropionate ester 131 
(200 mg, 0.404 
mmol), dibutylboron triflate (1.0 M in hexane, 0.81 ml, 0.81 mmol), 
diisopropy!ethYlamifle (0.21 ml, 1.2 mmol) and acrolein (0.11 ml, 1.2 mmol). 
Purification by flash chromatography (20% EtOAc in hexane) gave a mixture of 
diastereoisomers 137b and 138b that was separated by HPLC 
(199 mg, 89%) (ds anti: 
anti = 76 : 24, ds anti: 	= 99 : 1). 
(2S,3R)-Major diastereoisomer 137b: HPLC Rt  (10% EtOAc in hexane, flow rate: 5 
ml/min) = 66 mm; R f  (20% EtOAc in hexane) = 0.32; [aID 
= + 72 (c 1.0, CHCI3); Vmax 
(neat)/cm' 3516 (OH), 1683 (C0), 1603 (Ar), 1495 (Ar), 1153 (SO2N), 952 (CH2CH); 
'H NMR 6 (250 MHz, CDC13) 7.58, (2H, d, J 
= 8.0 Hz, ArH), 7.43 - 7.40 (3H, m, 
Arm, 7.30 (1 H, t, J— 7.4 Hz, Arm, 7.18 (2H, t, J = 7.7 
Hz, Arm, 6.97 (2H, s, Arm, 
6.81 (2H, d, J = 7.0 Hz, An]), 6.00-5.85 (1H, ddd, J = 
17.0, 10.3 & 6.5 Hz, CH2=CH), 
5.40 (1H, dt, J 17.0 & 1.3 Hz, CHCH D), 5.32 (1 H, dt, J = 
10.3 & 1.3 Hz, CHCHD), 
4.96 (1H, d, J— 8.8 Hz, CHPh), 4.92 (1H, d, J— 16.3 Hz, CHA
HBPh), 4.63 (1H, d, J 
16.3 Hz, CH AHBPh), 4.39 - 4.23 (2H, m, CHOH & C(2')HCH3), 
2.80 (1 H, dq qn, J 
7. 1, CHCH3), 2.45 (6H, s, 2 x o-CH3), 2.44 (3H, s, 
p-CH3), 1.42 (3H, d, J = 6.8 Hz, 
CHCH3) 1.20 (3H, d, J = 7.1 Hz, CHCH3); '3C NMR 
6 (90.5 MHz, CDCI3) 200.69 (C), 
142.72 (C), 140.96 (2 x  C), 140.13 (C), 138.85 (C), 138.17 (CH), 133.25 (C), 132.51 (2 
x CH), 129.07 (2 x CH), 128.84 (2 x CH), 128.73 (2 x CH), 127.92 (2 
x CH), 127.75 
(CH), 127.63 (CH), 117.59 (CH2), 75.58 (CH), 57.21 (CH), 54.03 (CH), 51.62 (CH), 
47.73 (CH2), 23.29 (2 x CH3), 21.29 (CH3), 17.61 (CH3
), 14.87 (CH3); nilz (FAB, 3-
NOBA) 552 ([M+H]E, 96%), 406 (73), 316 (100), 289 (70), 183 (63), 145 (38), 119 




(2R,3S)-Minor diastereoisomer 138b: HPLC R (10% EtOAc in hexane, flow rate: 5 
ml/min) = 78 mm; Rf (2O% EtOAc in hexane) = 0.28; Ia]D = + 35 (c 1.2, CHC13); Vinax 
(neat)/cm' 3511 (OH), 1685 (C0), 1603 (Ar), 1495 (Ar), 1153 (SO2N), 959 (CH2CH); 
'H NMR 8 (250 MHz, CDC13) 7.35, (2H, d, J = 8.0 Hz, ArH), 7.25 - 7.15 (3H, rn, 
An]), 7.07 (1 H, t, J = 7.4 Hz, An]), 6.94 (2H, t, J = 8.1 Hz, ArH), 6.75 (2H, s, ArE), 
6.62 (2H, d,J = 7.0 Hz, ArR), 5.60 (1 H, ddd,J = 17.0, 10.3 & 6.5 Hz, CH-)=CM, 5.10 
(1H, dt, J = 17.0 & 1.3 Hz, CHCHCHD), 5.02 (1H, dt, J 
= 10.3 & 1.3 Hz, 
CH—CHcHD), 4.74 (1H, d, J = 8.9 Hz, CHPh), 4.72 (1H, d, J = 
16.3 Hz, CHAHBPh), 
4.38 (III, d, J = 16.3 Hz, CHAHBPh), 4.17 -4.00 (2H, m, CHOH & C(2')HCH3), 
2.59 
(I H, dq qn, J = 7. 1, CHCH3), 2.23 (9H, s, 2 x o-CH3 & p-CH3), 
1.20 (3H, d, J= 6.8 
Hz, CHCH3) 1.06 (3H, d, J = 7.1 Hz, CHCH3); '3C NMR ö (90.5 MHz, CDC1
3) 200.18 
(C), 142.25 (C), 140.44 (2 x C), 139.47 (C),, 138.29 (C), 137.29 (CH), 132.60 (C), 
132.01 (2 x CH), 128.50 (2 x CH), 128.34 (2 x CH), 128.29 (2 x CH), 127.44 (2 x  CH), 
127.41 (CH), 127.27 (CH), 117.05 (CH2), 74.90 (CH), 56.49 (CH), 53.43 (CH), 51.13 
(CH), 47.32 (CH2), 22.77 (2 x  CH3), 20.80 (CH3), 17.15 (CH3), 14.45 (CH3); m/z (FAB, 
3-NOBA) 552 ([M+H], 54%), 406 (49), 316 (85), 289 (53), 183 (53), 119 (82), 91 
(90); HRMS (FAB, THIOG) {M+H] found 552.2244, C31H38NO4
S2 requires 552.2242. 
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2 '-(N-Benzyl-N-mesitylenesulfonylamino)-1 '-phenyipropyl (1 'S,2S,2 'R,3S)-2,4-
dimethyl-3-hydroxy-thiolpentanoate 137c 
OH 0 Ph 
	
OH 0 Ph 
Bn'SO2 	 Bn 





Method A: General procedure A was followed with thiolpropionate ester 131 (200 
mg, 0.404 mmol), dibutylboron triflate (1.0 M in hexane, 0.81 ml, 0.81 mmol), 
diisopropylethylamine (0.21 ml, 1.2 mmol) and isobutyraldehyde (0.11 ml, 1.2 mmol). 
Purification by flash chromatography (20% EtOAc in hexane) gave a mixture of 
diastereoisomers 137c and 138c that was separated by HPLC (215 mg, 94%) (ds anti: anti 
= 81 : 19, ds anti: syn = 99 : 0. 
(2S,3S)-Major diastereoisomer 137c: HPLC R (10% EtOAc in hexane, flow rate: 5 
ml/min) = 63 mm; Rf (20% EtOAc in hexane) = 0.37; laiD = + 84 (c 4.2, CHC13); Vmax 
(neat)/cm-1 3532 (OH), 1681 (C=O), 1604 (Ar), 1495 (Ar), 1153 (S02N); 111  NMR ö 
(250 MHz, CDC13) 7.56 (2H, d, J= 7.5 Hz, An]), 7.45-7.35 (3H, m, ArT), 7.28 (1H, t, 
J = 7.4 Hz, An]), 7.16 (2H, t, J = 7.8 Hz, An]), 6.96 (2H, s, ArT!), 6.81 (2H, d, J= 7.1 
Hz, ArT!), 4.94 (1H, d, J = 9.0 Hz, CHPh), 4.92 (1H, d, J = 16.2 Hz, CHAH BPh), 4.61 
(1H, d, J= 16.2 Hz, CHAHBP11), 4.32 (111, dq, J = 9.0 & 6.8 Hz, C(2')HCH3), 3.52 (1H, 
ddd = q, J = 6.9 Hz, CHOH), 2.90 (1H, dq qn, J = 6.9 Hz, CHCH3), 2.44 (9H, s, 2 x 
o-CH3 & p-CH3), 2.26 (1H, d,J = 7.3 Hz, 01]), 1.84-176 (1H, m, CH(CH3)2), 1.43 (3H, 
d, J = 6.8 Hz, CHCH3), 1.21 (311, d, J = 7.1 Hz, CHCH3), 1.05 (3H, d, J= 6.8 Hz, 
CH(CH3)A(CH3)B), 1.01 (3H, d, J= 6.8 Hz, CH(CH3)A(CH3)B); 13C NMR ö (90.5 MHz, 
CDC13) 201.89 (C), 142.72 (C), 140.95 (2 x  C), 140.12 (C), 138.81 (C), 133.21 (C), 
132.51 (2 x  CH), 129.09 (2 x  CH), 128.84 (2 x  CH), 128.74 (2 x  CH), 127.90 (2 x  CH), 
127.78 (CH), 127.62 (CH), 78.95 (CH), 57.15 (CH), 51.72 (CH), 51.53 (CH), 47.75 
31.26 (CH), 23.28 (2 x  CH3), 21.29 (CH3), 20.17 (CH3), 17.66 (CH3), 16.53 
15.61 (CH3); ni/z (FAB, THIOG) 568 ([M+H], 99%), 406 (25), 386 (25), 316 
129 
(58), 183 (42), 119 (76), 91(100); HRMS (FAB, 3-NOBA) [M+H] found 568.2557, 
C32H42N04S2 requires 568.2555. 
(2R,3R)-Minor diastereoisomer 138c: HPLC R (10% EtOAc in hexane, flow rate: 5 
ml/min) = 72 mm; Rf  (20% EtOAc in hexane) = 0.28; [a]D = + 38 (c 2.5, CHC1
3); V-11111  
(neat)/cm-1 3533 (OH), 1681 (C0), 1153 (S02N); 'H NMR 
6 (250 MHz, CDC13) 7.54 
(2H, d, J = 7.5 Hz, ArH), 7.45-7.36 (3H, in, ArH), 7.27 (1H, t, J — 
 7.3 Hz, ArH), 7.15 
(2H, t, J— 7.4 Hz, ArII), 6.95 (2H, s, ArH), 6.81 (2H, d, J = 
7.1 Hz, ArII), 4.91 (1H, d, 
J = 8.9 Hz, CIIPh), 4.90 (1H, d, J = 16.2 Hz, CHAHBPh), 4.57 (1 H, d, 
J=z 16.2 Hz, 
CHAHBPh), 4.30 (1 H, dq, J = 8.9 & 6.8 Hz, C(2')HCH3), 
3.48 (1H, br q, I = 5.1 Hz, 
CHOH), 2.86 (1 H, dq qn, J = 7.1 Hz, CHCH3), 2.43 (6H, s, 2 
x o-CI13), 2.42 (3H, s, 
p-CH3), 2.20 (1H, br d, J= 6.6 Hz, OH), 1.71-1.63 (111, in, CH(CH3)2), 
1.39 (3H, d, J 
6.8 Hz, CHCH3), 1.30 (3H, d, I = 7.1 Hz, CHCH3), 
0.96 (3H, d, I = 6.8 Hz, 
CH(CH3)A(CH3)B), 0.92 (3H, d, 1 = 6.8 Hz, CH(CH3)A(CH3)B) '3
C NMR 6 (90.5 MHz, 
CDC13) 201.60 (C), 142.40 (C), 140.58 (2 x 
C), 139.66 (C), 138.45 (C), 132.80 (C), 
132.16 (2 x CH), 128.63 (2 x CH), 128.44 (2 x CH), 128.41 (2 
x CH), 127.59 (2 x  CH), 
.127.42 (CH), 127.24 (CH), 78.64 (CH), 56.66 (CH), 51.25 (CH), 51.24 (CH), 47.50 
30.83 (CH), 22.92 (2 x CH3), 20.94 (CH3), 19.78 (CH3), 17.27 (CH3
), 16.17 
15.56 (CH3); m/z (FAB, 3-NOBA) 568 ([M+H], 66%), 524 (22), 406 (46), 316 
(89), 289 (68), 183 (62), 161 (13), 129 (68), 119 (92), 91(100); HRMS (FAB, THIOG) 
[M+H] found 568.2552, C32H42NO4S2  requires 568.2555. 
Method B: General procedure A was followed with thiolpropionate ester 131 (1 .0 g, 
2.0 mmol), dicyclohexylboron triflate (1.0 M in hexane, 4.4 ml, 4.4 mmol), 
triethylamine (0.67 ml, 4.8 mmol) and isobutyraldehyde (0.46 ml, 5.0 mmol). The 
reaction was stirred at - 78 °C for 2 h and warmed to 0 °C for 1 h. Purification by flash 
chromatography (20% EtOAc in hexane) gave a mixture of diastereoisomers 137c and 
138c that was separated by HPLC (1.08 mg, 94%) (ds anti : anti 
= 92: 8, ds anti ;sy, = 99: 
1) 
2 	(N_13enzylN_meSitY1efleSUlf0flYhminb)1 '-phenylp ropy l (1 
'S,2S,2'R,3S)-2,5- 
dimethyl3hydrOXythi01heX0ate 137d 
OH 0 	 P Ph 	 h  
BnLSO2 	 - 	Bn ' SO2 
137d 
77 : 23 
1 38d 
General procedure A was followed with thiolpropionate ester 131 (200 mg, 0.404 
mmol), dibutylboron triflate (1.0 M in hexane, 0.81 ml, 0.81 mmol), 
diisopropylethYlamifle (0.21 ml, 1.2 mmol) and isovaleraldehyde (0.11 ml, 1.2 mmol). 
Purification by flash chromatography (20% EtOAc in hexane) gave a mixture of 
diastereoisomerS 137d and 138d that was separated by HPLC (197 mg, 84%) (ds anti: 
anti = 77 : 23, ds anti: Sy" = 99 : 1). 
(2S,3S)-Major diastereoisomer 137d: HPLC R (10% EtOAc in hexane, flow rate: 5 
ml/min) = 72 mm; Rf (2O% EtOAc in hexane) = 0.36; [UID= 
+ 70 (c 0.50, CHC13); Vma% 
(neat)/cm' 3528 (OH), 1682 (C0), 1321(SO2N), 1152 (SON; 
1 11 NMR 8 (250 MHz, 
CDC13) 7.48 (2H, d, J = 7.5 Hz, Arm, 7.40 - 7.27 (3H, in, ArH), 7.23 (1 H, t, 
J = 7.4 
Hz, ArH), 7.10 (2H, t, J = 7.7 Hz, Arm, 6.89 (2H, s, ArH), 6.74 (2H, d, J 
= 7.1 Hz, 
ArH), 4.89 (1 H, d, J = 9.0 Hz, CHPh), 4.84 (1H, d, J = 16.2 Hz, CHA
HBPh), 4.54 (1H, 
d, J= 16.2 Hz, CHAHBPh), 4.23 (1H, dq, J = 9.0 & 6.8 Hz, 
C(2')HCH3), 3.78 (1H, ddd, 
J = 9.7, 6.2 & 3.4 Hz, CHOH), 2.68 (1H, dq, J = 7.1 & 6.2 Hz, 
CHCH3), 2.37 (6H, s, 2 
x o-CH3), 2.36 (3H, s,p-CH3), 1.95-1.79 (1H, in, CH(CH3)2), 
1.40 (1H, ddd, J= 13.9, 
9.7 & 4.6 Hz, CHEHF), 1.25 (1H, ddd, J = 13.9, 9.3 & 3.4 Hz, CHEHF), 
1.36 (3H, d, J 
6.8 Hz, CHCH3), 1.16 (3H, d, J = 7.1 Hz, CHCH3), 
0.97 (3H, d, J = 6.6 Hz, 
CH(CH3)A(CH3)B), 0.93 (3H, d, J = 6.6 Hz, CH(CH3)A(CH3)B); '3
C NMR 6 (90.5 MHz, 
CDC13) 201.47 (C), 142.75 (C), 140.95 (2 x C), 140.15 (C), 138.76 (C), 133.20 (C), 
132.52(2 x CH), 129.09 (2 x CH), 128.85 (2 x CH), 128.75 (2 
x CH), 127.92 (2 x CH), 
127.80 (CH), 127.63 (CH), 72.36 (CH), 57.09 (CH), 54.82 (CH), 51.59 (CH), 47.79 
44.31 (CH2), 24.81 (CH), 23.99 (CH3), 23.28 (2 
x  CH3), 21.94 (CH3), 21.29 
17.74 (CH3), 15.02 (CH3); ,n/z (FAB, 3-NOBA) 582 ([M+H], 80%), 406 (69), 
131 
317 (93). 289 (62), 241 (83), 183 (80), 154 (100); HRMS (FAB, THIOG) [M+H] 
found 582.2713, C33H44N04S2 requires 582.2712. 
(2R,3R)-Minor diastereoisomer 138d: HPLC R (10% EtOAc in hexane, flow rate: 5 
ml/min) = 84 mm; Rf (2O% EtOAc in hexane) = 0.33; [a]D =  + 40 (c 0.20, CHCI3); Vmax 
(neat)/cm-1  3526 (OH), 1681 (C0), 1153 (S02N); 'H NMR 3 (250 MHz, CDC1
3) 7.63 
(2H, d, J 7.5 Hz, ArH), 7.55 —7.40 (3H, m, ArH), 7.34 (111, t, 
J = 7.3 Hz, An]), 7.23 
(2H, t, J 7.7 Hz, An]), 7.03 (2H, s, An]), 6.91 (211, d, J = 
7.1 Hz, ArH), 5.00 (1 H, d, 
J = 16.2 Hz, CHAHBPh), 5.00 (1 H, d, J = 8.9 Hz, CHPh), 4.65 (1 H, d, 
J = 16.2 Hz, 
CH1I HBPh), 4.35 (1 H, dq, J = 8.9 & 6.8 Hz, CHCH3), 3.86 (1H, ddd, 
J = 9.5, 5.8 & 3.5 
Hz, CHOH), 2.80 (1H, dq, J = 7.1 & 5.8 Hz, CHCH3), 2.51 (6H, s, 2 
x  o-CH3), 2.50 
(3H, s, p-CH3), 2.10-1.80 (2H, br m, OH & CH(CH3)2), 
1.45 (3H. d, J = 6.8 Hz, 
CHCH3), 1.35 (311, d, J = 7.1 Hz, CHCH3), 1.45-1.20 (2H, m, CHCH2), 
1.03 (3H, d, J= 
6.6 Hz, CH(CH3)A(CH3)B), 0.97 (3H, d, J = 6.6 Hz, CH(CH3)A(CH3)B) 
13C NMR 6 
(90.5 MHz, CDCI3) 201.01 (C), 142.26 (C), 140.41 (2 x C), 139.66 (C), 138.31 (C), 
132.65 (C), 132.03 (2 x CH), 128.44 (2 x CH), 128.29 (2 
x CH), 128.27 (2 x CH), 
127.42 (2 x CH), 127.28 (CH), 127.12 (CH), 71.89 (CH), 56.35 (CH), 54.01 (CH), 
31.21 (CH), 47.39 (CH2), 43.59 (CH2), 24.20 (CH), 23.36 (CH3), 22.80 (2 
x CHA 
21.32 (CM3), 20.81 (CH3), 17.24 (CH3), 14.70 (CH3
); m/z (FAB, 3-NOBA) 582 
([M+H], 61%), 406 (62), 316 (98), 289 (35), 241 (70), 183 (69), 119 (90), 91(99); 
HRMS (FAB, THIOG) [M+H] found 582.2716, C33H44NO4S2 
requires 582.2712. 
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2'-(N-Benzyl-N-mesitylenesulfonylamino)-1 '-phenyipropyl (1 'S,2S,2 'R,3R)-3-
hydroxy-2-methyl-3-phenylthiolpropionate 137e 
OH 0 Ph 
Bn ' S02  
137e 
OH 0 Ph 
Bn ' SO2  
82:18 	138e  
90: 10 
82 : 18 
52 : 48 
49:51 
80 : 20 
81:19 
85 : 15 
Method A: General procedure A was followed with thiolpropionate ester 131 (200 
mg, 0.404 mmol), dibutylboron triflate (1.0 M in hexane, 0.81 ml, 0.81 mmol), 
diisopropylethylamine (0.21 ml, 1.2 mmol) and benzaldehyde (0.12 ml, 1.2 mmol). 
Purification by flash chromatography (20% EtOAc in hexane) gave a mixture of 
diastereoisomers 137e and 138e that was separated by HPLC (215 mg, 88%) (ds anti: anti 
= 82 : 18, ds anti: syti = 98 :2). 
(2S,3R)-Major diastereoisomer 137e: HPLC R (10% EtOAc in hexane, flow rate: 5 
ml/min) = 78 mm; R (20% EtOAc in hexane, flow rate: 10 ml/min) = 16 mm; R1 (20% 
EtOAc in hexane) = 0.38; [aI D = + 108 (c 7.85, CHC13); Vmax (neat)/cm' 3509 (OH), 
1683 (C=O), 1603 (Ar), 1494 (Ar), 1152 (SO2N); 'H NMR ö (250 MHz, CDC13) 7.70 
(2H, d, J= 8.0 Hz, ArE), 7.63 - 7.48 (8H, in, ArH), 7.42 (1H, t, J = 7.4 Hz, ArE), 7.30 
(2H, t, J= 7.7 Hz, ArJI), 7.10 (2H, s, An]), 6.92 (2H, d, J= 7.1 Hz, ArII), 5.10 (1H, d, 
J = 8.8 Hz, CL/Ph), 5.04 (1H, d, J = 16.3 Hz, CHAHBPh), 5.01 (1H, dd, J = 8.0 & 4.7 
Hz, CHOH), 4.72 (1H, d, J = 16.3 Hz, CHAHBPh), 4.41 (1H, dq, J = 8.8 & 6.8 Hz, 
C(2')HCH3), 3.18 (1H, dq, J 8.0 & 7.1 Hz, CHCH3), 2.92 (1H, d, J= 4.7 Hz, 011), 
2.58 (6H, s,2 x  o-CH3), 2.57 (3H, s,p-CH3), 1.48 (3H, d, J= 6.8 Hz, CHCH3), 1.18 
(3H, d, J= 7.1 Hz, CHCH3); '3C NMR ö (90.5 MHz, CDC13) 200.53 (C), 142.14 (C), 
141.34 (C), 140.38 (2 x  C), 139.59 (C), 138.35 (C), 132.69 (C), 131.94 (2 x  CH), 
128.54 (2 x  CH), 128.32 (4 x  CH), 128.26 (2 x  CH), 128.15 (CH), 127.91 (2 x  CH), 
127.33 (CH), 127.17 (CH), 126.23 (2 x  CH), 76.38 (CH), 56.68 (CH), 55.29 (CH), 
133 
51.07 (CH), 47.12 (CH2), 22.70 (2 x  CH3), 20.72 (CH3), 16.93 (CH3), 14.87 (CH
3); m/z 
(FAB, THIOG) 602 ([M+H], 74%), 406 (65), 316 (70), 288 (31), 195 (43), 183 (55), 
119 (85), 91 (100); HRMS (FAB, THIOG) [M+H] found 602.2397, C
35H40N04S2 
requires 602.2399. 
(2R,3S)-Minor diastereoisomer 138e: HPLC R (10% EtOAc in hexane, flow rate: 5 
ml/min) = 96 mm; R, (20% EtOAc in hexane, flow rate: 10 ml/min) = 18 mm; R (20% 
EtOAc in hexane) = 0.34; [U]D= -6.4 (c 2.2, CHC13); vinax (neat)/cm 1  3512 (OH), 1684 
(C0), 1603 (Ar), 1494 (Ar), 1152 (SON; 'H NMR 6 (250 MHz, CDC13) 7.36 (2H, d, 
J = 7.6 Hz, ArfI), 7.30 - 7.02 (9H, in, ArR), 6.94 (2H, t, J = 
7.7 Hz, An]), 6.75 (2H, s, 
An]), 6.61 (2H, d, J = 7.1 Hz, An]), 4.76 (1H, d, J = 8.9 Hz, CHPh), 4.73 (1 H, d, 
J 
16.3 Hz, CHAHBPh), 4.66 (1H, dd, J = 8.3 & 3.7 Hz, CHOH), 4.38 (1 H, d, 
J = 16.3 Hz, 
CHAHBPh), 4.10 (1H, dq, 18.9 & 6.8 Hz, C(2')HCH3), 
2.80 (1H, dq, J = 8.3 & 7.1 
Hz, CHCH3), 2.38 (1H, br d, J = 3.7 Hz, OH), 2.23 (9H, s,2 
x o-CH3 & p-CH3), 1.19 
(3H, d, 1=6.8Hz, CHCH3), 0.85 (3H, d, J = 7.1 Hz, CHCH3); 13C NMR 6 (90.5 MHz, 
CDC13) 200.96 (C), 142.74 (C), 141.54 (C), 140.95 (2 
x C), 140.02 (C), 138.86 (C), 
133.22 (C), 132.53 (2 x CH), 129.03 (2 x CH), 128.83 (4 
x CH), 128.78 (2 x  CH), 
128.51 (CH), 128.00 (2 x CH), 127.78 (CH), 127.59 (CH), 126.89 (2 
x CH), 76.85 
(CH), 57.07 (CH), 55.91 (CH), 51.72 (CH), 47.88 (CH2), 23.28 (2 x  CH3), 21.30 (CH3), 
17.65 (CH3), 15.49 (CH3); m/z (FAB, THIOG) 602 ([M+H], 74%), 406 (65), 289 (15), 
195 (43), 183 (55), 163 (52), 119 (85), 91(100), 77 (69); m/z (FAB, THIOG) 602 
([M+H], 45%), 406 (57), 316 (63), 290 (55), 195 (30), 183 (47), 91(90); HRMS 
(FAB, THIOG) [M+H] found 602.2387, C35H40N04S2 requires 602.2399. 
Method B: General procedure A was followed with thiolpropionate ester 131 (150 
mg, 0.303 mmol), dicyclohexylboron triflate (1.0 M in hexane, 0.91 ml, 0.91 mmol) and 
diisopropylethylamine (0.13 ml, 0.76 mmol). The reaction mixture was stirred at - 78 
°C for 45 mm, then benzaldehyde was added (97 pi, 0.91 mmol). The reaction was 
stirred at - 78 °C for 2.5 h and warmed to 0 °C for 1.5 h. Purification by flash 
chromatography (20% EtOAc in hexane) gave a mixture of diastereoisomers 137e and 
138e that was separated by HPLC (157 mg, 86%) (ds anti: anti 
= 90: 10, ds anti: syn = 99 
1). 
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Method C: General procedure A was followed with thiolpropionate ester 131 (60 mg, 
0.12 mmol), 9-BBN-triflate (0.5 M in hexane, 0.72 ml, 0.36 mmol) and 
diisopropylethylamifle (53 l, 0.30 mmol). The reaction mixture was stirred at - 78 °C 
for 1 h, then benzaldehyde was added (38 t1, 0.36 mmol). The reaction was stirred at - 
78 °C for 1.5 h and warmed to 0 °C for 1 h. Purification by flash chromatography (20% 
EtOAc in hexane) gave a mixture of diastereoisomers 137e and 138e that was separated 
by HPLC (59 mg, 81%) (ds anti: anti =82: 18, ds anti 	= 84: 16). 
Method 0: A solution of diethylboron triflate was generated in situ 
by dropwise 
addition of triflic acid (55 l, 0.61 mmol) to triethylborane (1.0 M in hexane, 0.61 ml, 
0.61 mmol). The solution was stirred at RT for 20 min and then cooled to - 78 °C. A 
solution of thiolpropinate ester 131 (100 mg, 0.202 mmol) at —78 °C in CH202 (10 ml) 
was added followed by diisopropylethylamifle (87 p1, 0.61 mmol). The reaction mixture 
was stirred at - 78 °C for 30 mm, then benzaldehyde was added (65 p1, 0.61 mmol). 
The reaction was stirred at - 78 °C for 2 h and warmed to 0 °C for 1.5 h. The mixture 
was quenched and extracted as described in general procedure A. Purification by flash 
chromatography (20% EtOAc in hexane) gave a mixture of diastereoisomers 137e and 
138e that was separated by HPLC (102 mg, 84%) (ds anti: anti = 80 : 20, ds anti: syn 
= 91: 
9). 
Method E: General procedure A was followed with thiolpropionate ester 131 
(150 
mg, 0.303 mmol) in CH202  (15 ml) at 0 °C, to which was added dibutylboron triflate 
(1.0 M in hexane, 0.91 ml, 0.91 mmol) then diisopropylethylamifle (0.13 ml, 0.76 
mmol). The reaction mixture was stirred at 0 °C for 45 mm, then benzaldehyde was 
added (97 p1, 0.91 mmol). The reaction was stirred at 0 °C for 2 h. Purification by flash 
chromatography (20% EtOAc in hexane) gave a mixture of diastereoisomers 137e and 
138e that was separated by HPLC (155 mg, 85%) (ds anti: anti = 
81: 19, ds anti: syn = 94: 
6, ds syn:syn = 51 :49). 
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Method F: General procedure A was followed with thiolpropionate ester 131 (150 
mg, 0.303 mmol) in CH202  (15 ml) at 0 °C, to which was added dicyclohexylboron 
triflate (1.0 M in hexane, 0.91 ml, 0.91 mmol) then triethylamine (0.11 ml, 0.76 mmol). 
The reaction mixture was stirred at 0 °C for I h, then benzaldehyde was added (97 pi. 
0.91 mmol). The reaction was stirred at 0 °C for 1 h. Purification by flash 
chromatography (20% EtOAc in hexane) gave a mixture of diastereoisomers 137e and 
138e that was separated by HPLC (158 mg, 87%) (ds an/I   ,,i = 82 : 18, ds an/i: syn = 95 
5, ds syn: syn = 65 : 35). 
Method G: General procedure A was followed with thiolpropionate ester 131 (60 mg, 
0.12 mmol) in CH202  (6 ml) at RT, to which was added dibutylboron triflate (1.0 M in 
hexane, 0.36 ml, 0.36 mmol) then diisopropylethylamine (53 tl, 0.30 mmol). The 
reaction mixture was stirred at RT for 1 h, then benzaldehyde was added (39 il, 0.36 
mmol). The reaction was stirred at RT for 2 h. Purification by flash chromatography 
(20% EtOAc in hexane) gave a mixture of diastereoisomers 137e and 138e that was 
separated by HPLC (60 mg, 82%) (ds antI: anti = 52 : 48, ds anti : syll = 83 : 13, ds 	: syn = 
73 : 27). 
Method H: General procedure A was followed with thiolpropionate ester 131 (60 mg, 
0.12 mmol) in CH202  (6 ml) at RT, to which was added dicyclohexylboron triflate (1.0 
M in hexane, 0.36 ml, 0.36 mmol) then triethylamine (43 p1, 0.30 mmol). The reaction 
mixture was stirred at RT for 1 h, then benzaldehyde was added (39 jil, 0.36 mmol). 
The reaction was stirred at RT for 2 h. Purification by flash chromatography (20% 
EtOAc in hexane) gave a mixture of diastereoisomers 137e and 138e that was separated 
by HPLC (52 mg, 71%) (ds anti: anti = 49 : 51, ds anti: syn = 96 : 4, ds 	: syn = 99 : 1). 
Method I: General procedure A was followed with thiolpropionate ester 131 (150 mg, 
0.303 mmol) in CH202  (15 ml) at - 78 °C, to whichwas added dicyclohexylboron 
chloride (0.20 ml, 0.91 mmol) then triethylamine (0.11 ml, 0.76 mmol). The reaction 
mixture was stirred at - 78 °C for 1 h, then benzaldehyde was added (97 p1, 0.91 
mmol). The reaction was stirred at - 78 °C for 1.5 h and warmed to 0 °C for 1 h. 
Purification by flash chromatography (20% EtOAc in hexane) gave a mixture of 
diastereoisomers 137e and 138e that was separated by HPLC (168 mg, 92%) (ds anti: anti 
90: 10,ds anti: syn 	97 :3). 
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Method J: General procedure A was followed with thiolpropionate ester 131 (150 
mg, 0.303 mmol) in diethylether (15 ml) at - 78 °C, to which was added 
dicyclohexylboron chloride (0.20 ml, 0.91 mmol) then triethylamine (0.11 ml, 0.76 
mmol). The reaction mixture was stirred at - 78 °C for 1 h, then benzaldehyde was 
added (97 p1, 0.91 mmol). The reaction was stirred at - 78 °C for 1.5 h and warmed to 0 
°C for 1 h. Purification by flash chromatography (20% EtOAc in hexane) gave a 
mixture of diastereoisomers 137e and 138e that was separated by HPLC (149 mg, 82%) 
(ds anti: anti 	85 : 15, ds anti:syn = 98:2). 
137 
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General procedure A was followed with thiolpropionate ester 131 (725 mg, 1.46 
mmol), dibutylboron triflate (1.0 M in hexane, 2.94 ml, 2.94 mmol), 
diisopropylethylamifle (0.76 ml, 4.4 mmol) and piperonal (0.65 g, 4.4 mmol). 
Purification by flash chromatography (20% EtOAc in hexane) gave a mixture of 
diastereoisomerS 1371, 138f, 141f and 1421 that was separated by HPLC (755 mg, 80%) 
(ds anti: anti = 85 : 15, ds nsn = 64 : 36, ds anhi:fl = 97 : 3). 
(2S,3R)-Major anti diastereoisomer 1371: HPLC R (10% EtOAc in hexane, flow 
rate: 5 ml/min) = 63 mm; R1 (20% EtOAc in hexane) = 0.24; [a]D=  + 99 (c 1.1, CHC13); 
vmax (neat)Icm' 3467 (OH), 1682 (C0), 1154 (S02N); 'H NMR 6 (250 MHz, CDC13) 
7.35 (2H, d, J= 8.0 Hz, Arm, 7.26 -7.15 (3H, in, Arm, 7.08 (1H, t, J = 
7.4 Hz, Arm, 
6.96 (2H, t, J = 7.6 Hz, An]), 6.75 (3H, d, J = 8.4 Hz, An-I), 6.65 
(2H, s, An]), 6.58 
(2H, d, J = 7.0 Hz, ArH), 5.86 (1H, d, J = 1.4 Hz, CHCHDO), 5.85 (1H, d, 
J = 1.4 Hz, 
CHCHDO), 4.75 (1H, d, J = 8.5 Hz, CHPh), 4.64 (1H, d, J = 16.3 Hz, CHA
HBPh), 4.60 
(1H, d, J = 8.3 Hz, CHOH), 4.39 (1H, d, J = 16.3 Hz, CHAHBPh), 4.09 (1H, dq, 
J = 8.5 
& 6.7 Hz, C(2')HCH3), 2.77 (1H, dq, J = 8.3 & 7.1 Hz, CHCH3
), 2.24 (6H, s, 2 x  o-
CH3), 2.23 (3H, s,p-CH3), 1.17 (3H, d, J = 6.7 Hz, CHCH3), 
0.82 (3H, d, J = 7.1 Hz, 
CHCH3); '3C NMR 8 (90.5 MHz, CDC13) 201.05 (C), 148.28 (C), 147.77 (C), 142.73 
(C), 140.97 (2 x  C), 140.19 (C), 138.93 (C), 135.91 (C), 133.29 (C), 132.52 (2 x CH), 
138 
129.09 (2 x CH), 128.84 (2 x CH), 128.74 (2 x CH), 127.92 (2 
x CH), 127.75 (CH), 
127.62 (CH), 120.53 (CH), 108.46 (CH), 106.99 (CH), 101.49 (CH2), 76.84 (CH), 57.29 
(CH), 55.98 (CH), 51.72 (CH), 47.70 (CH2), 23.29 (2 x  CH3), 21.30 (CH3), 17.48 
(CH3), 15.45 (CH3); m/z (FAB, 3-NOBA) 644 ([M-H]+, 99%), 406 (92), 289 (54), 207 
(76), 183 (57), 119 (90), 91(100); HRMS (FAB, 3-NOBA) [M-H found 644.2141, 
C36H38N06S2 requires 644.2141. 
(2R,3S)-Minor anti diastereoisomer 138f: HPLC R1  (10% EtOAc in hexane, flow 
rate: 5 ml/min) = 68 mm; Rf  (20% EtOAc in hexane) = 0.20; [a]D= - 8,3 (c 0.60, 
CHC13); viiax (neat)/cm" 3510 (OH), 1684 (C0), 1152 (SO2N); 'H NMR 6(250 MHz, 
CDC13) 7.35 (2H, d, J— 8.0 Hz, Arf]), 7.26 - 7.15 (3H, m, ArII), 7.07 (1H, t, J= 7.4 Hz, 
ArII), 6.95 (214, t, J = 7.7 Hz, ArH), 6.76 (2H, s, ArH), 6.66-6.57 (SH, m, ArII), 5.85 
(2H, s, CH20), 4.76 (1H, d, J = 9.0 Hz, CIIPh), 4.68 (1 H, d, J = 16.3 Hz, CHA
HBPh), 
4.59 (1H, d, J= 8.5 Hz, CHOH), 4.38 (IH, d, J= 16.3 Hz, CHAHBPh), 4.10 (11-1, dq, J= 
9.0 & 6.8 Hz, C(2')HCH 3), 2.76 (1H, dq, J = 8.5 & 7.2 Hz, CHCH3), 2.23 (9H, s, 2 
x  o-
CH3 &p-CH3), 1.18 (3H, d, J = 6.8 Hz, CHCH3), 0.85 (3H, d, J = 7.2 Hz, CHCH3); 
13C 
NMR 6 (90.5 MHz, CDC13) 201.63 (C), 148.87 (C), 148.41 (C), 143.41 (C), 141.61 (2 
C), 140.61 (C), 139.50 (C), 136.15 (C), 133.79 (C), 133.19 (2 x CH), 129.68 (2 x 
CH), 129.49 (2 x CH), 129.45 (2 x CH), 128.63 (2 x CH), 128.45 (CH), 128.27 (CH), 
121.27 (CH), 109.08 (CH), 107.68 (CH), 102.12 (CH2), 77.30 (CH), 57.73 (CH), 56.62 
(CH), 52.31 (CH), 48.52 (CH2), 23.95 (2 x CH3), 21.98 (CH3), 18.29 (CH3), 16.16 
(CH3); ink (FAB, THIOG) 646 ([M+H], 10%), 464 (23), 406 (47), 316 (40), 207 (37), 
183 (31), 119 (50), 91 (72); HRMS (FAB, THIOG) [M+H]+  found 646.2297, 
C36H40N06S2 requires 646.2297. 
(2S,3S)-Major syn diastereoisomer 141f: HPLC R (10% EtOAc in hexane, flow rate: 
5 ml/min) = 74 mm; Rf (20% EtOAc in hexane) = 0.18; [U] 	+ 89 (c 0.45, CHC13); 
vmax (neat)Icm' 3465 (OH), 1682 (C=O), 1154 (SO2N); 1H NMR 6 (250 MHz, 
CDC13) 
7.35-7.28 (2H, m, ArH), 7.26 -7.15 (3H, m, ArH), 7.08 (1H, t, J = 7.4 Hz, An]), 6.94 
(2H, t, J = 7.7 Hz, ArH), 6.74 (3H, d, J = 8.4 Hz, An]), 6.62 (214, s, ArT!), 6.58 (2H, d, 
J = 7.6 Hz, Arm, 5.81 (1H, d, J = 1.4 Hz, CHCHDO), 5.80 (1H, d, 
J = 1.4 Hz, 
CHCHDO), 4.76 (1H, d, J = 5.9 Hz, CHOH), 4.64 (1H, d, J = 16.3 Hz, CHA
HBPh), 4.62 
(1H, d, J = 8.5 Hz, CHPh), 4.28 (1H, d, J = 16.3 Hz, CHAHBPh), 4.00 (1H, dq, 
J= 8.5 
& 6.9 Hz, C(2')HCH3), 2.72 (1H, dq, J = 6.8 & 5.9 Hz, CHCH3), 2.22 (3H, 
s,p-CH3), 
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2.18 (6H, s, 2 x  o-CH3), 1.03 (3H, d, J = 6.9 Hz, CHCH3), 0.97 (3H, d, J = 6.8 Hz, 
CHCH3); 13C NMR ö (90.5 MHz, CDC13) 200.99 (C), 148.69 (C), 148.16 (C), 143.45 
(C), 141.60 (2 x C), 140.80 (C), 139.51 (C), 136.22 (C), 133.77 (C), 133.19 (2 
x  CH), 
129.71 (2 x CH), 129.51 (CH), 129.41 (2 x CH), 128.50 (2 x CH), 128.46 (2 x CH), 
128.30 (CH), 120.82 (CH), 109.13 (CH), 107.77 (CH), 102.08 (CR2), 75.41 (CH), 57.53 
(CH), 56.84 (CH), 52.26 (CH), 48.37 (CR2), 23.92 (2 x  CR3), 21.98 (CR3), 18.07 
(CR3), 13.74 (CR3); m/z (FAB, THIOG) 646 ({M+R]+, 10%), 464 (31), 406 (47), 207 
(37), 183 (31), 119 (50), 91(72), 77(47); m/z (FAB, THIOG) 646 ({M-H]+, 18%), 406 
(59), 316 (54), 207 (45), 91(91); HRMS (FAB, THIOG) [M+H] found 646.2296, 
C36H40N06S2 requires 646.2297. 
(2R,3R)-Minor syn diastereoisomer 142f: HPLC R (10% EtOAc in hexane, flow 
rate: 5 ml/min) = 58 mm; Rf  (20% EtOAc in hexane) = 0.20; IUI D = - 20 (c 0.15, 
CRC13); vmax (neat)/cm' 3466 (OR), 1709 (C=O); 1 H NMR ö (250 MHz, CDC13) 7.35-
7.28 (2R, m, ArH), 7.27-7.12 (3H, m, ArH), 7.11 - 7.04 (1H, m, ArH), 6.95 (2R, t, J 
7.2 Hz, ArH), 6.75 (2H, s, An]), 6.65 (1R, s, ArH), 6.58-6.52 (4R, m, An]), 5.82 (1H, 
d, J= 1.4 Hz, CHCHDO), 5.81 (1R, d, J= 1.4 Hz, CRCHDO), 4.78 (1R, d, 
J= 4.4 Hz, 
CHOH), 4.69 (1H, d, J = 16.2 Hz, CHAHBPh), 4.68 (1H, d, J = 9.1 Hz, CHPh), 4.35 
(1R, d, J = 16.2 Hz, CHAHBPh), 4.10 (1R, dq, J = 9.1 & 6.8 Hz, C(2')HCH 3), 2.68 (1R, 
dq, J = 7.1 & 4.4 Hz, CHCH3), 2.22 (9H, s, 3 x o-CH3 & p-CH3), 1.17 (3R, d, 
J = 6.8 
Hz, CHCH3), 1.06 (3H, d, J = 7.1 Hz, CHCH3); 13C NMR ö (90.5 MHz, CDC13) 201.84 
(C), 148.54 (2 x C), 143.44 (C), 141.60 (2 x C), 140.66 (C), 139.40 (C), 135.84 (C), 
133.75 (C), 133.19 (2 x CH), 129.67 (2 x CH), 129.45 (4 x CH), 128.58 (2 
x  CH), 
128.47 (CH), 128.28 (CH), 120.33 (CH), 109.01 (CH), 107.54 (CH), 101.97 (CR2), 
74.60 (CH), 57.48 (CH), 56.21 (CH), 52.30 (CH), 48.46 (CH2), 23.94 (2 x  CH3), 21.98 
(CR3), 18.33 (CH3), 12.63 (CR3); m/z (FAB, THIOG) 646 ([M-H], 19%), 464 (13), 
406 (44), 386 (43), 316 (42), 207 (43), 183 (27), 119 (51), 91(81); HRMS (FAB, 3-
NOBA) [M+H] found 646.2300, C36H40N06S2 requires 646.2297. 
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General procedure B: Synthesis of Masamune Anti Propionate Aldol Adducts 
To a stirred solution of Masamune propionate ester ent-134 (60 mg, 0.13 mmol) in 
CH2Cl2 (6 ml) at - 78 °C was added dicyclohexylboron triflate (1.0 M in hexane, 0.29 
ml, 0.29 mmol) then triethylamine (44 1, 0.31 mmol). The reaction mixture was stirred 
at - 78 °C for 1.5 h, then benzaldehyde was added (42 p1, 0.39 mmol). The reaction was 
stirred at - 78 °C for 2 h and warmed to 0 °C for 1.5 h. The mixture was quenched by 
the addition of pH 7 buffer and methanol (1:1, 3 ml) and diluted with methanol (6 ml) to 
make a homogeneous solution. After careful addition of H202 (30%, 1.5 ml) the mixture 
was stirred at RT for 18 h. 
NaC1 (10 ml, sat aq) was added and the mixture was extracted with CH2C12 (3 x 10 ml). 
The combined organics were washed with NaHCO3 (10 ml, sat aq) and NaCl (10 ml, sat 
aq), dried (MgSO4) and concentrated under reduced pressure to give the crude aldol 
product. Purification by flash chromatography (20% EtOAc in hexane) gave a mixture 
of diastereoisomers 147e and 148e that was separated by HPLC. 
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General procedure B was followed with Masarnune propionate ester ent-134 (60 mg, 
0.13 mmol), dicyclohexylboron triflate (1.0 M in hexane, 0.29 ml, 0.29 mmol), 
triethylamine (44 tl, 0.31 mmol) and benzaldehyde (42 l, 0.39 mmol). The reaction 
was stirred at - 78 °C for 2 h and warmed to 0 °C for 1.5 h. Purification by flash 
chromatography (20% EtOAc in hexane) gave a mixture of diastereoisomers 147e and 
148e that was separated by HPLC (68 mg, 93%) (ds anti 	> 99: 1, ds anti, anti = 98 : 2). 
(2S,3R)-Major anti diastereoisomer 147e: HPLC R (15% EtOAc in hexane, flow 
rate: 10 ml/min) = 26 mm; R (20% EtOAc in hexane) = 0.29; [aI D = - 18.8 (c 1.70, 
CHC13); 'max (neat)/cm' 3510 (OH), 1740 (CO), 1603 (Ar), 1495 (Ar), 1320 (SO
2N), 
1151 (SO2N); 'H NMR 6 (250 MHz, CDC13) 7.33-7.05 (13H, m, ArII), 6.82 (21-1, s, 
ArII), 6.78-6.70 (2H, m, An]), 5.74 (1 H, d, J- 3.8 Hz, CHPh), 4.67 (1H, d, J = 16.6 
Hz, CHAHBPh), 4.63 (1H, d, J = 8.3 Hz, CHOH), 4.42 (1H, d, J = 16.6 Hz, CHA
HBPh), 
3.97 (1H, dq, T = 7.0 & 3.8 Hz, C(2')HCH3), 2.96 (1H, br s, 01]), 2.70 (1H, dq, J = 8.3 
& 7.2 Hz, CHCO), 2.43 (6H, s, o-CH3), 2.21 (311, s,p-CH3), 1.03 (3H, d, J = 7.0 Hz, 
CHCH3), 0.87 (3H, d, J = 7.2 Hz, CHCH3); 13C NMR 6 (90.5 MHz, CDC13) 175.65 (C), 
143.63 (C), 142.54 (C), 141.33 (2 x C), 139.81 (C), 139.24 (C), 134.50 (C), 133.18 (2 
x 
CH), 129.60 (2 x CH), 129.47 (2 x CH), 129.36 (2 x CH), 129.17 (CH), 128.96 (CH), 
128.67 (2 x CH), 128.17 (CH), 127.69 (2 x CH), 126.83 (2 
x CH), 79.50 (CH), 77.38 
(CH), 57.83 (CH), 49.26 (Cl2), 48.29 (CH), 23.98 (2 x CH3), 21.93 (CH3), 15.52 
(CH3), 14.24 (CH3); in/z (ESI, +) 603 ([M+NH4], 100%), 586 ([M+H], 20), 406 (67); 
HRMS (ESI, +) [M+NH4] found 603.2887, C35H43N205S requires 603.2887. 
(2R,3S)-Minor anti diastereoisomer 148e: HPLC R (15% EtOAc in hexane, flow 
rate: 10 ml/min) = 29 mm; Rf (20% EtOAc in hexane) = 0.25; 'H NMR 6 (250 MHz, 
142 
CDC13) 7.33-7.05 (13H, m, An]), 6.79 (2H, s, ArM), 6.78 - 6.73 (2H, m, ArM), 5.79 
(1H, d, J = 4.1 Hz, CHPh), 4.70 (1H, d, J = 16.6 Hz, CHAHBPh), 4.67-4.60 (11-I, rn, 
CHOH), 4.42 (1H, d, J = 16.6 Hz, CHAHBPh), 4.05 (1H, dq, J = 6.9 & 4.1 Hz, 
C(2')HCH3), 2.75 (1H, qn, J = 7.2 Hz, CHCO), 2.43 (6H, s, o-CH3), 2.20 (3H, s, p-
CH3), 1.11 (3H, d, J = 7,0 Hz, CHCH3), 0.89 (31-1, d, J = 7.2 Hz, CHCH3). 
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General procedure C: Synthesis of Masamune Syn Propionate Aldol Adducts 
To a stirred solution of Masarnune propionate ester ent-134 (150 mg, 0.320 mmol) in 
CH2Cl2  (10 ml) at —78 °C was added dibutylboron triflate (1.0 M in hexane, 0.63 ml, 
0.63 mmol) then diisopropylethylarnine (0.17 ml, 0.96 mmol). The reaction mixture was 
stirred at - 78 °C for 2 h, then aldehyde was added (0.47 mmol). The reaction was 
stirred at - 78 °C for 1.5 h and warmed to 0 °C for 1 h. The mixture was quenched by 
the addition of pH 7 buffer and methanol (1:1, 4 ml) and diluted with methanol (6 ml) to 
make a homogeneous solution. After careful addition of H202 (30%, 2 ml) the mixture 
was stirred at RT for 18 h. 
NaCl (30 ml, sat aq) was added and the mixture was extracted with CH2C12 (3 x 20 ml). 
The combined organics were washed with NaHCO3  (30 ml, sat aq) and NaCl (30 ml, sat 
aq), dried (MgSO4) and concentrated under reduced pressure to give the crude aldol 
product. Purification by flash chromatography (20% EtOAc in hexane) gave a mixture 
of diastereomeric aldol adducts. 
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General procedure C was followed with Masamune propionate ester ent-134 (150 mg, 
0.320 mmol), dibutylboron triflate (1.0 M in hexane, 0.63 ml, 0.63 mmol), 
diisopropylethylamine (0.17 ml, 0.96 mmol) and isobutyraldehyde (43 p1, 0.47 mmol). 
Purification by flash chromatography (20% EtOAc in hexane) gave a mixture of 
diastereoisomers 149c and 150c (142 mg, 82%) (ds 	anti = 94 : 6). 
(2S,3R)-Major diastereoisomer 149c: R f (20% EtOAc in hexane) = 0.32; laiD = - 10 (c 
0.70, CHC13 ); Vmax (neat)/cm' 3533 (OH), 1736 (CO), 1153 (SO2N); 'H NMR 6 (250 
MHz, CDCI3) 7.30-7.12 (8H, m, An]), 7.00-6.90 (2H, m, ArH), 6.85 (2H, s, ArJI), 5.88 
(1H, d, J= 3.7 Hz, CHPh), 4.70 (1H, d, J = 16.7 Hz, CHAH BPh), 4.60 (1H, d, J= 16.7 
Hz, CHAHBPh), 4.06 (1H, qd, J= 7.0 and 3.7 Hz, C(2')HCH3), 3.38 (1H, dd, J= 8.5 & 
3.0 Hz, CHOH), 2.50 (6H, s, o-CH3), 2.40 (1H, qd, J= 7.2 & 3.0 Hz, CHCO), 2.24 (3H, 
s,p-CH3), 1.56-1.52 (1H, m, (CH3)2C11), 1.14 (3H, d, J= 7.0 Hz, CH3CHN), 1.10 (3H, 
d, J= 7.2 Hz, CH3CHCO), 0.93 (3H, d, J= 6.6 Hz, (CH3)2CH), 0.77 (3H, d, J= 6.6 Hz, 
(CH02CH); 13C NMR 6 (90.5 MHz, CDC13) 175.93 (C), 143.62 (C), 141.22 (2 x  C), 
139.54 (C), 139.35 (C), 134.34 (C), 133.18 (2 x  CH), 129.48 (4 x  CH), 128.99 (CH), 
128.13 (3 x  CH), 126.88 (2 x  CH), 79.45 (CH), 77.25 (CH), 57.86 (CH), 49.23 (CH2), 
42.60 (CH), 31.36 (CH), 24.04 (2 x  CH3), 21.90 (CH3), 20.16 (CH3), 19.91 (CH3), 
13.68 (CH3), 10.45 (CH3); m./z (FAB, 3-NOBA) 552 ([M+H], 15%), 406 (82), 316 
(76), 183 (18), 119 (81), 91(100); FIRMS (FAB, THIOG) [M+H] found 552.2784, 
C32H42N05S requires 552.2784. 
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(2S,3S)-Minor diastereoisomer 150c: R1(20% EtOAc in hexane) = 0.43; [u]D= -20 (c 
0.20, CHCI3); Vinax (neat)/cm' 3539 (OH), 1737 (CO), 1152 (S02N); 'H NMR ö (250 
MHz, CDC13) 7.40-7.20 (8H, m, ArII), 6.97-6.87 (4H, m, An]), 5.89 (1 H, d,J= 4.4 Hz, 
CHPh), 4.87 (1H, d, JA-B = 16.5 Hz, CHAHBPh), 4.63 (1H, d, JAB = 16.5 Hz, 
CHAHBPh), 4.20 (1H, qd, J 7.0 & 4.4 Hz, C(2')HCH3), 3.48 (1H, dd, J= 7.2 & 4.5 
Hz, CHOH), 2.70 (111, qn, J = 7.2 Hz, CHCO), 2.57 (6H, s, o-CH3), 2.36 (3H, s, p-
CH3), 1.81 (1H, sptd,J = 6.8 and 4.5 Hz, (CH02CR), 1.32 (3H, d, J = 7.0 Hz, 
CH3CHN), 1.25 (3H, d, J = 7.2 Hz, CH3CHCO), 1.04 (3H, d, J = 6.8 Hz, (CH3)2CH), 
1.02 (3H, d, J = 6.8 Hz, (CH3)2CH); 13C NMR 6 (90.5 MHz, CDC13) 176.03 (C), 143.57 
(C), 141.30 (2 x C), 139.57 (C), 139.21 (C), 134.42 (C), 133.14 (2 x CH), 129.43 (2 
CH), 129.34 (2 x CH), 128.97 (CH), 128.70 (2 x CH), 128.19 (CH), 126.98 (2 
x  CH), 
79.23 (CH), 78.76 (CH), 57.76 (CH), 49.28 (CH2), 44.03 (CH), 31.21 (CH), 23.95 (2 x 
CH3 ), 21.91 (CH3 ), 21.00 (CH3 ), 16.63 (CH3), 15.38 (CH3 ), 14.62 (CH3); m/z (FAB, 3-
NOBA) 552 ([M+H], 6%), 406 (80), 316 (78), 289 (31), 183 (52), 129 (50), 119 (84), 
91 (95); HRMS (FAB, THIOG) [M+H] found 552.2789, C32H42N0 5S requires 
552.2784. 
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General procedure C was followed with Masarnune propinate ester ent-134 (150 mg, 
0.320 mmol), dibutylboron triflate (1.0 M in hexane, 0.64 ml, 0.64 mmol), 
diisopropylethylamifle (0.17 ml, 0.96 mmol) and isovaleraldehyde (53 l, 0.48 mmol). 
Purification by flash chromatography (20% EtOAc in hexane) gave a mixture of 
diastereoisomers 149d and 150d (108 mg, 61%) (ds . anti = 83 17). 
(2S,3R)-Major diastereoisomer 149d: R f (2O% EtOAc in hexane) = 0.25; [aID = - 3.0 
(c 0.75, CHC13); vmax (neat)/cm' 3530 (OH), 1735 (CO), 1153 (SO2N); 
1H NMR 6(250 
MHz, CDC13) 7.37-7.21 (8H, in, ArII), 7.05-6.98 (2H, in, ArR), 6.92 (2H, s, An]), 5.95 
(111, d, J = 3.7 Hz, CIJPh), 4.71 (1H, d, J = 17.0 Hz, CHAHBPh), 
4.64 (1H, d, J= 17.0 
Hz, CHAHBPh), 4.14 (1 H, qd, J = 7.0 & 3.7 Hz, C(2')HCH3), 
3.94-3.90 (1 H, in, 
CHOH), 2.57 (6H, s, o-CH3), 2.25 (1H, qd, J = 7.3 & 3.0 Hz, CH3CHCO), 2.32 (3H, s, 
p-CH3), 1.83-1.70 (1H, m, CH(CH3)2), 1.41 (1H, ddd, J = 13.7, 9.8 & 5.1 Hz, 
CHCHD), 
1.23 (3H, d, J= 7.0 Hz, CH3CHN), 1.20 (311, d, J= 7.3 Hz, CH3CHCO), 
1.03 (1H, ddd, 
,J = 13.7, 8.9 & 3.6 Hz, CHCHD), 0.92 (611, d, J— 6.6 Hz, (CH3)2CHCH2); 
'3C NMR 6 
(62.9 MHz, CDC13) 175.04 (C), 142.98 (C), 140.56 (2 
x C), 138.86 (C), 138.70 (C), 
133.66 (C), 132.53 (2 x CH), 128.84 (4 x CH), 128.79 (CH), 127.53 (3 
x CH), 126.22 
(2 x CH), 78.77 (CH), 69.43 (CH), 57.23 (CH), 48.60 (CH2
), 44.73 (CH), 42.91 (CH2), 
24.90 (CH), 23.85 (CH3), 23.38 (2 x CH3), 22.24 (CH3), 21.25 (CH3
), 12.98 (CH3), 
10.57 (CH3); m/z (FAB, 3-NOBA) 566 ([M+H], 48%), 406 (86), 316 (81), 183 (55), 




(2S,3S)-Minor diastereoisomer 150d: Rf (20% EtOAc in hexane) = 0.29; laiD  = - 18 (c 
0.45, CHC13); Vmax (neat)/cm-1  3529 (OH), 1731 (CO), 1153 (S02N); 'H NMR 6 (250 
MHz, CDC13) 7.25-7.08 (8H, m, ArH), 6.85-6.80 (4H, m, An]), 5.76 (1H, d, J = 4.4 Hz, 
CHPh), 4.68 (1H, d, J = 16.4 Hz, CHAHBPh), 4.46 (111, d, J = 16.4 Hz, CHAHBPh), 4.04 
(1H, qd, J = 6.9 and 4.4 Hz, C(2')HCH3), 3.61-3.5 8 (1H, m, CHOH), 2.44-2.33 (1H, m, 
CH 3CHCO), 2.41 (6H, s, o-CH3), 2.20 (3H, s,p-CH3), 1.85-1.70 (1H, m, CH(CH3)2), 
1.37-1.25 (1H, m, CHCHD), 1.18-1.00 (1H, m, CHCHD), 1.14 (311, d, J = 6.9 Hz, 
CH3CI4N), 1.06 (3H, d, J = 7.3 Hz, CH3CHCO), 0.86 (3H, d, 
J=z  6.7 Hz, CH-CHCH2), 
0.81 (3H, d, J = 6.5 Hz, CH3CHCH2); '3C NMR 6 (90.5 MHz, CDC13) 174.52 (C), 
142.45 (C), 140.16 (2 x C), 138.30 (C), 138,01 (C), 133.23 (C), 132.00 (2 x  CH), 
128.31 (4 x CH), 127.88 (CH), 127.56 (3 x  CH), 125.91 (2 x CH), 78.10 (CH), 71.24 
(CH), 56.56 (CH), 48.14 (CH2), 45.87 (CH), 43.63 (CH2), 24.29 (CH), 23.63 (CH3), 
22.87 (2 x  CH3), 21.39 (CH3), 20.78 (CH3), 14.10 (CH3), 13.46 (CH3); m/z (FAB, 3-
NOBA) 564 ([M+H]1 , 6%),406 (30); HRMS (FAB, 3-NOBA) [M-H] found 564.2781, 
C33H42NO5S requires 564.2784. 
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Genera' procedure C was followed with Masamune propionate ester ent-134 (188 mg, 
0.392 mmol), dibutylboron triflate (1.0 M in hexane, 0.78 ml, 0.78 mmol), 
diisopropylethylamine (0.21 ml, 1.2 mmol) and benzaldehyde was added (63 I, 0.59 
mmol). The reaction was stirred at - 78 °C for 1 h and warmed to 0 °C for 1 h. 
Purification by flash chromatography (20% EtOAc in hexane) gave a mixture of 
diastereoisomers 149e and 150e that was separated by HPLC (192 mg, 84%) (ds 	ant, 
= 89: 11). 
(2S,3S)-Major diastereoisomer 149e: HPLC R (15% EtOAc in hexane, flow rate: 10 
ml/min) = 28 mm; Rf (20% EtOAc in hexane) = 0.18; [a]D = - 29 (c 1.0, CHC13); Vnax 
(neat)/cm 3513 (OH), 1737 (CO), 1603 (Ar), 1495 (Ar), 1323 (SO2N), 1153 (S02N); 
'H NMR 6 (250 MHz, CDC13) 7.66-7.40 (13H, m, ArT!), 7.25 - 7.15 (2H, rn, ArT!), 7.13 
(2H, s, ArE), 6.12 (1H, d, J = 3.5 Hz, CIIPh), 5.20 (1H, t, J = 3.6 Hz, CHOH), 4.85 
(1H, d, J= 16.8 Hz, CHAHBPh), 4.75 (1H, d, J = 16.8 Hz, CHAHBPh), 4.28 (1H, qd, J= 
7.0 & 3.5 Hz, C(2')HCH3), 3.17 (1H, d, J = 3.4 Hz, 011), 2.85-2.70 (1H, m, CHCH3), 
2.77 (6H, s, o-CH3), 2.52 (3H, s,p-CH3), 1.35 (3H, d,J = 7.0 Hz, CHCH3), 1.30 (3H, d, 
J = 7.2 Hz, CHCH3); '3C NMR 6 (62.9 MHz, CDC13) 174.66 (C), 143.03 (C), 141.79 
(C), 140.62 (2 x C), 139.00 (C), 138.62 (C), 133.70 (C), 132.57 (2 x  CH), 128.88 (4 
CH), 128.68 (2 x CH), 128.37 (CH), 127.82 (CH), 127.65 (2 x  CH), 127.56 (CH), 
126.36 (2 x  CH), 126.24 (2 x  CH), 79.00 (CH), 73.24 (CH), 57.23 (CH), 48.58 (CH2), 
46.64 (CH), 23.42 (2 x  CH3), 21.28 (CH3), 12.93 (CH3), 10.95 (CH3); m/z (ESI, +) 603 
([M+NH4], 100%), 586 ([M+H],  30); HR1VIS (ESI, +) [M+NH4] found 603.2889, 
C35H43N205S requires 603.2887. 
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(2S,3R)-Minor diastereoisomer 150e: HPLC R (15% EtOAc in hexane, flow rate: 10 
ml/min) = 25 mm; Rf (20% EtOAc in hexane) = 0.21; [a] D  = - 18 (c 0.90, CHC13); Vmax 
(neat)/cm 1  3509 (OH), 1740 (C0), 1603 (Ar), 1495 (Ar), 1320 (SO2N), 1151 (S02N); 
111 NMR 6 (250 MHz, CDC13) 7.35-7.00 (13H, m, Ark!), 6.82 (2H, s, Ark!), 6.78 - 6.70 
(2H, m, ArII), 5.75 (1H, d, J = 3.8 Hz, CHPh), 4.67 (1H, d, J = 16.6 Hz, CHAHBPh), 
4 64 (1H, dd, J = 8.3 & 4.4 Hz, CHOH), 4.42 (1H, d, J = 16.6 Hz, CHAHBPh), 4.00 (1H, 
qd, J=z 7.0 & 3.8 Hz, C(2')HCH3), 3.95 (1H, d, J = 4.4 Hz, OH), 2.70 (1 H, dq, J = 8.3 
& 7.2 Hz, CHCH3), 2.43 (6H, s, o-CH3), 2.23 (3H, s, p-CH3), 1.04 (3H, d, J = 7.0 Hz, 
CIICH3), 0.87 (3H, d, J = 7.2 Hz, CHCH3); '3C NMR ö (62.9 MHz, CDC13) 174.99 (C), 
142.97 (C), 141.90 (C), 140.70 (2 x C), 139.16 (C), 138.61 (C), 133.89 (C), 132.53 (2 x 
CH), 128.96 (2 x CU), 128.82 (2 x CH), 128.72 (2 x CH), 128.53 (CH), 128.32 (CH), 
128.05 (2 x CH), 127.53 (CH), 127.05 (2 x CH), 126.21 (2 x CH), 78.86 (CH), 76.75 
(CH), 57.19 (CH), 48.63 (CH2), 47.66 (CH), 23.33 (2 x  CH3), 21.28 (CH3), 14.88 
(CH3), 13.61 (CH3). 
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6.3 EXPERIMENTAL PROCEDURES FOR CHAPTER 3 
(1 'S,2'R)- 	 '-phenylpropyl-2-methOXY- 
thiolacetate 163 
To a stirred solution of thiol 117 (5.0 g, 13 rnmol), methoxyacetic acid (1.0 ml, 13 
mmol) and DMAP (134 mg, 1.10 mmol) in CH2C12  (20 ml) was added EDCI (2.5 g, 14 
mmol) at 0 °C. The reaction mixture was stirred at 0 CC for 2 h and then at RT for 14 h. 
The solution was concentrated and the residue was dissolved in EtOAc (30 ml) and 
washed with NH4C1 (2 x 20 ml, sat aq) and NaCl (2 x 20 ml, sat aq). The organics were 
combined and dried (MgSO4) and the volatiles removed under reduced pressure. 
Purification by flash chromatography (10% EtOAc in hexane) gave 163 as a colourless 
solid (4.2 g, 71%); Rf  (10% EtOAc in hexane) = 0.17; mp 76-77°C; [aID 60 (c 2.3, 
CHC13); Vmax (neat)/cm-1 1693 (C0), 1603 (Ar), 1495 (Ar), 1152 (SON); 
'H NMR ö 
(250 MHz, CDC13) 7.44 (2H, d, J= 7.6 Hz, ArII), 7.29-7.24 (3H, m, An]), 7.14 (1H, t, 
J = 7.4 Hz, ArH), 7.01 (2H, t, J = 7.2 Hz, ArR), 6.82 (2H, s, An]), 6.70 (2H, d, J= 
7.1 
Hz, An]), 4.83 (1H, d, J = 9.1 Hz, CHPh), 4.78 (1 H, d, JA-B = 16.2 Hz, CHAHBPh), 4.46 
(1H, d, JA-B = 16.2 Hz, CHAHBPh), 4.17 (1H, dq, J = 9.1 and 6.8 Hz, CHCH3), 3.99 
(1H, d, JC-D = 16.1 Hz, CHCHDCO), 3.92 (IH, d, JAB = 16.1 Hz, CHCHDCO), 3.37 (3H, 
s, OCH3), 2.29 (3H, s, p-CH3), 2.28 (6H, s, o-CH3), 1.27 (3H, d, J = 6.8 Hz, CH
3CH); 
'3C NMR 6 (62.9 MHz, CDC13) 196.93 (C), 142.20 (C), 140.45 (2 x C), 139.81 (C), 
138.35 (C), 132.63 (C), 132.01 (2 x CH), 128.61 (2 x CH), 128.26 (4 x CH), 127.51 (2 
x CH), 127.29 (CH), 127.09 (CH), 77.04 (CH2), 60.06 (CH3), 56.35 (CH), 49.96 (CH), 
47.29 (CH2), 22.83 (2 x CH3), 20.77 (CH3), 17.29 (CH3); m/z (FAB, THIOG) 588 
([M+H], 9%), 406 (47), 316 (56), 207 (42), 183 (44), 169 (18), 119 (79), 91(97), 79 
(65), 77 (64); m/z (FAB, THIOG) 512 ([M+H], 4%), 406 (21), 316 (43), 207 (16), 183 
(30), 119 (61), 105 (48), 91(74), 77 (46), 31(14); HRMS (FAB, 3-NOBA) [M+H] 
found 512.1926, C28H34N04S2 requires 512.1929. 
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(1 'S,2 'R)2'(NBenzyI-N-mesity1enesu1foflY1aIfliflO)-1 '-phenylpropyl-2-benzyloxy-
thiolacetate 166 
To a stirred solution of thiol 117 (6.0 g, 14 mmol), benzyloxyacetic acid (2.6 ml, 17 
mmol) and DMAP (171 mg, 1,40 mmol) in CH2C12  (30 ml) was added DIC (2.7 ml, 17 
mmol) at 0 °C. The reaction mixture was stirred at 0 °C for 1 h (a bright yellow colour 
appeared) and then at RT for 14 h. The diisopropylurea formed was removed by 
filtration and the filtrate was concentrated. NaCl (40 ml, sat aq) was added and the 
mixture was extracted with CH2C12 (3 x 30 ml) and washed with NaCl (20 ml, sat aq), 
HC1 (20 ml, 1 N aq), NaCl (20 ml, sat aq), NaHCO3  (20 ml, sat aq) and NaCl (20 ml, sat 
aq). The organics were dried (MgSO4) and the volatiles removed under reduced 
pressure. Purification by flash chromatography (10% EtOAc in hexane) gave 166 as a 
waxy solid (5.6 g, 69%); Rf  (10% EtOAc in hexane) = 0.23; [UID 40.7 (c 5.50, CHC13 ); 
Vnax (neat)/cm' 1691 (C0), 1603 (Ar), 1495 (Ar), 1153 (SON; 'H NMR 6 (250 
MHz, CDC13) 7.40 (2H, d, Jr  7.6 Hz, ArH), 7.28-7.24 (8H, in, ArH), 7.10 (1H, t, J 
7.4 Hz, ArH), 7.00 (2H, t, J = 7.1 Hz, ArH), 6.78 (2H, s, ArH), 6.68 (2H, d, J= 7.0 Hz, 
ArH), 4.81 (1H, d, J = 9.2 Hz; CHPh), 4.75 (1H, d, JA-13 = 16.2 Hz, CHAHBPh), 4.49 
(2H, s, OCH2Ph), 4.42 (1H, d, JA-B = 16.2 Hz, CHAHBPh), 4.15 (1H, dq, J = 9.2 and 6.8 
Hz, CHCH3), 4.02 (111, d, JC-D = 16.1 Hz, CHCH DCO), 3.95 (1H, d, JA-B = 16.1 Hz, 
CHCHDCO), 2.25 (9H, s, o-CH3 and p-CH3), 1.22 (3H, d, J = 6.8 Hz, CH3CH);' 3C 
NMR 6 (62.9 MHz, CDC13) 197.00 (C), 142.18 (C), 140.44 (2 x C), 139.84 (C), 138.36 
(C), 136.47 (C), 132.66 (C), 132.01 (2 x CH), 128.60 (2 x CH), 128.39 (2 x CH), 
128.29 (2 x CH), 128.25 (CH), 128.01 (2 x CH), 127.70 (2 x CH), 127.54 (2 x CH), 
127.28 (CH), 127.09 (CH), 74.43 (CH2), 73.85 (CH2), 56.38 (CH), 50.06 (CH), 47.30 
(CH2), 22.75 (2 x CH3), 20.77 (CH3), 17.31 (CH3); m/z (FAB, THIOG) 610 ([M+Na], 
6%), 406 (47), 316 (56), 207 (42), 183 (44), 169 (18), 119 (79), 91(97), 79 (65), 77 
(64); HRMS (FAB, 3-NOBA) [M+H] found 588.2262, C34H38N04S2 requires 
588.2242. 
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Methyl 2-(tert-butyldimethylsilyloxy)acetate 191 
OMe 
>Si 
To a stirred solution of methyl glycolate (2.4 g, 26 mmol) in DMF (25 ml) was added 
imidazole (4.5 g, 65 mmol) and tert-butyl-dimethylsilyl chloride (4.8 g, 31 mmol) at 0 
°C. The reaction mixture was stirred at RI for 4 h. NaCl (30 ml, sat aq) was added and 
the mixture was extracted with Et20 (3 x  20 ml) and washed with NaCl (20 ml, sat aq). 
The organics were dried (MgSO4) and the volatiles removed under reduced pressure. 
Purification by flash chromatography (10% EtOAc in hexane) gave 191 as a colourless 
oil (5.41 g, 100%); Rf (10% EtOAc in hexane) = 0.44; Vmax (neat)/cm 1764 (CO), 1256 
(SiGH3), 1006 (SiO), 838 (SiCH3); 111  NMR 6 (250 MHz, CDCI3) 4.13 (2H, s, 
CH2CO), 3.61 (3H, s, OCH3), 0.81 (9H, s, 3 x  CH3), 0.00 (6H, s, 2 x  CH3); '3C NMR ö 
(62.9 MHz, CDC13) 171.63 (C), 61.29 (CH2), 51.21 (CH3), 25.40 (3 x  CH3), 18.04 (C), 
- 5.83 (2 x  CH3); m/z (FAB, IHIOG) 205 ([M+H], 58%), 189 (28), 147 (63), 131 (23), 
119 (32), 101 (12), 89 (100); HRMS (FAB, 3-NOBA) [M+H] found 205.1254, 
C9H2103S1 requires 205.1260. 
Methyl 2(tertbutyldiphenylSilYlOXY)aCetate 192 
To a stirred solution of methyl glycolate (1.2 g, 13 mmol) in DMF (15 ml) was added 
imidazole (2.3 g, 33 mmol) and teri-butyl-diphenylsilyl chloride (4.2 ml, 16 mmol) at 0 
°C. The reaction mixture was stirred at RT for 4 h. NaCl (20 ml, sat aq) was added and 
the mixture was extracted with Et20 (3 x 20 ml) and washed with NaC1 (20 ml, sat aq). 
The organics were dried (MgSO4) and the volatiles removed under reduced pressure. 
Purification by flash chromatography (10% EtOAc in hexane) gave 192 as a colourless 
oil (4.31 g, 98%); R1  (10% EtOAc in hexane) = 0.41; Vfliax (neat)/cm' 1763 (CO), 1589 
(Ar), 1472 (Ar); 1H NMR ö (250 MHz, CDC13) 7.64-7.54 (4H, m, ArII), 7.29-7.19 (6H, 
in, ArJI), 4.13 (214, s, CH2CO), 3.49 (31-1, s, OCH3), 0.98 (911, s, 3 x  CH3); '3C NMR 
(62.9 MHz, CDC13) 171.15 (C), 135.27 (4 x CH), 132.50 (2 x C), 129.62 (2 
x  CH), 
127.51 (4 x CH), 61.80 (CH2), 51.18 (CH3), 26.40 (3 x  CH3), 18.96 (C); HRMS 
(Electrospray, polyethylenimine) [M+NH4] found 346.1835, C19H28NO3Si requires 
346.1833. 
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Tert-butyldiphenylSilyl 2(tertbuty1dipheflY1Si1YIOXY)acetate 193 
0 
r - -'- 0' i si 
To a stirred solution of glycolic acid (550 mg, 7.23 mmol) in pyridine (20 ml) was 
added teri-butyl-diphenylsilyl chloride (7,7 ml, 29 mmol). The reaction mixture was 
stirred at RT for 3.5 h. NaCl (20 ml, sat aq) was added and the mixture was extracted 
with CH2C12 (3 x 20 ml) and washed with HCl (3 x 20 ml, 1 N aq) and NaCl (20 ml, sat 
aq). The organics were dried (MgSO4) and the volatiles removed under reduced 
pressure. Purification by flash chromatography (10% EtOAc in hexane) gave 193 as a 
colourless oil (3.81 g, 95%) which was shown to be unstable and was used immediately 
in the following reaction; Rç (10% EtOAc in hexane) = 0.55; VIflax (neat)/cm 1754 
(CO), 1590 (Ar); H NMR 6 (250 MHz, CDC13) 7.61 (4H, d, J = 7.7 Hz, ArII), 7.53 
(4H, d, J= 7.7 Hz, ArH), 7.34-7.15 (12H, in, An]), 4.28 (2H, s, OCH2CO), 
0.97 (9H, s, 
C(CH3)3), 0.96 (9H, s, C(CH3)3); 13C NMR 6 (62.9 MHz, CDC13) 169.85 (C), 135.39 (4 
CH), 135.13 (4 x CH), 132.68 (2 x C), 131.52 (2 x C), 129.93 (2 
x CH), 129.72(2 x 
CH), 127.67 (4 x CH), 127.57 (4 x CH), 62.79 (CH2), 26.73 (3 
x  CH3), 26.52 (3 x 
CH3), 19.03 (2 >< Q. 
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2(Tert-butyidiphenyIsi1y1OXY)aCetic acid 194 
OH 
To a stirred solution of silylester 193 (3.63 g, 6.58 mmol) in THF (2 ml) and MeOH (4 
ml) was added a solution of K2CO3 (2.8 g, 20 mmol) in H20 (2 ml) at RT. After stirring 
at RI for 30 mm, the mixture was acidified to pH 3 using HC1 (1 N aq) and the solution 
was extracted with Et20 (3 x 10 ml). The organics were washed with NaCl (2 x  10 ml, 
sat aq), and dried (MgSO4), and the volatiles removed under reduced pressure to give a 
colourless oil which was purified by flash chromatography (20% EtOAc in hexane-1% 
AcOH) to give the acid 194 as a colourless oil (1.78 g, 86%) which was shown to be 
unstable and was used immediately in the following reaction; Rf (20% EtOAc in 
hexane) = 0.23; Vmax (neat)/cm' 3137 (br, OH), 1731 (C0), 1590 (Ar); 'H NMR 
(250 MHz, CDC13) 10.90 (1H, br, 011), 7.55 (4H, d, J = 7.3 Hz, ArII), 7.32-7.17 (6H, 
in, An]), 4.14 (2H, s, OCH2CO), 0.97 (6H, s, C(CH3)3); '3C NMR 6 (62.9 MHz, 
CDCI3) 176.20 (C), 135.33 (4 x CH), 131.55 (2 x C), 129.43 (2 x CH), 127.51 (4 x 
CH), 61.64 (CH2), 26.51 (3 x  CH3), 19.04 (C). 
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(1 'S,2 'R)-2-( Tert-butyldiphenylsiiyloxy)-2 '-(N-benzyl-N-mesitylenesulfonylamino)-
1'-phenylpropyl thiolacetate 189 
0 Ph 
\ '0 b BnSO 
y 
To a stirred solution of fresh prepared TBDPS-protected glycolic acid 194 (1.70 g, 5.41 
mmol) in CH2C12 (5 ml) was added a solution of thiol 117 (1.01 g, 2.30 mmol) in 
CH2C12  (5 ml), then DMAP (28 mg, 0.23 mmol) and DIC (0.73 ml, 4.6 mmol). The 
reaction mixture was stirred at RT for 14 h. The diisopropylurea formed was removed 
by filtration and the filtrate was concentrated. NaCl (20 ml, sat aq) was added and the 
mixture was extracted with CH2C12 (3 >< 10 ml) and washed with NaCl (10 ml, sat aq), 
HCI (10 ml, I  aq), NaCl (10 ml, sat aq), NaHCO3 (10 ml, sat aq) and NaCl (10 ml, sat 
aq). The organics were dried (MgSO4) and the volatiles removed under reduced 
pressure. Purification by flash chromatography (10% EtOAc in hexane) gave 189 as a 
waxy solid (1.65 g, 98%); R f (10% EtOAc in hexane) = 0.35; [U]D 40.0 (c 4.40, CHC13); 
Vmax (neat)/cm' 1694 (C=O), 1603 (Ar), 1495 (Ar); 1H NMR ö (250 MHz, CDC13 ) 
7.61-7.55 (41-1, in, ArIJ), 7.43-7.24 (111-1, m, ArII), 7.15 (11-1, t, J = 7.3 Hz, ArII), 7.04 
(21-1, t, J= 7.6 Hz, An]), 6.84 (21-1, s, An]), 6.75 (21-1, d, J = 7.1 Hz, ArH), 4.84 (1H, d, 
JA-B = 16.3 Hz, CHAHBPh), 4.80 (1H, d, J = 8.7 Hz, CHPh), 4.50 (1H, d, JA-B = 16.3 Hz, 
CHAHBPh), 4.21 (1H, dq, Jr  8.7 & 6.8 Hz, CHCH3), 4.15 (21-1, d, J = 1.5 Hz, CH) 
CO), 2.32 (61-1, s, o-CH3), 2.30 (31-1, s,p-CH3), 1.24 (31-1, d, J = 6.8 Hz, CH3CH) 1.08 
(9H, s, (CH3)3C); ' 3C NMR ö (62.9 MHz, CDC13) 198.95 (C), 142.19 (C), 140.44 (2 
C), 140.21 (C), 138.48 (C), 135.35 (4 x C), 134.67 (C), 132.89 (C), 132.04 (3 x CH), 
129.94 (CH), 128.53 (3 x CH), 128.23 (3 x CH), 127.78 (C), 127.73 (3 x CH), 127.61 
(3 x CH), 127.22 (CH), 127.01 (CH), 69.10 (CH2), 56.52 (CH), 50.08 (CH), 47.45 
(CH2), 26.53 (3 x CH3 ), 23.47 (2 x CH3), 20.80 (CH3 ), 19.09 (C), 17.31 (CI-13 ); HRMS 
(EST, +) [M+H] found 736.2955, C43H50NO4S2Si requires 736.2945. 
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General procedure D: Synthesis of Me-Protected Syn Glycolate Aldol Adducts 
To a stirred solution of thiolpropionate ester 163 (150 mg, 0.294 mmol) in CI-12C12 (10 
ml) at - 78 °C was added the boron triflate (1.0 M in hexane, 0.88 mmol) then amine 
base (0.74 mmol). The reaction mixture was stirred at - 78 °C for 2 h, then aldehyde 
was added (0.88 mmol). The reaction was stirred at - 78 °C for 2 h and then at 0 °C for 
1 h. The mixture was quenched by the addition of pH 7 buffer and methanol (1:1, 4 ml) 
and diluted with methanol (4 ml) to make a homogeneous solution. After careful 
addition of H202  (30% aq, 2 ml) the mixture was stirred at RT for 1 h. 
NaCl (20 ml, sat aq) was added and the mixture was extracted with CH2C12 (3 x 10 ml). 
The combined organics were washed with NaHCO3  (10 ml, sat aq) and NaCl (10 ml, sat 
aq), dried (MgSO4) and concentrated under reduced pressure to give the crude aldol 
product. Purification by flash chromatography (20% EtOAc in hexane) gave a mixture 
of diastereoisomers that was separated by HPLC. 
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21(NBenzyl-N_mesitylefleSUlfOflYlamin0)4 '-phenylpropyl (1 'S,2S,2'R,3R)-3-
hydroxy.2methoxy-4-methYl-thiO1Pefltafl0ate 167c 
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General procedure D was followed with thiolpropionate ester 163 (300 mg, 0.588 
mrnol), dicyclohexylboron triflate (1.0 M in hexane, 1.8 ml, 1.8 mmol), triethylamine 
(206 .il, 1.48 mmol) and isobutyraldehyde (162 p1, 1.76 mmol). Purification by flash 
chromatography (20% EtOAc in hexane) gave a mixture of diastereoisomers 167c, 
168c, 169c and 170c that was separated by HPLC (228 mg, 67%) (ds anti anti = 93: 7, 
ds syn: anti = 98 : 2, ds syn: syn = 65 : 35). 
(2S,3R)-Major syn diastereoisomer 167c: HPLC R (10% EtOAc in hexane, flow 
rate: 10 ml/min) = 54 mm; R f  (20% EtOAc in hexane) = 0.32; [aID = + 127 (c 0.45, 
CHCI3 ); Vnax (neat)/cm' 3519 (OH), 1685 (C=O), 1603 (Ar), 1495 (Ar), 1322 (SO2N), 
1152 (SO2N); 'H NMR ö (250 MHz, CDC13) 7.40 (2H, d, J = 7.5 Hz, ArfI), 7.31-7.21 
(3H, in, ArH), 7.20 (1H, t, J— 7.4 Hz, ArH), 7.01 (2H, t, J = 7.1 Hz, ArH), 6.81 (2H, s, 
ArH), 6.68 (2H, d, J = 7.1 Hz, ArH), 4.78 (1H, d, J = 9.1 Hz, CHPh), 4.74 (1H, d, J= 
16.3 Hz, CHAHBPh), 4.48 (1H, d, 1= 16.3 Hz, CHAHBPh), 4.18 (1H, dq, J = 9.1 & 6.8 
Hz, CHCH3), 3.70 (1H, d, J = 3.3 Hz, CHOCH3), 3.46 (1H, dd, J = 7.2 & 3.3 Hz, 
CHOH), 3.37 (3H, s, OCH3), 2.29 (9H, s, 2 x  o-CH3 &p-CH3), 1.84-1.68 (2H, br in, 
OH & CH(CH3)2), 1.28 (3H, d, J = 6.8 Hz, CHCH3), 0.98 (3H, d, J = 6.7 Hz, 
CH(CH3)A(CH3)B), 0.90 (3H, d, J = 6.7 Hz, CH(CH3 )A(CH3)B); 13C NMR 6 (90.5 MHz, 
CDC13) 200.21 (C), 142.00 (C), 140.29 (2 x C), 139.66 (C), 138.14 (C), 132.46 (C), 
131.79 (2 x CH), 128.40 (2 x CH), 128.05 (4 x CH), 127.40 (2 x CH), 127.04 (CH), 
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126.84 (CH), 87.20 (CH), 77.68 (CH), 59.95 (CH3), 56.55 (CH), 50.17 (CH), 46.97 
(CH2), 30.39 (CH), 22.59 (2 x  CH3), 20.60 (CH3), 19.10 (CH3), 17.66 (CH3), 16.84 
(CH3); m/z (FAB, THIOG) 584 ([M+H], 13%), 402 (21), 316 (34), 295 (27), 119 (30), 
91 (100); HRMS (FAB, THIOG) [M+H] found 584.2489, C32H42N05S2 requires 
584.2504. 
(2R,3S)-Minor syn diastereoisomer 168c: HPLC R (10% EtOAc in hexane, flow 
rate: 10 ml/min) = 65 mm; R1  (20% EtOAc in hexane) = 0.27; [U]D = - 8.0 (c 0.25, 
CHC13); Vmax (neat)/cm' 3530 (OH), 1685 (C0), 1603 (Ar), 1495 (Ar), 1321 (SON, 
1153 (SO2N); 'H NMR 6 (250 MHz, CDC13) 7.41 (2H, d, J= 7.5 Hz, ArH), 7.31-7.21 
(3H, rn, ArH), 7.11 (1 H, t, J = 7.3 Hz, An]), 7.02 (2H, t, J = 7.6 Hz, An]), 6.81 (2H, s, 
An]), 6.71 (2H, d, J = 7.0 Hz, An]), 4.81 (1H, d, 1 = 16.3 Hz, CHAHBPh), 4.81 (1 H, d, 
J= 9.1 Hz, CHPh), 4.46 (1H, d, J = 16.3 Hz, CHAHBPh), 4.18 (111, dq, J = 9.1 & 6.8 
Hz, CHCH3), 3.69 (11-I, d, J = 4.0 Hz, CHOCH3), 3.43 (3H, s, OCH3), 3.34 (1H, dd, J= 
6.3 & 4.0 Hz, CHOH), 2.29 (9H, s, 2 x  o-CH3 & p-CH3), 1.64-1.48 (211, br m, OH & 
CH(CH3)2), 1.26 (3H, d, J = 6.8 Hz, CHCH3), 0.88 (3H, d, J = 6.7 Hz, 
CH(CH3)A(CH3)B), 0.82 (31-1, d, J= 6.7 Hz, CH(CH3)A(CH3)B). 
(2S,3S)-Major anti diastereoisomer 169c: HPLC R (10% EtOAc in hexane, flow 
rate: 10 ml/min) = 60 mm; Rf (20% EtOAc in hexane) = 0.29; [aID = - 1.7 (c 0.60, 
CHC13); max (neat)/cm' 3523 (OH), 1685 (C0), 1603 (Ar), 1495 (Ar), 1321 (SON, 
1153 (SO2N); 'H NMR 6 (250 MHz, CDC13) 7.43 (2H, d, J = 7.6 Hz, An]), 7.32-7.23 
(3H, m, ArH), 7.11 (1H, t,J = 7.3 Hz, An]), 7.00 (2H, t,J = 7.2 Hz, ArH), 6.81 (2H, s, 
An]). 6.71 (211, d, J=r  7.1 Hz, An]), 4.81 (111, d, J= 16.3 Hz, CHAHBPh), 4.81 (111, d, 
J— 9.1 Hz, CHPh), 4.46 (1H, d, J = 16.3 Hz, CHAHBPh), 4.18 (111, dq, J = 9.1 & 6.8 
Hz, CHCH3), 3.62 (111, d, J= 6.6 Hz, CHOCH3), 3.43-3.37 (1H, m, CHOH), 3.40 (311, 
s, OCH3), 2.28 (9H, s, 2 x  o-CH3 & p-Cl])), 1.78-1.65 (1H, m, CH(CH3)2), 1.64-1.48 
(111, br, 01]), 1.27 (3H, d, J = 6.8 Hz, CHCH3), 0.84 (3H, d, J = 6.8 Hz, 
CH(CH3)A(CH3)B), 0.82 (3H, d, J= 6.7 Hz, CH(CH3)A(CH3)B); '3C NMR 6 (90.5 MHz, 
CDC13) 200.08 (C), 142.23 (C), 140.44 (2 x C), 139.68 (C), 138.38 (C), 132.71 (C), 
132.04 (2 x CH), 128.53 (2 x  CH), 128.29 (4 x  CH), 127.51 (2 x  CH), 127.30 (CH), 
127.10 (CH), 87.98 (CH), 76.36 (CH), 59.75 (CH3), 56.39 (CH), 50.50 (CH), 47.44 
(CH2), 29.03 (CH), 22.78 (2 x  CH3), 20.80 (CH3), 19.34 (CH3), 17.42 (CH3), 16.08 
(CH-3); m/z (FAB, THIOG) 584 ([M+H], 22%), 406 (29), 316 (56), 295 (50), 183 (31), 
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119 (74), 91 (100); HRMS (FAB, THIOG) [M+H] found 584.2511, C32H42N05S2 
requires 584.2504. 
(2R,3R)-Minor anti diastereoisomer 170c: HPLC R (10% EtOAc in hexane, flow 
rate: 10 ml/min) = 53 mm; Rf (20% EtOAc in hexane) = 0.32; [aID = + 20 (c 0.25, 
CHC13); Vmax (neat)/cm-1 3521 (OH), 1684 (C0), 1603 (Ar), 1495 (Ar), 1321 (SON, 
1153 (SO2N); 1H NMR 6 (250 MHz, CDC13) 7.40 (2H, d, J = 8.1 Hz, An]), 7.31-7.18 
(3H, m, ArM), 7.13 (1H, t, J = 7.3 Hz, An]), 7.01 (2H, t, J= 7.7 Hz, Ar!]), 6.81 (2H, s, 
Ar!]), 6.73 (2H, d, J = 7.2 Hz, Ar!]), 4.80 (1 H, d, J= 8.6 Hz, CHPh), 4.76 (1 H, d, J= 
16.3 Hz, CHAHBPh), 4.48 (1H, d, J = 16.3 Hz, CHAHBPh), 4.21 (1H, dq, J = 8.6 & 6.8 
Hz, CHCH3), 3.63 (1H, d, J = 6.1 Hz, CHOCH3), 3.51 (1H, dd, J = 6.1 Hz, CHOH), 
3.33 (3H, s, OCH3), 2.30 (6H, s, 2 x  o-CH3), 2.29 (3H, s, p-CH3), 1.91-1.78 (IH, m, 
CH(CH3)2), 1.26 (3H, d, J = 6.8 Hz, CHCH3), 0.94 (3H, d, J = 6.8 Hz, 
CH(CH3)A(CH3)B), 0.90 (3H, d, J= 6.7 Hz, CH(CH3)A(CH3)B). 
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2'-(N-Benzyl-N-mesitylenesulfonylamiflO)-1 '-phenyipropyl (1 'S,2S,2 'R,3R)-3-
hydroxy-2-methoxy-5-methyl-thiOlheXaflOate 167d 
OH 0 Ph 
	







65:35 	168d "[:: 
General procedure D was followed with thiolpropionate ester 163 (150 mg, 0.294 
mmol), dicyclohexylboron triflate (1.0 M in hexane, 0.88 ml, 0.88 mmol), triethylamine 
(103 p1, 0.74 mmol) and isovaleraldehyde (97 j.il, 0.88 mmol). Purification by flash 
chromatography (20% EtOAc in hexane) gave a mixture of diastereoisomers 167d and 
168d that was separated by HPLC (154 mg, 88%) (ds s)n : y,, = 65 : 35, ds 	anti = 98 
2) 
(2S,3R)-Major syn diastereolsomer 167d: HPLC R (20% EtOAc in hexane, flow 
rate: 10 ml/min) = 21 mm; R1 (20% EtOAc in hexane) = 0.26; [U]D = + 4.31 (c 3.25, 
CHC13); vmax (neat)/cm' 3520 (OH), 1684 (C0), 1603 (Ar), 1495 (Ar), 1322 (SON, 
1153 (SO2N); 'H NMR 6 (250 MHz, CDC13) 7.42 (2H, d, J = 8.1 Hz, An]), 7.31-7.22 
(3H, m, An]), 7.10 (1H, t, J = 7.4 Hz, ArT!), 6.97 (2H, t, J = 7.7 Hz, An]), 6.80 (2H, s, 
An]), 6.70 (2H, d, J = 7.0 Hz, An]), 4.80 (1H, d, J = 16.3 Hz, CHAHBPh), 4.78 (1H, d, 
J= 9.0 Hz, CJIPh), 4.44 (1H, d, J = 16.3 Hz, CHAHBPh), 4.16 (1H, dq, J = 9.0 & 6.8 
Hz, CHCH3), 3.70-3.58 (1H, m, CHOH), 3.46 (1H, d, J = 5.1 Hz, CHOCH3), 3.40 (3H, 
s, OCH3), 2.28 (6H, s,2 x o-CH3),2.27 (3H, s,p-CH3), 2.07 (1H, bn d, J= 5.6 Hz, OH), 
1.66-1.52 (1H, m, CHCH2), 1.27-1.15 (1H, m, CHCHD), 1.25 (3H, d, J = 6.8 Hz, 
CHCH3), 0.95-0.80 (1H, m, CHCHD), 0.76 (3H, d, J = 6.6 Hz, CH(CH3)(CH3)), 0.66 
(3H, d, J = 6.6 Hz, CH(CH3)(CH3)); '3C NMR 6 (90.5 MHz, CDC13) 199.21 (C), 
142.21 (C), 140.40 (2 x C), 139.74 (C), 138.35 (C), 132.68 (C), 132.01 (2 x  CH), 
128.45 (2 >< CH), 128.26 (2 x CH), 128.22 (2 x CH), 127.44 (2 x  CH), 127.27 (CH), 
127.07 (CH), 90.19 (CH), 70.59 (CH), 59.80 (CH3), 56.14 (CH), 50.59 (CH), 47.44 
40.93 (CH2), 24.02 (CH), 23.22 (CH3), 22.73 (2 x  CH3), 21.22 (CH3), 20.77 
17.48 (CH3); m/z (FAB, THIOG) 598 ([M+H], 30%), 416 (41), 316 (49), 309 
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(47), 119 (65), 91 (100); HRMS (FAB, THIOG) [M+H] found 598.2641, 
C33H44N05S2 requires 598.2660. 
(2R,3S)-Minor syn diastereoisomer 168d: HPLC R (20% EtOAc in hexane, flow 
rate: 10 ml/min) = 19 mm; R f (20% EtOAc in hexane) = 0.30; laiD = + 83.2 (c 2.20, 
CHC13); vmax (neat)/cm' 3520 (OH), 1684 (C0), 1603 (Ar), 1495 (Ar), 1322 (SON, 
1153 (SO2N); 1H NMR ö (250 MHz, CDCI3) 7.40 (2H, d, J = 7.9 Hz, An]), 7.30-7.20 
(3H, m, An]), 7.13 (1H, t, J= 7.0 Hz, An]), 7.01 (2H, t, J= 7.1 Hz, ArH), 6.80 (2H, s, 
An]), 6.67 (2H, d, 1=7.0 Hz, An]), 4.79 (1H, d, J = 9.2 Hz, CHPh), 4.75 (1H, d, 1= 
16.2 Hz, CHAHBPh), 4.45 (1H, d, J = 16.2 Hz, CHAHBPh), 4.19 (1H, dq, J = 9.2 & 6.8 
Hz, CHCH3), 3.87-3.75 (1H, m, CHOH), 3.48 (1 H, d, J = 4.3 Hz, CHOCH3), 3.35 (3H, 
s, OCH3), 2.27 (9H, s, 2 x  o-CH3 &p-CH3), 2.12 (1H, br d, J = 7.1 Hz, OH), 1.80-1.67 
(I H, m, CHCH2), 1.40 (1H, ddd,J = 13.8, 9.8 & 5.0 Hz, CHCHD), 1.27 (3H, d,J = 6.8 
Hz, CHCH3), 1.16 (1H, ddd, J = 13.8, 8.8 & 3.4 Hz, CHCHD), 0.89 (3H, d, J = 6.6 Hz, 
CH(CH3)(CH3)), 0.83 (3H, d, I = 6.6 Hz, CH(CH3)(CH3)); ' 3C NMR 6 (90.5 MHz, 
CDC13) 199.87 (C), 142.20 (C), 140.47 (2 x C), 139.83 (C), 138.27 (C), 132.68 (C), 
131.99(2 x CH), 128.63 (2 x  CH), 128.27 (2 x CH), 128.22 (2 x CH), 127.59 (2 x  CH), 
127.27 (CH), 127.07 (CH), 89.85 (CH), 70.76 (CH), 60.15 (CH3), 56.61 (CH), 50.25 
(CH), 47.23 (CH2), 41.66 (CH2), 24.26 (CH), 23.31 (CH3), 22.76 (2 x  CH3), 21.53 
(CH3), 20.79 (CH3), 17.21 (CH3). 
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2 '(N_Benzyl-N-mesitylenesu1fOflYlaJfliflO)-1 '-phenylpropyl (1 'S,2S,2'R,3R)-3-
hydroxy-2-methoxy-3-phenYl thiopropionate 167e 
OH 0 Ph 
C-1J OMe BnSO2 
167e 









Method A: General procedure D was followed with thiolpropionate ester 163 (150 
mg, 0.294 mmol), dicyclohexylboron triflate (1.0 M in hexane, 0.88 ml, 0.88 mmol), 
triethylamine (103 j.tl, 0.74 mmol) and benzaldehyde (94 tl, 0.88 mmol). Purification 
by flash chromatography (20% EtOAc in hexane) gave a mixture of diastereoisomers 
167e and 168e that was separated by HPLC (163 mg, 90%) (ds . : = 66 : 34, ds syn: 
anti =91- : 9,ds anti: anti =99 :1). 
(2S,3R)-Major syn diastereoisomer 167e: HPLC R (20% EtOAc in hexane, flow 
rate:10 ml/min) = 29 mm; Rf  (20% EtOAc in hexane) = 0.23; [aI D = + 21.1 (c 2.85, 
CHC13); vniax (neat)/cm' 3500 (OH), 1687 (C0), 1603 (Ar), 1495 (Ar), 1321 (S02N), 
1153 (SO2N); 1 H NMR 6 (250 MHz, CDC13) 7.44-7.35 (2H, m, ArH), 7.31-7.10 (7H, 
m, ArII), 7.08-6.97 (4H, m ArH), 6.84 (2H, s, An]), 6.67 (2H, d, J = 7.1 Hz, ArR), 4.77 
(IH, d, J = 16.2 Hz, CHAHBPh), 4.77-4.69 (1H, m, CHOH), 4.74 (1H, d, 1 9.2 Hz, 
CHPh), 4.39 (1H, d, J = 16.2 Hz, CHAHBPh), 4.14 (1H, dq, J = 9.2 & 6.8 Hz, CHCH3), 
3.74 (1H, d, I = 5.5 Hz, CHOCH3), 3.32 (3H, s, OCH3), 2.80 (1H, br d, I = 3.9 Hz, 
01]), 2.30 (3H, s,p-CH3), 2.28 (6H, s, 2 x  o-CH3), 1.18 (3H, d, 1=6.8 Hz, CHCH3); 
'3C NMR 6 (90.5 MHz, CDC13) 197.65 (C), 142.20 (C), 140.40 (2 x  C), 139.63 (C), 
138.30 (C), 138.18 (C), 132.60 (C), 132.00 (2 x CH), 128.51 (2 x CH), 128.24 (4 x 
CH), 128.13 (2 x CH), 127.98 (CH), 127.51 (2 x CH), 127.25 (CH), 127.07 (CH), 
126.32 (2 x CH), 90.99 (CH), 74.49 (CH), 59.79 (CH3), 56.06 (CH), 50.64 (CH), 47.30 
(CH2), 22.71 (2 x  CH3), 20.76 (CH3), 17.43 (CH3); m/z (FAB, THIOG) 618 ([M+H], 
12%), 406 (39), 316 (56), 183 (55), 151 (47), 119 (92), 91 (100); HRMS (FAB, 
GLYCEROL) [M+H] found 618.2343, C351-140N05S2 requires 618.2347. 
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(2R,3S)-Minor syn diastereoisomer 168e: HPLC R (20% EtOAc in hexane, flow 
rate: 10 ml/min) = 25 mm; Rf (20% EtOAc in hexane) = 0.26; [a]D= + 95 (c 2.8, 
CHC13); Vmax (neat)/cm' 3500 (OH), 1685 (C0), 1603 (Ar), 1495 (Ar), 1321 (SO2N), 
1152 (S02N); 'H NMR 8 (250 MHz, CDC13) 7.42-7.35 (2H, in, ArII), 7.30-7.20 (8H, 
in, ArII), 7.16-7.07 (1H, in An]), 6.98 (2H, t, J = 7.7 Hz, An]), 6.79 (2H, s, ArH), 6.61 
(2H, d, J = 7.1 Hz, An]), 4.91 (1H, br s, CHOH), 4.73 (1H, d, J = 16.2 Hz, CHAHBPh), 
4.73 (1H, d, J = 9.2 Hz, CHPh), 4.40 (1 H, d, J = 16.2 Hz, CHAHBPh), 4.12 (1H, dq, J= 
9.2 & 6.8 Hz, CHCH3), 3.77 (1H, d, J = 3.9 Hz, CHOCH3), 3.21 (3H, s, OCH3), 2.80 
(1H, br d, J = 5.6 Hz, 01]), 2.27 (3H, s,p-CH3), 2.25 (6H, s,2 x  o-CH3), 1.30 (3H, d, J 
= 6.8 Hz, CHCH3); '3C NMR 6 (90.5 MHz, CDCI3) 198.86 (C), 142.18 (C), 140.47 (2 
C), 139.73 (C), 139.11 (C), 138.29 (C), 132.67 (C), 131.98(2 x  CH), 128.65(2 x  CH), 
128.23 (6 x  CH), 127.91 (CH), 127.54 (2 x  CH), 127.26 (CH), 127.05 (CH), 126.14 (2 
x CH), 90.37 (CH), 74.22 (CH), 60.34 (CH3), 56.47 (CH), 50.39 (CH), 47.19 (CH2). 
22.74 (2>< CH3), 20.77 (CH3), 17.26 (CH3). 
Method B: General procedure 0 was followed with thioipropionate ester 163 (150 
mg, 0.294 mmol), dicyciohexyiboron triflate (1.0 M in hexane, 0.88 ml, 0.88 mmol) and 
diisopropyiethyiamine (0.13 ml, 0.74 mmol). The reaction mixture was stirred at - 78 
°C for 1 h, then benzaldehyde was added (94 jil, 0.88 mmol). The reaction was stirred at 
- 78 °C for 2 h and warmed to 0 °C for 1.5 h. Purification by flash chromatography 
120% EtOAc in hexane) gave a mixture of diastereoisomers 167e and 168e that was 
separated by HPLC (154 mg, 85%) (ds 	= 68 : 32, ds syn : anti = 95 : 5, ds anti anti 
99 : 1). 
Method C: General procedure D was followed with thiolpropionate ester 163 (150 
mg, 0.294 mmol), dibutylboron triflate (1.0 M in hexane, 0.88 ml, 0.88 mmol) and 
triethylamine (104 p1, 0.74 mmol). The reaction mixture was stirred at - 78 °C for 1 h, 
then benzaldehyde was added (94 p1, 0.88 mmol). The reaction was stirred at - 78 °C 
for 2 h and warmed to 0 °C for 1.5 h. Purification by flash chromatography (20% 
EtOAc in hexane) gave a mixture of diastereoisomers 167e and 168e that was separated 
by HPLC (152 mg, 84%) (ds syn : syn = 26 :74, 	anti = 91: 9, ds anti: anti = 62: 38). 
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Method D: General procedure D was followed with thiolpropionate ester 163 (150 
mg, 0.294 mmol), dibutylboron triflate (1.0 M in hexane, 0.88 ml, 0.88 mmol) and 
diisopropylethylamine (0.13 ml, 0.74 mmol). The reaction mixture was stirred at - 78 
°C for 1 h, then benzaldehyde was added (94 il, 0.88 mmol). The reaction was stirred at 
- 78 °C for 2 h and warmed to 0 °C for 1.5 h. Purification by flash chromatography 
(20% EtOAc in hexane) gave a mixture of diastereoisomers 167e and 168e that was 
separated by HPLC (141 mg, 78%) (ds syn:syn 31 :69, dssyn:anti = 98 :2, ds anti: anti = 
49: 51). 
Method E: General procedure D was followed with thiolpropionate ester 163 (100 
mg, 0.196 mmol), 9-BBN-triflate (0.5 M in hexane, 1.2 ml, 0.59 mmol) and 
triethylamine (69 l, 0.49 mmol). The reaction mixture was stirred at - 78 °C for 1 h, 
then benzaldehyde was added (63 il, 0.59 mmol). The reaction was stirred at - 78 °C 
for 2 h and warmed to 0 °C for 1.5 h. Purification by flash chromatography (20% 
EtOAc in hexane) gave a mixture of diastereoisomers 167e and 168e that was separated 
by HPLC (88 mg, 73%) (ds 	= 21: 79, ds syn : anti = 99: 1). 
Method F: General procedure D was followed with thiolpropionate ester 163 (100 
mg, 0.196 mmol), 9-BBN-triflate (0.5 M in hexane, 1.2 ml, 0.59 mmol) and 
diisopropylethylamine (86 il, 0.49 mmol). The reaction mixture was stirred at - 78 °C 
for 1 h, then benzaldehyde was added (63 s.d, 0.59 mmol). The reaction was stirred at - 
78 °C f6f 2 h and warmed to 0 °C for 1.5 h. Purification by flash chromatography (20% 
EtOAc in hexane) gave a mixture of diastereoisomers 167e and 168e that was separated 
by HPLC (96 mg, 80%) (ds 	:syn 47 : 53, dssyn:anti = 96 : 4, ds anti: anti = 99 0- 
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General procedure E: Synthesis of Bn-Protected Syn Glycolate Aldol Adducts 
To a stirred solution of thiolpropionate ester 166 (150 mg, 0.256 mmol) in CH202 (10 
ml) at - 78 °C was added the boron triflate (1.0 M in hexane, 0.77 mmol) then amine 
base (0.64 mmol). The reaction mixture was stirred at - 78 °C for I h, then 
benzaldehyde was added (82 tl, 0.77 rnrnol). The reaction was stirred at - 78 °C for 2 h 
and then at 0 °C for 1.5 h. The mixture was quenched by the addition of pH 7 buffer and 
methanol (1:1, 4 ml) and diluted with methanol (4 ml) to make a homogeneous solution. 
After careful addition of H202  (30% aq, 2 ml) the mixture was stirred at RT for 30 mm. 
NaCl (10 ml, sat aq) was added and the mixture was extracted with CH202 (3 x 10 ml). 
The combined organics were washed with NaHCO3  (10 ml, sat aq) and NaCl (10 ml, sat 
aq), dried (MgSO4) and concentrated under reduced pressure to give the crude aldol 
product. Purification by flash chromatography (20% EtOAc in hexane) gave a mixture 
of diastereoisomers 171e and 172e that was separated by HPLC. 
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2'-(N_Benzyl-N-mesitylenesulfonylaifliflO)-1 '-phenyipropyl (1 'S,2S,2 'R,3R)- 2-
benzoxy-3-hydroxy-3-phenyl thiopropionate 171e 
OH 0 Ph 
CI -"NO BnsO2 
171e 









55 : 45 
42: 58 
62: 38 
Method A: General procedure E was followed with thiolpropionate ester 166 (150 
mg, 0.256 mmol), dicyclohexylboron triflate (1.0 M in hexane, 0.77 ml, 0.77 mmol) and 
triethylamine (90 tl, 0.64 mmol). Benzaldehyde was added (82 il, 0.77 mmol). 
Purification by flash chromatography (20% EtOAc in hexane) gave a mixture of 
diastereoisomers 171e and 172e that was separated by HPLC (159 mg, 90%) (ds 
= 74 : 26, ds syn : anti = 99 1). 
(2S,3R)-Major syn diastereoisomer 171e: HPLC R (20% EtOAc in hexane, flow 
rate: 10 ml/min) = 20 mm; Rf (20% EtOAc in hexane) = 0.28; LUID = + 13.7 (c 6.50, 
CHCI3); vmax (neat)/crn 1  3512 (OH), 1690 (C0), 1603 (Ar), 1494 (Ar), 1321 (SO2N), 
1152 (S02N); 'H NMR 6 (250 MHz, CDC13) 7.42-7.33 (211, m, An]), 7,28-7.20 (6H, 
m, ArJHT), 7.20-7.10 (6H, m, AnTI), 7.05-6.96 (4H, rn, Arf]), 6.80 (2H, s, ArIf), 6.68 (2H, 
d, J = 7.1 Hz, ArH), 4.80-4.70 (1H, br, CHOH), 4.77(111, d, J= 16.3 Hz, CHAHBPh), 
4.75 (1H, d, J = 8.9 Hz, CHPh), 4.51 (1H, d, J = 11.2 Hz, CHCHDPh), 4.40(111, d, J= 
16.3 Hz, CH AHBPh), 4.26 (1H, d, J = 11.2 Hz, CHCHDPh), 4.15 (1H, dq, Jr 8.9 & 6.8 
Hz, CHCH3), 3.94 (1H, d, J = 5.2 Hz, CHCOS), 2.78 (1H, br d, J= 4.7 Hz, 01]), 2.27 
(9H, s,2 x  o-CH3 &p-CH3), 1.18 (3H, d, J— 6.8 Hz, CHCH3); 13C NMR 6 (90.5 MHz, 
CDC13) 197.77 (C), 142.17 (C), 140.33 (2 x  C), 139.59 (C), 138.28 (2 x  C), 135.89 (C), 
132.61 (C), 131.97 (2 x CH), 128.42 (2 x  CH), 128.30 (3 x  CH), 128.20 (4 x  CH), 
128.06 (4 x CH), 127.84 (CH), 127.52 (2 x CH), 127.20 (CH), 127.04 (CH), 126.21 (2 
x CH), 88.26 (CH), 74.49 (CH), 73.89 (CH2), 56.07 (CH), 50.77 (CH), 47.33 (CH2), 
22.69 (2 x  C113), 20.72 (CH3), 17.42 (CH3); m/z (FAB, THIOG) 716 ([M+Na], 7%), 
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512 (22), 406 (36), 316 (49), 134 (25), 119 (60), 91(100); FIRMS (FAB, THIOG) 
[M+H] found 694.2657, C41H44N05S2 requires 694.2660. 
(2R,3S)-Minor syn diastereoisomer 172e: HPLC R (20% EtOAc in hexane, flow 
rate: 10 ml/min) = 18 mm; R1 (20% EtOAc in hexane) = 0.31; [U]D= + 48 (c 8.1, 
CHC13); Vnax (neat)/cm 3522 (OH), 1684 (C0), 1603 (Ar), 1495 (Ar), 1319 (S02N), 
1153 (S02N); 111  NMR 8 (250 MHz, CDC13) 7.46-7.37 (2H, in, An]), 7.32-7.12 (12H, 
in, ArH), 7.08-6.98 (4H, in, An]), 6.82 (2H, s, An]), 6.66 (2H, d, J = 7.1 Hz, An]), 
4.96 (1H, br s, CHOH), 4.79 (1H, d, J = 9.0 Hz, CHPh), 4.77 (1H, d, J = 16.2 Hz, 
CHAHBPh), 4.48 (1H, d, J= 11.2 Hz, CHCHDPh), 4.44 (1H, d, J= 16.2 Hz, CHAHBPh), 
4.17 (1H, d, 1= 11.2 Hz, CHCHDPh), 4.15 (1H, dq, J = 9.0 & 6.8 Hz, CHCH3), 3.99 
(1H, d, 1= 3.8 Hz, CHCOS), 2.91 (1H, br, 01]), 2.29 (9H, s, 2 >< o-CH3 &p-CH3), 1.24 
(3H, d, J= 6.8 Hz, CHCH3); 13C NMR ö (90.5 MHz, CDC13) 198.93 (C), 142.13 (C), 
140.40(2 x C), 139.75 (C), 139.15 (C), 138.26 (C), 135.80 (C), 132.66 (C), 131.94(2 
CH), 128.60 (2 >< CH), 128.19 (3 x  CH), 128.12 (4 x  CH), 128.00 (4 x  CH), 127.76 
(CH), 127.52 (2 x  CH), 127.21 (CH), 127.01 (CH), 126.05 (2 x  CH), 87.62 (CH), 74.33 
(CH), 74.23 (CH2), 56.48 (CH), 50.51 (CH), 47.16 (CH2), 22.71 (2 x  CH3), 20.73 
(CH3), 17.23 (CH3). 
Method B: General procedure E was followed with thiolpropionate ester 166 (150 
mg, 0.256 mmol), dicyclohexylboron tniflate (1.0 M in hexane, 0.77 ml, 0.77 mmol) and 
diisopropylethylamine (0.11 ml, 0.64 mmol). The reaction mixture was stirred at - 78 
°C for 1 h, then benzaldehyde was added (82 t1, 0.77 mmol). The reaction was stirred at 
- 78 °C for 2 h and warmed to 0 °C for 1.5 h. Purification by flash chromatography 
(20% EtOAc in hexane) gave a mixture of diastereoisomers 171e and 172e that was 
separated by HPLC (148 mg, 84%) (ds syn : syn 65 :35, ds sm : anti = 99 : 1). 
Method C: General procedure E was followed with thiolpropionate ester 166 (150 
mg, 0.256 mmol), dibutylboron tniflate (1.0 M in hexane, 0.77 ml, 0.77 mmol) and 
triethylamine (90 p1, 0.64 mmol). The reaction mixture was stirred at - 78 °C for 1 h, 
then benzaldehyde was added (82 jil, 0.77 mmol). The reaction was stirred at - 78 °C 
for 2 h and warmed to 0 °C for 1.5 h. Purification by flash chromatography (20% 
EtOAc in hexane) gave a mixture of diastereo isomers 171e and 172e that was separated 
by HPLC (156 mg, 82%) (ds syn : syn = 36: 64, ds syn anti = 99 : 1). 
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Method D: General procedure E was followed with thiolpropionate ester 166 (150 
mg, 0.256 mmol), dibutylboron triflate (1.0 M in hexane, 0.77 ml, 0.77 mmol) and 
diisopropylethylamine (0.11 ml, 0.64 mmol). The reaction mixture was stirred at - 78 
°C for 1 h, then benzaldehyde was added (82 l, 0.77 mmol). The reaction was stirred at 
- 78 °C for 2 h and warmed to 0 °C for 1.5 h. Purification by flash chromatography 
(20% EtOAc in hexane) gave a mixture of diastereoisomers 171e and 172e that was 
separated by HPLC (131 mg, 74%) (ds 	= 28: 72, ds 	anti 94 : 6). 
Method E: General procedure E was followed with thiolpropionate ester 166 (100 
mg, 0,170 mmol), 9-BBN-triflate (0.5 M in hexane, 1.0 ml, 0.51 mmol) and 
triethylamine (61 il, 0.43 mmol). The reaction mixture was stirred at - 78 °C for I h, 
then benzaldehyde was added (55 p.1, 0.51 mmol). The reaction was stirred at - 78 °C 
for 2 h and warmed to 0 °C for 1.5 h. Purification by flash chromatography (20% 
EtOAc in hexane) gave a mixture of diastereoisomers 171e and 172e that was separated 
by HPLC (94 mg, 80%) (ds )'n sj'n 31: 69, 	: anti = 93 :7). 
Method F: General procedure E was followed with thiolpropionate ester 166 (100 
mg, 0.170 mmol), 9-BBN-triflate (0.5 M in hexane, 1.0 ml, 0.51 mmol) and 
diisopropylethylamine (75 p.1, 0.43 mmol). The reaction mixture was stirred at - 78 °C 
for 1 h, then benzaldehyde was added (55 p.1, 0.51 mmol). The reaction was stirred at - 
78 °C for 2 h and warmed to 0 °C for 1.5 h. Purification by flash chromatography (20% 
EtOAc in hexane) gave a mixture of diastereoisomers 171e and 172e that was separated 
by HPLC (93 mg, 79%) (ds 	: 	43 : 57, ds syn: anti = 97 : 3). 
Method G: General procedure E was followed with thiolpropionate ester 166 (150 
mg, 0.256 mmol), dicyclohexylboron triflate (1.0 M in hexane, 0.77 ml, 0.77 mmol) and 
triethylamine (90 p.1, 0.64 mmol). The reaction mixture was stirred at 0 °C for 1 h, then 
benzaldehyde was added (82 p.1, 0.77 mmol). The reaction was stirred at 0 °C for 1 h. 
Purification by flash chromatography (20% EtOAc in hexane) gave a mixture of 
diastereoisomers 171e and 172e that was separated by HPLC (107 mg, 60%) (ds syn syn 
= 55 : 45, ds syn : anti= 68 : 32). 
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Method H: General procedure E was followed with thiolpropionate ester 166 (150 
mg, 0.256 mmol), dibutylboron triflate (1.0 M in hexane, 0.77 ml, 0.77 mmol) and 
diisopropylethylamine (0.11 ml, 0.64 mmol). The reaction mixture was stirred at 0 °C 
for 1 h, then benzaldehyde was added (82 il, 0.77 mmol). The reaction was stirred at 0 
°C for 2 h. Purification by flash chromatography (20% EtOAc in hexane) gave a 
mixture of diastereoisorners 171e and 172e that was separated by HPLC (120 mg, 68%) 
(ds s:yn ; syn = 42 : 58, ds syn : anti = 93 : 7). 
Method I: General procedure E was followed with thiolpropionate ester 166 (150 mg, 
0.256 mmol), dicyclohexylboron triflate (1.0 M in hexane, 0.77 ml, 0.77 mmol) and 
triethylamine (90 iil, 0.64 mmol). The reaction mixture was stirred at RT for 1 h, then 
benzaldehyde was added (82 iii, 0.77 mmol). The reaction was stirred at RT for 1 h. 
Purification by flash chromatography (20% EtOAc in hexane) gave a mixture of 
diastereoisomers 171e and 172e that was separated by HPLC (156 mg, 88%) (ds 	syn 
= 62 : 38, ds syn : anti = 93 : 7). 
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General procedure F: Synthesis of Bn-Protected Anti Glycolate Aldol Adducts 
To a stirred solution of thiolpropionate ester 166 (150 mg, 0.256 mmol) in solvent (15 
ml) at - 78 °C was added dicyclohexylboron chloride (166 j.tl, 0.770 mmol) then amine 
base (0.64 mmol). The reaction mixture was stirred at - 78 °C for 1 h, then 
benzaldehyde was added (82 tl, 0.77 mmol). The reaction was stirred at - 78 °C for 2 h 
and then at 0 °C for 1.5 h. The mixture was quenched by the addition of pH 7 buffer 
and methanol (1:1, 4 ml) and diluted with methanol (4 ml) to make a homogeneous 
solution. After careful addition of H202 (30% aq, 2 ml) the mixture was stirred at RT for 
30 min. 
NaCl (20 ml, sat aq) was added and the mixture was extracted with CH2C12 (3 x 10 ml). 
The combined organics were washed with NaHCO3 (10 ml, sat aq) and NaCl (10 ml, sat 
aq), dried (MgSO4) and concentrated under reduced pressure to give the crude aldol 
product. Purification by flash chromatography (20% EtOAc in hexane) gave a mixture 
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Method A: General procedure F was followed with thiolpropionate ester 
166 (150 
mg, 0.256 mmol) in CH202  (15 ml) at - 78 °C, to which was added dicyclohexylboron 
chloride (166 tl, 
0.770 mmol), then triethylamine (90 t1, 0.64 mmol). Benzaldehyde 
was added (82 tl, 0.77 mmol). Purification by flash chromatography (20% EtOAc in 
hexane) gave a mixture of diastereoisomers 181e and 182e (174 mg, 98%), (ds 
an/I: anti = 
77 : 23, by 'H NMR 
integration of diastereomeric mixture). Major diastereoisomer 
iSle was separated by HPLC (ds an/i: = 98 : 2). 
(2S,3S)-Major anti diastereoisomer 181e: HPLC R 
(20% EtOAc in hexane, flow 
rate: 10 ml/min) = 21 mm; Rf  (20% EtOAc in hexane) = 0.27; [u]D 
- 50 (c 0.70, 
CHC13); Vmax (neat)/cm' 3501 (OH), 1683 (C0), 1603 (Ar), 1495 (Ar), 1321 (SON, 
1152 (SON; 'H NMR ö (250 MHz, CDC13
) 7.45-6.98 (18H, m, An]), 6.83 (2H, s, 
Arm, 6.70 (2H, d, J = 7.0 Hz, Arm, 4.80 (1H, d, J = 
16.3 Hz, CHAHBPh), 4.77 (1H, d, 
J = 8.8 Hz, Ch), 4.72 (111, dd, J = 6.4 & 3.8 Hz, 
CHOH), 4.46 (1H, d, J = 11.3 Hz, 
CHcHDPh), 4.45 (1H, d,J 16.3 Hz, CHAHBPh), 4.19 (1H, 
d,J 11.3 Hz, CHCHDPh), 
4.13 (1H, dq, J 8.8 & 6.8 Hz, CHCH3), 3.97 (1H, d, 
J= 6.4 Hz, CHCOS), 2.78 (1H, d, 
J = 3.8 Hz, OH), 2.30 (9H, s, 2 x o-CH3 &p-CH3), 
1.20 (3H, d, J = 6.8 Hz, CHCH3); 
13C NMR 6 (90.5 MHz, CDCI3) 199.56 (C), 142.21 (C), 140.35 (2 
x C), 139.62 (C), 
138.57 (C), 138.37 (C), 136.15 (C), 132.69 (C), 132.01 (2 x CH), 128.37 (2 
x CH), 
128.26 (6 x CH), 127.96 (6 x CH), 127.56 (2 
x CH), 127.23 (CH), 127.03 (CH), 126.80 
(2 x CH), 86.87 (CH), 74.63 (CH), 74.06 (CH2
), 56.15 (CH), 50.87 (CH), 47.45 (CH2), 
22.73 (2 x CH3), 20.76 (CH3), 17.33 (CH3
); nilz (FAB, 3-NOBA) 694 (M+H], 3.1%), 
173 
406 (37), 316 (100), 119 (100), 91 (100); FIRMS (FAB, 3-NOBA) [M] found 
693.2585, C41H43N05S2 requires 693.2583. 
(2R,3R)-Minor anti diastereoisOmer 182e: HPLC R 
(20% EtOAc in hexane, flow 
rate: 10 ml/min) = 22 mm; R1 (20% EtOAc in hexane) = 0.26; 
'H NMR ö (250 MHz, 
CDCI3) diagnostic peaks 4.04 (1 H, d, J 
= 6.1 Hz, CHCOS), 2.89 (1 H, d, J = 4.3 Hz, 
OH), 1.10 (3H, d, J = 6.8 Hz, CHCH3); '3C NMR 
ö (90.5 MHz, CDCI3) diagnostic 
peaks 199.49 (C), 140.40 (2 x  C), 139.88 (C), 138.65 (C), 138.29 (C), 136.22 (C), 
128.58 (2 x CH), 128.22 (6 x CH), 127.91 (6 x CH), 127.52 (2 x CH), 127.13 (CH), 
87.17 (CH), 74.81 (CH), 74.38 (CH2), 56.38 (CH), 50.46 (CH), 47.25 (CH
2), 17.21 
(CH3) 
Method B: General procedure F was followed with thiolpropionate ester 
166 (150 
mg, 0.256 mmol) in CH202  (15 ml) at - 78 °C, to which was added dicyclohexylboron 
chloride (166 d, 0.770 mmol), then diisopropylethYlamine (0.11 ml, 0.64 mmol). The 
reaction mixture was stirred at - 78 °C for I h, then benzaldehyde was added (82 ti, 
0.77 mmol). The reaction was stirred at - 78 °C for 2 h and warmed to 0 °C for 2 h. 
Purification by flash chromatography (20% EtOAc in hexane) gave a mixture of 
diastereoisomers 181e and 182e (86 mg, 49%), (ds anti : anti 
= 71 : 29, by 'H NMR 
integration of diastereomeric mixture). Major diastereoisomer 181e was separated by 
HPLC (ds anti 	= 94: 6). 
Method C: General procedure F was followed with thiolpropionate ester 
166 (150 
mg, 0.256 mmol) in diethylether (15 ml) at - 78 °C, to which was added 
dicyclohexylboron chloride (166 tl, 0.770 mmol), then triethylamine (90 tl, 0.64 
mmol). Benzaldehyde was added (82 tl, 0.77 mmol). Purification by flash 
chromatography (20% EtOAc in hexane) gave a mixture of diastereoisomerS 
181e and 
182e (163 mg, 92%), (ds anti anti = 77 : 23, by 
'H NMR integration of diastereomeric 
mixture). Major diastereoisomer 181e was separated by HPLC 







To a solution of diol 183 (51 mg, 0.20 mmol) in pyridine (1.0 ml) at 0 °C was added 
DMAP (2.0 mg, 0.02 mmol) and benzoyl chloride (94 tI, 0.80 mmol). The reaction 
mixture was stirred at RT for 14 h. The reaction mixture was diluted with Et20 (15 ml) 
and was washed with HCl (2 x 10 ml, 1 N aq). NaCl (1 x 10 ml), NaHCO3 
(2 x  10 ml, 
sat aq) and NaC1 (2 < 10 ml, sat aq). The organics were dried (MgSO4) and the volatiles 
removed under reduced pressure. Flash chromatography (10% EtOAc in hexane) 
afforded 184 as a colourless oil (88 mg, 96%); Rf 
 (10% EtOAc in hexane) = 0.28; [a ID 
= - 30.4 (c 2.50, benzene) lit.'39 - 31.6 (c 0.95, benzene); 1 H NMR ô (250 MHz, 
CDC13)'39  8.11 (2H, d, J= 7.1 Hz, ArH), 7.99 (2H, d, J= 
7.1 Hz, ArH), 7.63-7.55 (2H, 
m, ArH), 7.50-7.30 (10H, m, ArH), 7.28-7.16 (4H, m, ArH), 6.31 (1H, d, J = 5.6 Hz, 
CHPh), 4.68 (1H, d, J = 11.8 Hz, CHAHBPh), 4.63 (1H, dd, J = 11.8 & 4.0 Hz, 
CH2OBz), 4.61 (1H, d, J = 11.8 Hz, CHAHBPh), 4.52 (1H, dd, J 
= 11.8 & 6.2 Hz, 
CH2OBz), 4.24 (111, ddd, J = 6.2, 5.6 & 4.0 Hz, CHOBn); 13
C NMR 6 (90.6 MHz, 
CDC13) 167.38 (C), 166.34 (C), 138.58 (C), 138.11 (C), 134.29 (CH), 134.11 (CH), 
131.20 (C), 130.94 (C), 130.82 (2 x CH), 130.75 (2 x CH), 129.55 (2 
x CH), 129.53 (2 
x CH), 129.41 (5 x CH), 129.08 (2 x CH), 128.84 (CH), 128.26 (2 
x CH), 79.85 (CH), 
76.01 (CH), 73.93 (CH2), 64.67 (CH2). 
'H spectroscopic data in good agreement with the literature. 139 
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General procedure G: Synthesis of TBDPS-Protected Syn Glycolate Aldol Adducts 
To a stirred solution of TBDPS-protected thiolester 190 (60 mg, 0.08 mmol) in CH202 
(6 ml) at - 78 °C was added the boron chloride or triflate (0.24 mmol) then amine base 
(0.20 mmol). The reaction mixture was stirred at - 78 °C for 1 h, then benzaldehyde was 
added (26 il, 0.24 mmol). The reaction was stirred at - 78 °C for 2 h and then at 0 °C 
for 1.5 h. The mixture was quenched by the addition of pH 7 buffer and methanol (1:1, 
4 ml) and diluted with methanol (4 ml) to make a homogeneous solution. After careful 
addition of H202 (30% aq, 1 ml) the mixture was stirred at RT for 30 mm. 
NaCl (10 ml, sat aq) was added and the mixture was extracted with CH2C12 (3 >< 10 ml). 
The combined organics were washed with NaHCO3 (10 ml, sat aq) and NaCl (10 ml, sat 
aq), dried (MgSO4) and concentrated under reduced pressure to give the crude aldol 
product. Purification by flash chromatography (10% EtOAc in hexane) and then HPLC 
gave a mixture of diastereomeric aldol adducts 195e and 196e. 
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2' 	
' -phenylpropyl (1 'S,2S,2 'R,3R)- 2-(tert- 
thiolpropionate 195e 
OH 0 Ph 	 OH 0 Ph 
	
L) OTBDPS NBn 	 - 	OTBDPS NBn 
SO2 502 
195e 	 92:8 	196e 	r 90:10 
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Method A: General procedure G was followed with TBDPS-protected thiolester 190 
(60 mg, 0.08 mmol), dicyclohexylboron triflate (1.0 M in hexane, 0.24 ml, 0.24 mmol), 
triethylamine (28 l, 0.20 mmol) and benzaldehyde (26 l, 0.24 mmol). Purification by 
flash chromatography (10% EtOAc in hexane) and then HPLC gave a mixture of 
diastereoiSOmers 195e and 196e (56 mg, 82%), (ds y, : p, 
= 92 : 8, by 'H NMR 
integration of diastereomeric mixture). 
(2S,3R)-Major syn diastereoiSOmer 195e: HPLC R 
(10% EtOAc in hexane, flow 
rate: 10 ml/min) = 30 mm; Rf  (20% EtOAc in hexane) = 0.43; [alo = 
+ 24.4 (c 0.90, 
CHC13) (92:8 diastereomeriC mixture); Vmax (neat)/cm-1 
 3510 (OH), 1684 (C0), 1600 
(Ar), 1494 (Ar), 1321 (SO2N), 1152 (SON; 'H NMR 
S (250 MHz, CDC13) 7.61-6.95 
(21H, in, Arm, 6.81 (2H, s, Arm, 6.76 (2H, d, J = 7.0 Hz, Arm, 6.62 (2H, d, 
J= 7.1 
Hz, Arm, 4.75 (1H, d, J = 16.3 Hz, CHAHBPh), 4.59 (1H, d, J- 
9.6 Hz, Ch), 4.56 
(1H, d, J= 4.4 Hz, CHOH), 4.35 (1H, d, J- 4.4 Hz, 
CHCOS), 4.33 (1H, d, 1 = 16.3 Hz, 
CHAHBPh), 4.10 (1H, dq, J = 6.8 Hz, CHCH3), 
2.30 (6H, s,2 x o-CH3), 2.24 (3H, s,p-
CH3), 1.11 (3H, d, J = 6.8 Hz, CHCH3), 1.07 (9H, s, 
C(CH3)3); '3C NMR S(90.5 MHz, 
CDC13) 197.15 (C), 142.15 (C), 140.46 (2 
x  C), 139.82 (C), 138.32 (C), 137.72 (C), 
135.78 (2 x CH), 135.73 (2 x CH), 132.66 (C), 132.21 (C), 132.01 (2 x CH), 131.72 
(C), 130.13 (CH), 130.08 (CH), 128.67 (2 x CH), 128.21 (3 x CH), 128.13 (2 x CH), 
127.80 (2 x CH), 127.75 (2 x CH), 127.62 (4 x CM), 127.23 (CH), 126.91 (CH), 126.41 
(2 x CH), 82.49 (CH), 76.15 (CH), 55.93 (CH), 50.69 (CH), 47.24 (CM2), 26.77 (3 x 
CH3), 22.71 (2 x CH3), 20.58 (CH3), 19.13 (C), 17.93 (CH
3); ni/z (ESI, -) 840 ([M-H], 
4%), 801 (95), 633 (18), 367 (100); HRMS 
(ESI, -) [M-Hf found 840.3186, 
C50H54NO5S2Si requires 840.3207. 
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(2R,3S)-Minor syn diastereoisomer 196e: HPLC R 
(10% EtOAc in hexane, flow 
rate: 10 ml/min) = 30 mm; Rf  (20% EtOAc in hexane) = 0.43; 'H NMR 
ö (250 MHz, 
CDC13) diagnostic peaks 6.85 (2H, s, An]), 6.55 (2H, d, 
J = 7.1 Hz, An]), 4.64 (1H, d, 
J = 9.7 Hz, Ch), 4.39 (III, d, J = 16.3 Hz, CHA
HBPh), 4.37 (III, d, J = 3.9 Hz, 
CHCOS), 1.12 (3H, d, J = 6.8 Hz, CHCH3), 1.04 (9H, s, 
C(CH3)3); '3C NMR 6 (90.5 
MHz, CDC13) diagnostic peaks 196.70 (C), 142.12 (C), 140.40 (2 
x C), 140.08 (C), 
138.49 (C), 137.92 (C), 132.94 (C), 131.56 (C), 131.16 (C), 129.90 (CH), 128.99 (CH), 
128.55 (2 x  CH), 128.38 (CH), 128.30 (CH), 127.92 (2 x CH), 127.77 (2 x CH), 127.67 
(4 x CH), 127.50 (2 x CH), 127.45 (2 x 
CH), 127.19 (CH), 126.85 (CH), 126.48 (2 x 
CH), 82.60 (CH), 76.27 (CH), 56.20 (CH), 50.51 (CH), 47.35 (CH2), 22.48 (2 
x  CH3), 
20.79 (CH3), 19.17 (C), 17.64 (CH3). 
Method B: General procedure G was followed with TBDPS-protected thiolester 
190 
(60 mg, 0.08 mmol), dicyclohexylboron chloride (52 tl, 0.24 mmol), triethylamine (28 
ti, 0.20 mmol) and benzaldehyde (26 l, 0.24 mmol). Purification by flash 
chromatography (10% EtOAc in hexane) and then HPLC gave a mixture of 
diastereoisomers 195e and 196e (65 mg, 95%), (ds 	
= 90 : 10, by 'H NMR 
integration of diastereomeric mixture). 
Method C: General procedure G was followed with TBDPS-protected thiolester 
190 
(60 mg, 0.08 mmol), dibutylboron triflate (1.0 M in hexane, 0.24 ml, 0.24 mmol), 
diisopropylethylamifle (35 l, 0.20 mmol) and benzaldehyde (26 tI, 0.24 mmol). 
Purification by flash chromatography (10% EtOAc in hexane) and then HPLC gave a 
mixture of diastereoisomers 195e and 196e (53 mg, 77%), (ds y,:y,
= 61: 39, by lii 
NMR integration of diastereomeric mixture). 
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General procedure H: Optimised Synthesis of TBDPS-Protected Syn Glycolate 
Aldol Adducts 
To a stirred solution of TBDPS-protected thiolester 190 (25 mg, 0.03 mmol) in CH202 
(5 ml) at - 78 °C was added dicyclohexylboron triflate (1.0 M in hexane, 0.10 ml, 0.10 
mmol) then triethylamine (14 pi, 0.10 mmol). The reaction mixture was stirred at - 78 
°C for 1 h, then aldehyde was added (0.10 mmol). The reaction was stirred at - 78 °C for 
2 h and then at 0 °C for 1.5 h. The mixture was quenched by the addition of pH 7 buffer 
and methanol (1:1, 4 ml) and diluted with methanol (4 ml) to make a homogeneous 
solution. After careful addition of H202  (30% aq, I ml) the mixture was stirred at RT for 
30 mm. 
NaCl (10 ml, sat aq) was added and the mixture was extracted with CH2C12 (3 x 10 ml). 
The combined organics were washed with NaHCO3  (10 ml, sat aq) and NaCl (10 ml, sat 
aq), dried (MgSO4) and concentrated under reduced pressure to give the crude aldol 
product. Purification by flash chromatography (10% EtOAc in hexane) and then HPLC 
gave a mixture of diastereomeric aldol adducts. 
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2 '(N_BenzylN_mesitYlefleSUlfO0Ytam1n0) 1' -phenylpropyl (1 
'S,2S,2 'R,3R)- 2-(tert-
b uty IdiphenyIsiIyIoxy)3hydroxy4methy1thb0lPent4 neoate 195a 
OH 0 Ph 	 OH 0 Ph 
	
OTBDPS NBn 	 OTBDPS NBn 
SO2 SO2 
92: 8 
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General procedure H was followed with TBDPS-protected thiolester 190 (25 mg, 0.03 
mmol), dicyclohexylboron triflate (1.0 M in hexane, 0.10 ml, 0.10 mmol), triethylamine 
(14 1, 0.10 mmol) and methacrolein (10 i1, 0.12 mmol). Purification by flash 
chromatography (10% EtOAc in hexane) and then HPLC gave a mixture of 
diastereoisomerS 195a and 196a (21 mg, 76%), (ds . : . = 92 : 8, by 1
H NMR 
integration of diastereomeric mixture). 
(2S,3R)-Major syn diastereoisomer 195a: HPLC R (10% EtOAc in hexane, flow 
rate:10 ml/min) = 27 mm; R1  (20% EtOAc in hexane) = 0.48; [aID = - 4.0 (c 0.50, 
CHC13) (96:4 diastereomeric mixture); Vmax (neat)/cm' 3521 (OH), 1684 (C0), 1603 
(Ar), 1495 (Ar), 1321 (SO2N), 1152 (SON; '11 NMR 6 (250 MHz, CDC13) 7.65-7.55 
(4H, in, ArII), 7.45-7.15 (11H, in, An]), 7.10 (1H, t, J= 7.7 Hz, ArIf), 6.98 (2H, t, J= 
7.4 Hz, An]), 6.81 (2H, s, ArR), 6.66 (2H, d, J = 7.8 Hz, An]), 4.81 (1H, d, J = 16.3 
Hz, CHAHBPh), 4.68 (1H, d, J = 9.4 Hz, CHPh), 4.59 (1H, br s, 
=CHCHD), 4.53 (1H, hr 
s, =CHCHD), 4.41 (IH, d, J = 16.3 Hz, CHAHBPh), 4.29 (1H, d, 
J = 4.0 Hz, CHCOS), 
4.19 (1H, dq, J 6.7 & 9.4 Hz, CHCH3), 3.8 9 (1H, br s, CHOH), 2.29 (3H, 
s,p-CH3), 
2.27 (6H, s, 2 x  o-CH3), 2.08 (1H, br, 01]), 1.25 (3H, s, CH2 CCH3), 
1.20 (3H, d, J 
6.7 Hz, CHCH3), 1.12 (9H, s, C(CH3)3); 13C NMR 6 (90.5 MHz, CDCI3
) 196.87 (C), 
142.19 (C), 140.68 (C), 140.47 (2 x C), 139.83 (C), 138.38 (C), 135.78 (2 
x CH), 
135.76 (2 x CH), 132.77 (C), 132.28 (C), 132.03 (2 
x CH), 131.67 (C), 130.25 (CH), 
130.16 (CH), 128.59 (2 x CH), 128.21 (2 x CH), 128.11 (2 
x CH), 127.82 (2 x  CH), 
127.73 (2 x CH), 127.60 (2 x CH), 127.22 (CH), 126.93 (CH), 112.82 (CH
2), 80.17 
(CH), 77.10 (CH), 56.07 (CH), 50.75 (CH), 47.39 (CH2), 26.82 (3 x  CH3), 22.75 (2 
x 
CH3), 20.81 (CH3), 19.21 (C), 18.48 (CH3), 17.87 (CH3
); m/z (EST, -) 804 ([M—H], 
180 
100%), 415 (6); IIRMS (ESI, -) {M—H], found 804.3224, C47H54NO5S2Sj requires 
804.3207. 
(2R,3S)-Minor syn diastereoisOmer 196a: HPLC R 
(10% EtOAc in hexane, flow 
rate: 10 ml/min) = 27 mm; R1  (20% EtOAc in hexane) = 0.48; 
'H NMR 6 (250 MHz, 
CDCI3) diagnostic peaks 6.79 (2H, s, ArH), 6.44 (2H, d, 
J = 7.9 Hz, ArR), 4.72 (1H, d, 
J = 8.6 Hz, Ch), 4.56 (1H, br s, CHCHD), 
4.49 (1H, br s, =CHCHD), 2.32 (3H, s,p-
CH3), 2.23 (611, s, 2 x o-CH3), 1.16 (3H, d, 1 = 7.0 Hz, 
CHCH3), 1.06 (911, s, C(CH3)3); 
'3C NMR 6 (90.5 MHz, CDC13) diagnostic peaks 140.39 (2 
x C), 138.21 (C), 56.21 
(CH), 22.88 (2 x CH3). 
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2' (N_BenzylN_meSitYleneSu1f0nY1mu1b0)4 ' -phenyipropyl (1 'S,2S,2 'R,3R)- 2-(tert- 
195c 
OH 0 Ph 	 01-i 0 Ph 
	
OTBDPS NBn 	 OTBDPS NBn 
SO2 502 
95: 5 
195c 	 196c 	
L) 
General procedure H was followed with TBDPS-protected thiolester 
190 (25 mg, 0.03 
mmol), dicyclohexylboron triflate (1.0 M in hexane, 0.10 ml, 0.10 mmol), triethylarnine 
(14 tl, 0.10 mmol) and isobutyraldehyde (10 1, 0.12 mmol). Purification by flash 
chromatography (10% EtOAc in hexane) and then HPLC gave a mixture of 
diastereoisomers 195c and 196c (20 mg, 73%), (ds 	
= 95 : 5, by 1H NMR 
integration of diastereomeric mixture). 
(2S,3R)-Major syn diastereoisomer 195c: HPLC R 
(10% EtOAc in hexane, flow 
rate:10 ml/min) = 22 mm; Rf  (20% EtOAc in hexane) = 0.52; [UID 
= - 10 (c 0.40, 
CHC13) (95:5 diastereomeric mixture); Vnax 
(neat)/cm' 3567 (OH), 1685 (C=O), 1603 
(Ar), 1495 (Ar), 1322 (SO2N), 1153 (SON); 111 NMR ö (250 MHz, CDC1
3) 7.62-7.58 
(4H, in, Arm, 7.45-7.20 (11H, in, Arm, 7.11 (1H, t, 
J= 7.3 Hz, Arm, 7.00 (2H, t, J= 
7.8 Hz, Arm, 6.81 (2H, s, Arm, 6.70 (2H, d, J = 7.1 Hz, Arm, 4.81 (1H, d, 
J = 16.3 
Hz, CHAHBPh), 4.71 (1H, d, J = 9.2 Hz, Ch), 4.43 (1H, d, 
J— 16.3 Hz, CHAHBPh), 
4.31 (1H, d, J = 3.5 Hz, CHCOS), 4.22 (1H, dq, J = 
6.8 & 9.2 Hz, CHCH3), 3.03 (1 H, 
dt, J = 7.8 & 3.8 Hz, CHOH), 2.28 (9H, s,2 
x o-CH3  &p-CH3), 1.80 (1H, d, J = 4.3 Hz, 
O, 1.50-1.38 (1H, in, CH(CH3)2), 1.22 (3H, d, 
J = 6.8 Hz, CHCH3), 1.11 (9H, s, 
C(CH3)3), 0.61 (3H, d, J = 6.6 Hz, CHCH3), 
0.48 (3H, d, J = 6.6 Hz, CHCH3); 13C 
NMR ö (90.5 MHz, CDC13) 198.34 (C), 142.21 (C), 140.45 (2 
x C), 139.76 (C), 138.38 
(C), 135.81 (2 x CH), 135.73 (2 x 
CH), 132.83 (C), 132.43 (C), 132.03 (2 x CH), 
131.77 (C), 130.21 (CH), 130.14 (CH), 128.54 (2 x CH), 128.19 (4 
x CH), 127.81 (2 x 
CH), 127.72 (2 x CH), 127.58 (2 x 
CH), 127.20 (CH), 126.94 (CH), 79.89 (CH), 79.67 
(CH), 56.45 (CH), 50.70 (CH), 47.46 (CH2), 28.74 (CH), 26.86 (3 
x CH3), 22.76 (2 x 
CH3), 20.82 (CH3), 19.24 (CH3), 18.79 (CH3), 18.33 (CH
3), 17.61 (C); m/z (ESI, -) 806 
182 
({M—H], 100%), 367 (7); HRMS (ESI, -)[M—Hl-  found 806.3364, C47H56NO5S2S 
requires 806.3364. 
(2R,35)-Minor syn diastereoisomer 196c: HPLC R (10% EtOAc in hexane, flow 
rate: 10 ml/min) = 22 mm; Rf (20% EtOAc in hexane) = 0.52; 1H NMR ö (250 MHz, 
CDC13) diagnostic peaks 0.71 (3H, d, I = 6.5 Hz, CHCH3), 0.55 (3H, d, 1 = 6.9 Hz, 
CHCH3); '3C NMR 6 (90.5 MHz, CDC13) diagnostic peaks 28.95 (CH). 
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2 '(N_BenzylN_meSitYlefleSU1f011Ylamin0)A '-phenylpropyl (1 'S,2S,2 'R,3R)- 2-(tert- 
1 95d 
OH 0 Ph 	 OH 0 Ph 
	
OTBDPS NBn 	 OTBDPS NBn 
SO2 SO2 
95: 5 
195d 	Lji 	 196d 	LTJJ 
General procedure H was followed with TBDPS-protected thiolester 190 (25 mg, 0.03 
mmol), dicyclohexylboron triflate (1.0 M in hexane, 0.10 ml, 0.10 mmol), triethylamine 
(14 l, 0.10 mmol) and isovaleraldehyde (11 1, 0.10 mmol). Purification by flash 
chromatography (10% EtOAc in hexane) and then HPLC gave a mixture of 
diastereoisomers 195d and 196d (18 mg, 64%), (ds syn :y, = 95 : 5, by 'H NMR 
integration of diastereomeric mixture). 
(2S,3R)-Major syn diastereoisomer 195d: HPLC R (10% EtOAc in hexane, flow 
rate:10 ml/min) = 23 mm; R f  (20% EtOAc in hexane) = 0.51; laiD = - 8.0 (c 0.25, 
CHC13 ) (95:5 diastereomeric mixture); Vmax (neat)/cm' 3549 (OH), 1686 (C=O), 1603 
(Ar), 1495 (Ar), 1323 (S02N), 1153 (SO2N); 1H NMR 6 (250 MHz, CDC13) 7.67-7.59 
(4H, m, ArH), 7.45-7.20 (11H, m, ArH), 7.11 (1H, t, J= 7.6 Hz, An]), 7.00 (2H, t, J= 
7.3 Hz, ArH), 6.81 (2H, s, An]), 6.71 (2H, d, J = 7.8 Hz, ArH), 4.81 (1H, d, J= 16.3 
Hz, CHAHBPh), 4.70 (1H, d, J = 9.2 Hz, CHPh), 4.41 (1H, d, J = 16.3 Hz, CHA
HBPh), 
4.25 (1H, d, J = 3.2 Hz, CHCOS), 4.21 (1H, dq, J = 6.8 & 9.2 Hz, CHCH3), 3.52-3.45 
(1H, m, CHOH), 2.29 (9H, s,2 x  o-CH3 &p-CH3), 1.43 (1H, d, J= 5.9 Hz, Oil) 1.42-
1.39 (1H, m, CH(CH3)2), 1.21 (3H, d, J= 6.8 Hz, CHCH3), 1.13 (9H, s, C(CH3)3), 1.09 
(1H, ddd, J = 13.8, 9.8 & 4.9 Hz, CHCHD), 0.75 (1H, ddd, J = 13.8, 9.2 & 3.3 Hz, 
CHCHD), 0.61 (3H, d, 1 = 6.5 Hz, CHCH3), 0.49 (3H, d, J = 6.5 Hz, CHCH3 ); 13
C NMR 
ö (90.5 MHz, CDC13) 198.64 (C), 142.22 (C), 140.45 (2 x C), 139.85 (C), 138.37 (C), 
135.84 (2 x CH), 135.67 (2 x CH), 132.82 (C), 132.75 (C), 132.03 (2 
x CH), 131.76 
(C), 130.20 (CH), 130.14 (CH), 128.51 (2 x CH), 128.22 (2 x CH), 128.15 (2 x  CH), 
127.86 (2 x CH), 127.74 (2 x CH), 127.61 (2 x CH), 127.22 (CH), 126.95 (CH), 82.28 
(CH), 72.29 (CH), 56.19 (CH), 50.72 (CH), 47.49 (CH2), 39.98 (CH2), 26.91 (3 x  CH3), 
184 
23.92 (CH), 23.14 (CH3), 22.75 (2 x  CH3), 21.18 (CH3), 20.82 (CH3
), 19.34 (C), 17.77 
(CH3); m/z (ESI, -) 820 ({M—HI[, 1000,/o), 288 (4); HRMS 
(ESI, -) [M—H] found 
820.3540, C4gH5gNO5S2Sj requires 820.3520. 
(2R,3S)-Minor syn diastereolsomer 196d: HPLC R (10% EtOAc in hexane, flow 
rate: 10 ml/min) = 23 mm; R(20% EtOAc in hexane) = 0.51; 'H NMR 8 (250 MHz, 
CDC13) diagnostic peaks 0.55 (31-1, d, J= 6.5 Hz, CHCH3). 
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6.4 EXPERIMENTAL PROCEDURES FOR CHAPTER 4 
General procedure I: Hydrolysis Reaction 
To a stirred solution of the unprotected aldol adduct (114 mg, 0.201 mmol) in THF (4 
ml) was added a solution of LiOH (26 mg, 0.60 mmol) in H20 (2 ml) at RT. After 
stirring at RT for 30 mm, the mixture was acidified to pH 3 using HC1 (1 N aq) and the 
solution was extracted with Et20 (3 x 10 ml). The organics were washed with NaCl (2 x 
10 ml, sat aq), and dried (MgSO4), and the volatiles removed under reduced pressure to 
give a colourless oil which was purified by flash chromatography (20% EtOAc in 
hexane-1% AcOH) to recover the auxiliary 117 and the acid product as a colourless oil. 
(2S,3S)-2,4-Dimethyl-3-hydroxy-pentanoic acid 143 97 
OH 0 
OH 
General procedure I was followed with aldol adduct 137c (114 mg, 0.201 mmol) in 
TFIF (4 ml), to which was added a solution of LiOH (26 mg, 0.60 mmol) in H20 (2 ml) 
at RT. Purification by flash chromatography (20% EtOAc in hexane-1% AcOH) gave 
auxiliary 117 (88 mg, 100%) and acid 143 as a colourless oil (29 mg, 99%); R, (20% 
EtOAc in hexane-l% AcOH) = 0.23; [aID = + 14.3 (c 0.70, CHC13) lit- 97 + 14.1 (c 1. 1, 
CHC13); Vmax (neat)/cm 3425 (br, OH), 1714 (C=O); 'H NMR 6 (250 MHz, CDC13) 
6.20-5.50 (21-1, br, 2 x Off), 3.36 (1H, dd, J = 6.5 & 5.4 Hz, CHOH), 2.61 (1H, dq = 
qn, J = 7.1 Hz, CHCH3), 1.80— 1.67 (1H, sptd, J = 6.8 & 5.4 Hz, CH(CH3)2), 1.17 (31-1, 
d, J = 7.1 Hz, CHCH3), 0.92 (31-1, d, J = 6.8 Hz, CH(CH3)A(CH3)B), 0.86 (31-1, d, J = 6.8 
Hz, CH(CH3)A(CH3)B); 13C NMR 6 (90.6 MHz, CDCI3) 182.39 (C), 79.08 (CH), 43.70 
(CH), 31.75 (CH), 20.77 (CH3), 17.16 (CH3), 15.62 (CH3); m/z (THIOG) 147 ([M+H], 
60%), 129 (64), 45 (100); HRMS (THIOG) [M+Hf' found 147.1024, C71-11503 requires 
147.1021. 
'H spectroscopic data in good agreement with the literature. 97 
187 
(2R,3R)-2,4-Dimethyl-3-hydroxy-pentanoic acid 144 
OH 0 
OH 
General procedure I was followed with aldol adduct 138c (114 mg, 0.201 mmol) in 
TI-IF (4 ml), to which was added a solution of LiOH (26 mg, 0.60 mmol) in H20 (2 ml) 
at RT. Purification by flash chromatography (20% EtOAc in hexane-l% AcOH) gave 
auxiliary 117 (78 mg, 88%) and acid 144 as a colourless oil (26 mg, 86%); R (20% 
EtOAc in hexane-1% AcOH) = 0.23; laiD = - 16.0 (c 0.25, CHC13)lit. 
98 - 15.3 (c 1.2, 
CHC13); Vmax (neat)/cm-1  3417 (br, OH), 1713 (C=O); 111 NMR 6 (250 MHz, CDC13) 
5.35 —4.45 (2H, br, 2 x 011), 3.36 (1H, t, J = 5.6 Hz, CHOH), 2.62 (1 H, dq = qn, J 
7.1 Hz, CHCH3 ), 1.80 - 1.67 (1H, m, CH(CH3)2), 1.18 (3H, d, J = 7.1 Hz, CHCH3), 
0.92 (3H, d, J= 6.7 Hz, CH(CH3)A(CH3)B), 0.87 (3H, d, J=r 6.7 Hz, CH(CH3)A(CH3)B); 
'3c NMRö (90.6 MHz, CDC13) 182.40 (C), 79.09 (CH), 43.71 (CH), 31.74 (CH), 20.77 
(CH3), 17.16 (CH3), 15.62 (CH3); m/z (THIOG) 147 ([M+H], 49%), 129 (57), 91 
(100); HRMS (THIOG) [M+H] found 147.1024, C7H1503 requires 147.1021. 
'H spectroscopic data in good agreement with the literature. 98 
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(2S,3R)-3-Hydroxy-2-methyl-3-pheflYl propionic acid 145 
97 
OH 0 
0-11~ i'OH  
General procedure I was followed with aldol adduct 137e (27 mg, 0.040 mmol) in 
THF (4 ml), to which was added a solution of LiOH (38 mg, 0.90 mmol) in H20 (2 ml) 
at RT. Purification by flash chromatography (20% EtOAc in hexane-1% AcOH) gave 
auxiliary 117 (11 mg, 89%) and acid 145 as a colourless oil (8 mg, 98%); Rf (20% 
FtOAc in hexane-1% AcOH) = 0.16; [a]n = + 17.5 (c 0.40, CHC13) lit-9' + 17.8 (c 2.0, 
CHC13); Vmax (neat)/cm' 3268 (br, OH), 1704 (C=O); 'H NMR ö (250 MHz, CDCI3) 
7.34 —7.22 (5H, m, An]), 5.40-4.80 (2H, br, 2 x 011), 4.65 (1H, d, J= 8.9 Hz, CHOH), 
2.78 (1H, dq, J = 8.9 & 7.2 Hz, CHCH3), 0.95 (3H, d, J = 7.2 Hz, CHCH3); '3C NMR 
(90.6 MHz, CDC13) 180.09 (C), 141.01 (C), 128.52(2 x CH), 128.23 (CH), 126.65 (2 >< 
CH), 77.10 (CH), 76.26 (CH), 14.24 (CH3); m/z (THIOG) 181 ([M+H], 14%), 163 
(38),91 (100); HRMS (THIOG) [M+H] found 18 1.0870, C10H1303 requires 18 1.0865. 
'H spectroscopic data in good agreement with the literature. 97 
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General procedure J: Reduction to Alcohol 
To a solution of aldol adduct 137e (100 mg, 0.166 mmol) in THF (2.5 ml) was added a 
solution of NaBH4 (63 mg, 1.7 rnmol) in THF (2.5 ml + 10 drops of H20) and the 
reaction stirred at RT for 1 h. HC1 (IN aq) was added carefully until no more 
effervescence occurred and the solution extracted with CH2C17 (3 x 10 ml). The 
organics were washed with NaHCO3 0 x 10 ml) and H20 (2 x 10 ml). The organics 
were combined, dried (MgSO4) and the volatiles removed under reduced pressure. Flash 
chromatography (50% EtOAc in hexane) afforded the 1 ,3-diol product as a colourless 
oil and recovered auxiliary 117. 
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(1R,2R)-2-Methyl-1-phenyl-propane-1,3-diOI 146 99 
OH 
OH 
General procedure J was followed with aldol adduct 137e (100 mg, 0.166 rnmol) in 
THF (2.5 ml), to which was added a solution of NaBH4 (63 mg, 1.7 mrnol) in THF (2.5 
ml + 10 drops of H20). Purification by flash chromatography (50% EtOAc in hexane) 
afforded the 1,3-diol 146 as a colourless oil (46 mg, 99%) and recovered auxiliary 117 
(23 mg, 83%); R f (50% EtOAc in hexane) = 0.19; LaI D = + 32.0 (c 0.50, CHC13), lit- 99 + 
35.2 (c 0.34, CHC13); Vmax (neat) / cm-1 3349 (br, 2 x  OH), 1602 (Ar), 1495 (Ar); 'H 
NMR 5 (250 MHz, CDC13) 7.31-7.22 (5H, m, ArH), 4.47 (1H, d, J = 8.4 Hz, CHOH), 
3.71 (1H, dd, .1 = 10.9 & 4.0 Hz, CHAHBOH), 3.66 (1H, dd, J = 10.9 & 7.1 Hz, 
CH AHBOH), 2.86-2.74 (2H, br, 2 x  011), 1.98 (1H, qnd, J = 7.0 & 4.0 Hz, CHCH3), 
0.63 (3H, d, J = 7.0 Hz, CH,); 13C NMR 6 (90.6 MHz, CDC13) 144.37 (C), 129.50 (2 
CH), 128.92 (CH), 127.70 (2 x  CH), 81.94 (CH), 69.03 (CH2), 42.73 (CH), 14.85 
(CH3); m/z (FAB, THIOG) 167 ([M+H], 13%), 149 (66), 94 (100); HRMS (FAB, 
THIOG) [M+H] found 167.1070, C,0H1502 requires 167.1072. 







General procedure J was followed with aldol adduct 181e (176 mg, 0.254 mmo!) in 
THF (2.0 ml), to which was added a solution of NaBH4 (98 mg, 2.5 mmol) in THF (2.0 
ml + 15 drops of H20). Purification by flash chromatography (50% EtOAc in hexane) 
afforded the 1,3-diol 183 as a colourless oil (51 mg, 78%) and recovered auxiliary 117 
(92 mg, 83%); R (50% EtOAc in hexane) = 0.24; 'H NMR 6 (250 MHz, CDC13)139 
7.65-7.35 (10H, in, ArH), 5.13 (1H, d, J = 5.3 Hz, CHOH), 4.72 (1H, d, J= 11.5 Hz, 
CHAHBPh), 4.64 (1H, d, J = 11.5 Hz, CHAHBPh), 3.90 (2H, br s, CH20H), 3.80 (1H, td, 
J = 5.1 & 3.9 Hz, CHOBn), 2.94 (1H, br, OH), 2.36 (1H, br, Oil); '3C NMR ö (90.6 
MHz, CDC13) 141.96 (C), 138.73 (C), 129.52 (2 x  CH), 129.43 (2 x  CH), 129.02 (2 x 
CH), 128.97 (CH), 128.80 (CH), 127.43 (2 x  CH), 83.33 (CH), 75.19 (CH), 73.34 
(CH2), 62.47 (CH2). 
'H spectroscopic data in good agreement with the literature. 139 
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(1R,2R)-2-Methyl-1 -pip eronyl-propane-1,3-diOl 201 
OH 
OH 
General procedure J was followed with aldol adduct 137f (10 mg, 0.020 mmol) in 
THF (5 ml), to which was added a solution of NaBH4 (38 mg, 1.0 rnrnol) in THF (5 ml 
+ 20 drops of H20) and the reaction stirred at RT for 14 h. Purification by flash 
chromatography (50% EtOAc in hexane) afforded the 1,3-diol 201 as a colourless oil (3 
mg, 94%) and recovered auxiliary 117 (6 mg, 88%); R f (50% EtOAc in hexane) = 0.24; 
'H NMR 5 (250 MHz, CDC13) 6.80 (1H, s, An]), 6.71 (2H, d, J= 1.0 Hz, An]), 5.89 
(2H, s, OCH20), 4.39 (1H, d, I = 8.6 Hz, CHOH), 3.72 (1 H, dd, I = 10.9 & 3.8 Hz, 
CHAHBOH), 3.64 (1H, dd, I = 10.9 & 7.4 Hz, CHAHBOH), 2.02 - 1.86 (IH, m, 
CHCH3), 0.62 (3H, d, J = 7.0 Hz, CH3CH). 
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General procedure K: Silyl Protection of Aldol Adducts 
To a stirred solution of unprotected aldol-adduct (80 mg, 0.13 mmol) in C142C12 (2 ml) 
at 0 °C was added 2,6-lutidine (48 jil, 0.40 mmol) and then tert-butyldimethylsilyl 
triflate (70 tl, 0.30 mmol). The reaction mixture was stirred at 0 °C for 2 h. 
NaCl (20 ml, sat aq) was added and the mixture was extracted with CH2C12 (3 x 15 ml). 
The combined organics were washed with NaC1 (30 ml, sat aq), dried (MgSO4) and 
concentrated under reduced pressure to give a colourless oil. Purification by flash 
chromatography (20% EtOAc in hexane) gave the desired silyl protected aldol-adduct 
as a colourless oil. 
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2 '-(N-Benzyl-N-m esitylenesulfonylamino)-1 '-phenyipropyl (1 'S,2S,2 'R,3R)-3-(tert-
butyldimethylsilyloxy)-2-methyl-3-PheflylthiOlPrOPiOnate 202 
General procedure K was followed with aldol-adduct 137e (80 mg, 0.13 mmol) in 
CH-)C12 (2 ml) at 0 °C, to which was added 2,6-lutidine (48 jtl, 0.40 mmol) and then ten-
butyldimethylsilyl triflate (70 tl, 0.30 mmol). The reaction mixture was stirred at 0 °C 
for 2 h. Purification by flash chromatography (20% EtOAc in hexane) gave a mixture of 
the desired product and the tert-butyldimethylsilyl alcohol that was separated by HPLC 
to give 202 (46 mg 48%, 88% brsm). HPLC R (15% EtOAc in hexane, flow rate: 10 
ml/min) = 11 mm; R1 (20% EtOAc in hexane) = 0.58; [all) = + 103 (c 1.95, CHC13); Vmax 
(neat)/cm' 1692 (C=O), 1604 (Ar), 1495 (Ar), 1324 (SO2N), 1155 (S02N); 'H NMR ö 
(250 MHz, CDCI3) 7.58 (2H, d, J— 8.0 Hz, Ar/I), 7.47 - 7.20 (9H, rn, An]), 7.08 (2H, t, 
J = 7.8 Hz, Ar/I), 6.93 (2H, s, Ar/I), 6.75 (2H, d, J = 7.0 Hz, An]), 4.94 (1H, d, J = 
16.0 Hz, CHAHBPh), 4.91 (1H, d, J = 10.0 Hz, CHPh), 4.85 (1H, d, J = 8.8 Hz, CHOSi), 
4.53 (1H, d, J=  16.0 Hz, CHAHBPh), 4.25 (1H, dq, J = 10.0 & 6.8 Hz, CHCH3), 2.90 
(1H, dq, J= 8.8 & 7.1 Hz, CHCH3), 2.42 (3H, s,p-CH3), 2.37 (6H, s, 2 x  o-CH3), 1.43 
(3H, d, J= 6.8 Hz, CHCH3), 0.85 (9H, s, 3 x  CH3), 0.75 (3H, d, J = 7.1 Hz, CHCH3), 
0.00 (3H, s, CH3), -0.23 (3H, s, CH3); 13C NMR ö (90.5 MHz, CDC13) 199.68 (C), 
142.61 (C), 142.42 (C), 141.07(2 x C), 140.73 (C), 138.91 (C), 133.20 (C), 132.53 (2 x 
CH), 129.39 (2 x  CH), 128.85 (2 x CH), 128.68 (3 x  CH), 128.51 (3 x  CH), 128.17 
(CH), 127.92 (2 x CH), 127.36 (2 x CH), 77.32 (CH), 57.88 (CH), 56.54 (CH), 51.55 
(CH), 47.76 (CR2), 26.14 (3 x  CR3), 23.25 (2 x  CH3), 21.31 (CR3), 18.92 (CH3), 18.38 
(C), 15.07 (CR3), -4.29 (CR3), -4.80 (CH3). 
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-O 0 Ph 
We BnS02 
General procedure K was followed with aldol-adduct 167d (56 mg, 0.090 mmol) in 
CH2C12  (1.5 ml) at 0 °C, to which was added 2,6-lutidine (32 [tI, 0.27 mrnol) and then 
tert-butyldimethylsilyl triflate (54 i1, 0.23 rmnol). The reaction mixture was stirred at 0 
°C for 2 h. Purification by flash chromatography (20% EtOAc in hexane) gave 205 (42 
mg 63%, 90% brsm); Rf (20% EtOAc in hexane) = 0.64; [UJD = - 12.1 (c 1.90, CHC13); 
Vmax (neat)/cm' 1686 (C0), 1603 (Ar), 1495 (Ar), 1155 (S02N); 1 H NMR ö (250 
MHz, CDC13) 7.61 (211, d, J = 8.1 Hz, An]), 7.50-7.35 (3H, rn, An]), 7.25 (1H, t, J= 
7.3 Hz, An]), 7.10 (2H, t, J = 7.7 Hz, ArH), 6.95 (211, s, An]), 6.80 (2H, d, J = 7.0 Hz, 
An]), 4.97 (1H, d, J= 16.2 Hz, CHAHBPh), 4.92 (1H, d, J = 9.5 Hz, CHPh), 4.60 (1 H, 
d, J = 16.2 Hz, CHAHBPh), 4.30 (1H, dq, J = 9.5 & 6.8 Hz, CHCH3), 3.86 (1H, m, 
CHOSi), 3.62 (111, d, J= 4.9 Hz, CHOCH3), 3.50 (3H, s, OCH3), 2.45 (3H, s,p-CH3), 
2.40 (6H, s, 2 x  o-CH3), 1.70-1.55 (111, m, CH(CH3)2), 1.45 (3H, d, J = 6.8 Hz, 
CHCH3), 1.30-1.00 (2H, m, CH2CH), 0.88 (3H, d, J = 6.5 Hz, CHCH3), 0.87 (911, s, 3 
x 
CH3), 0.78 (311, d, J = 6.5 Hz, CHCH3), 0.08 (311, s, CH3), 0.00 (3H, s, CH3); 13C 
NMR 8 (90.5 MHz, CDC13) 199.93 (C), 142.65 (C), 141.00 (2 x C), 140.31 (C), 138.96 
(C), 133.17 (C), 132.53 (2 x CH), 129.22 (2 x CH), 128.80 (2 x CH), 128.69 (2 x CH), 
128.12 (2 x CH), 127.81 (CH), 127.47 (CH), 91.48 (CH), 72.25 (CH), 59.95 (CH3), 
56.87 (CH), 50.65 (CH), 47.81 (CH2), 42.34 (CM2), 26.25 (3 x  CH3), 24.35 (CH), 23.38 
(2 x  CH3), 23.24 (CH3), 22.36 (CH3), 21.30 (CH3), 18.55 (C), 18.26 (CH3), -3.97 (CH), 
-4.45 (CH3). 
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General procedure L: Reduction to Aldehyde 
To a stirred solution of TBS-protected aldol adduct (39 mg, 0.050 mmol) in CH2Cl2 (1 
ml) at -78 °C was added DIBAL (solution 1 M in CH202, 100 jil, 0.100 mrnol). The 
reaction mixture was stirred at -78 °C for 2 h and then quenched by addition of NH4C1 
(2 ml, sat aq), warmed to RT and stirred for a further 20 mm. 
The resulting mixture was filtered through Celite, dried over MgSO4 and concentrated 
under reduced pressure to give a colourless oil which was purified by flash 
chromatography (10% EtOAc in hexane) to recover the auxiliary 117 and to isolate the 
TBS-protected aldehyde as a colourless oil. 
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(2S,3R)3(tert-butyl-dimethylsilyloxy)-2-methyl-3-PheflYl-PrOPaflat 203150 
General procedure L was followed with TBS-protected aldol adduct 202 (39 mg, 
0.050 mmol) in CH2C12  (1 ml) at -78 °C, to which was added DIBAL (solution 1 M in 
CH2Cl2, 100 t1, 0.100 rnmol). Purification by flash chromatography (10% EtOAc in 
hexane) recovered auxiliary 117 (20 mg, 84%) and afforded TBS-protected aldehyde 
203 as a colourless oil (2 mg, 13%); R(10% EtOAc in hexane) = 0.53; Lalii = + 40.0 (c 
0.10, CHC13), lit. ent.'48 - 60.0 (c 0.90, CHC13); Vmax (neat)/cm 2709 (CHO), 1727 
(CHO), 1602 (Ar), 1492 (Ar); 1H NMR ö (250 MHz, CDC13) 10.05 (1H, d, J= 2.7 Hz, 
CHO), 7.63 - 7.50 (5H, in, ArII), 5.02 (1H, d, J = 7.6 Hz, CHOSi), 2.95 (1H, dqd, J= 
7.6, 7.0 & 2.7 Hz, CHCH3), 1.14 (3H, d, J = 7.0 Hz, CHCH3), 1.10 (9H, s, 3 x CH3), 
0.25 (3H, s, CH3Si), 0.00 (3H, s, CH3Si); 13C NMR 6 (90.5 MHz, CDC13) 204.44 (C), 
142.13 (C), 128.18 (2 x CH), 127.71 (CH), 126.58 (2 x CH), 76.69 (CH), 54.45 (CH), 
25.57 (3 x  CH3), 17.94 (C), 10.97 (CH3), -4.64 (CH3), -5.34 (CH3); m/z (FAB, THIOG) 
279 ([M+H], 6.5%), 237 (35), 221 (81), 163 (67), 116 (35), 108 (45), 94(65). 




General procedure L was followed with TBS-protected aldol adduct 205 (39 mg, 0.05 
mmol) in CH202 (1.5 ml) at -78 °C, to which was added DIBAL (solution I M in 
CH202 220 p1, 0.220 mmol). Purification by flash chromatography (10% EtOAc in 
hexane) recovered auxiliary 117 (17 mg, 71%) and afforded TBS-protected aldehyde 
206 as a colourless oil (8 mg, 53%); Rf (10% EtOAc in hexane) = 0.51; [a]D = + 13 (c 
0. 15, CHC13); vmax(neat)/cm 1734 (CHO); 'H NMR 6 (250 MHz, CDCI3) 9.68 (1 H, d, 
J= 1.5 Hz, COIl), 3.98 (1H, dt, J= 8.5 & 4.6 Hz, CHOSi), 3.49 (1H, dd, J= 4.6 & 1.5 
Hz, CHOCH3), 3.35 (3H, s, OCH3), 1.65-1.50 (1H, m, CH(CH3)2), 1.40 (1H, ddd, J= 
13.7, 8.1 & 4.9 Hz, CHAHBCH), 1.21 (1H, ddd, J = 13.7, 8.4 & 4.9 Hz, CHAHBCH), 
0.82 (3H, d, J = 6.6 Hz, CHCH3), 0.80 (3H, s, CH(CH3)3), 0.78 (3H, d, J = 6.6 Hz, 
CHCH3), 0.01 (3H, s, CH3), 0.00 (3H, s, CH3); 13C NMR 6 (90.5 MHz, CDC13) 204.90 
(C), 89.24 (CH), 71.98 (CH), 59.82 (CH3), 43.21 (CH2), 26.83 (3 >< CH3), 25.10 (CH), 
24.30 (CH3), 23.07 (CH3), 19.11 (C), -3.46 (CH3), -3.52 (CH3); m/z (ESI, +) 298 
([M+Na], 100%), 196 (15), 205 (14); HRMS (ESI, +) [M+Na] found 298.1927, 
C14H3103NaSi requires 298.1935. 
199 
General procedure M: Transthiolesterification Reaction 
To a stirred solution of aldol adduct (100 mg, 0.176 mmol) in dry DMF (4 ml) at RT, 
was added diisopropylethylamine (460 l, 2.64 mmol) followed by N-acetylcysteamine 
(290 pA, 2.73 mmol). The reaction mixture was stirred for I h at RT. NaCl (15 ml, sat 
aq) was added and the mixture was extracted with Et20 (3 x  10 ml). The organics were 
washed with NaCl (2 x  10 ml, sat aq), and dried (MgSO4), and the volatiles removed 
under reduced pressure to give a colourless oil which was purified by flash 
chromatography with gradient elution (20% EtOAc in hexane) to recover the auxiliary 
117, then (EtOAc to 10% MeOH in EtOAc) to isolate the SNAc thiolester product as a 
colourless oil. 
200 
2'-(Acetylamino)ethyl (2S,3S)2,4dimethyl-3-hydrOXY-thiO1Pentan0ate 209 
OH 0 
-TY 0 
General procedure M was followed with aldol adduct 137c (100 mg, 0.176 mmol) in 
dry DMF (4 ml) at RT, to which was added diisopropylethylarnine (460 tl, 2.64 mmol) 
followed by N-acetylcysteamine (290 tl, 2.73 mmol). Purification by flash 
chromatography with gradient elution (20% EtOAc in hexane) recovered the auxiliary 
117 (72 mg, 93%), then (EtOAc to 10% MeOH in EtOAc) gave the SNAc thiolester 209 
as a colourless oil (39 mg, 88%); Rf (EtOAc) = 0.16; laiD = + 20.0 (c 0.25, CHC13); Vmal  
(neat)/crn' 3399 (br, OH & NH), 1658 (C=O), 1555 (C=O); 'H NMR 6 (250 MHz, 
CDC13) 5.90-5.60 (1H, br, NH), 3.42 - 3.36 (3H, m, CHOH & CH2NHCO), 2.97 (2H, t, 
J = 6.1 Hz, CH2S), 2.80 (1 H, dq = qn, J = 7.0 Hz, CHCH3), 2.30-2.15 (1H, br, OH), 
1.89 (3H, s, CH3CONH), 1.75 - 1.60 (1H, dspt oct, Jr  6.8 Hz, CH(CH3)2), 1.15 (3H, 
d, J = 7.0 Hz, CHCH3), 0.92 (3H, d, J = 6.8 Hz, CH(CH3)A(CH3)B), 0.85 (3H, d, J= 6.8 
Hz, CH(CH3)A(CH3)B); '3C NMR 6 (90.6 MHz, CDC13) 205.62 (C), 171.43 (C), 79.59 
(CH), 52.60 (CH), 40.44 (CH2), 31.80 (CH), 29.59 (CH2), 24.22 (CH3), 20.90 (CH3), 
16.96 (CH3), 16.54 (CH3); m/z (THIOG) 248 ([M+H], 46%), 217 (32), 120 (59); 
HRMS (THIOG) [M+H] found 248.1320, C11 H22NO3S requires 248.1320. 
201 
2 '-(Acetylamino)ethyl (2S,3R)-3-hydroxy-2-methyl-3-PiPer0flYl thiolpropionate 
210 




General procedure M was followed with aldol adduct 137f (90 mg, 0.14 mmol) in dry 
DMF (4 ml) at RI, to which was added diisopropylethylamine (360 .il, 2.09 mmol) 
followed by N-acetylcysteamine (230 i1, 2.09 mmol). Purification by flash 
chromatography with gradient elution (20% EtOAc in hexane) recovered the auxiliary 
117 (47 mg, 77%), then (EtOAc to 10% MeOH in EtOAc) gave the SNAc thiolester 210 
as a colourless oil (39 mg, 86%); R1 (EtOAc) = 0.20; lab = + 76 (c 0.55, CHC13); Vniax 
(neat)/cm-1  3307 (OH), 3085 (NH), 1652 (C0), 1555 (C0); 'H NMR ö (250 MHz, 
CDC13) 6.78 (lH, s, ArH), 6.71 (2H, d, J = 1.0 Hz, ArII), 5.88 (2H, s, OCH20), 5.87-
5.81 (1H, br, NH), 4.65 (1H, d, J = 8.8 Hz, CHOH), 3.42-3.35 (2H, m, CH2NHCO), 
3.04-2.86 (3H, rn, CH2S & CHCH3), 2.75-2.50 (1H, br, OH), 1.88 (3H, s, CH3CONH), 
0.91 (3H, d, J = 7.1 Hz, CHCH3); '3C NMR ö (90.6 MHz, CDC13) 204.58 (C), 171.48 
(C), 149.01 (C), 148.55 (C), 136.49 (C), 121.40 (CH), 109.14 (CH), 107.77 (CH), 
102.19 (CH2), 77.64 (CH), 56.84 (CH), 40.35 (CH2), 29.77 (CH2), 24.21 (CH3), 16.33 
(CH3); m/z (IHIOG) 326 ([M+I-1], 15%), 308 (64), 217 (33), 189 (76), 91(100); 
HRMS (THIOG) [M+H] found 326.1060, C15H20N05S requires 326.1062. 
202 
Methyl 	 212 
OH 0 
OP 
To a stirred solution of aldol adduct 137f (26 mg, 0.040 rnmol) in MeOH (2 ml) was 
added NaOMe (80 tl, 1 M in MeOH, 0.080 mrnol) at RT. The reaction mixture was 
stirred at RT for 30 mm. Cation exchange resin AG 50W-X8 in its hydrogen form was 
added, and the mixture stirred for 10 min until a neutral pH was reached. The reaction 
mixture was filtered to recover the resin and the filtrate was concentrated under reduced 
pressure to give a colourless oil which was purified by flash chromatography (20% 
EtOAc in Hexane) to recover the auxiliary 117 (18 mg, 100%) and the methyl ester 212 
as a colourless oil (9.0 mg, 94%); R (20% EtOAc in Hexane) = 0.15; [U]D = 23.3 (c 
0.45, CHCI3); Vmax (neat)/cm-1 3527 (OH), 1727 (C=O); 'H NMR ö (250 MHz, CDC13) 
6.78 (1H, s, ArII), 6.70 (2H, s, ArII), 5.89 (2H, s, OCH2), 4.60 (1H, dd, J = 8.7 & 3.9 
Hz, CHOH), 3.67 (3H, s, OCH3 ), 2.79 (1H, d, J = 3.9 Hz, 011), 2.68 (1H, dq, J = 8.7 & 
7.2 Hz, CHCH3), 0.93 (3H, d, J = 7.2 Hz, CH3CH); 13C NMR 6 (90.6 MHz, CDC13) 
177.27 (C), 148.93 (C), 148.41 (C), 136.50 (C), 121.42 (CH), 109.10 (CH), 107.84 
(CH), 102.12 (CH2), 77.31 (CH), 52.99 (CH3), 48.17 (CH), 15.49 (CH3); nz/z (FAB, 
THIOG) 237 ([M-H], 66%), 221 (100), 214 (49), 197 (34), 165 (84); HRMS (FAB, 
THIOG) [M-H]+  found 237.0684, C12H1305 requires 237.0685. 
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AcOH acetic acid 
Aq aqueous 
Ar aryl 
9-BBN 9-borabicyclo [3,3,1 ]nonane 
Bn benzyl 
Bp boiling point 





DCC N, N-dicyclohexylcarbodiimide 
DCM dichioromethane 
DEPT distortionless enhancement polarisation transfer 
DIBAL diisobutylaluminium hydride 






D SC N, N-disuccinimidylcarbonate 
EDCI 1-(3,3 -dimethylaminopropyl)-3 -ethyl-carbodiimide 




Et20 diethyl ether 
EtOAc ethylacetate 
EtOH ethanol 
FAB fast atom bombardment 
212 
HPLC high perfomance liquid chromatography 





L unspecified ligand 
LA Lewis acid 
LDA lithium diisopropylamide 







rnp melting point 
MPAA 4-mercaptophenyl acetic acid 
MPM p-rnethoxyphenylmethyl 
Ms methanesulfonyl 
NCL native chemical ligation 
NMR nuclear magnetic resonance 
OHA 1,2,3,4,6,7,8,9-octahydroanthraCeflyl 
P unspecified protecting group 




ppm parts per million 
Py pyridine 
Rf  retention factor 
Rt retention time 







TB S tert-butyidimethylsilyl 
'Bu tert-butyl 
TES triethylsilyl 
TFA trifluoroacetic acid 
Tf trifluorornethanesulfonyl 
THF tetrahydrofuran 
THIOG 1 -thioglycine 
TIP 2,4,6-triisopropylphenyl 
TIPS triisopropylsilyl 







APPENDIX 1: Crystal Structure Data of Glycolate Aldol Adduct 167e 
Contact 	Anna Collins, anna.collins@ed.ac.uk  
A. CRYSTAL DATA 
Empirical formula 	 C35 H39 Ni 05 S2 
Formula weight 	 617.83 
Wavelength 	 0.71073 A 
Temperature 	 150 K 
Crystal system 	 Orthorhombic 
Space group 	 P 2121 21 
Unit cell dimensions 	 a = 7.0937(3) A alpha = 90 deg. 
Volume 





b = 13.3879(6) A beta = 90 deg. 
c = 33.7824(16) A gamma = 90 deg. 
3208.3(2) AA3 














0.55 x 0.35 x 0.23 mm 
Bruker SMART 
1.636 to 30.506 deg. 
-9<=h<=9, -18<=k<=19, -47<=1<=43 
42448 
Independent reflections 




	 Semi-empirical from equivalents 
(Tmin 0.82, Tmax0.95) 
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C. SOLUTION AND REFINEMENT. 
Solution 	 direct (S1R92 (Altomare et al., 1994)) 
Refinement type 	 Full-matrix least-squares on FA2 
Program used for refinement 	CRYSTALS 
Hydrogen atom placement 	geom 
Hydrogen atom treatment 	constr 
Data 	 9221 
Restraints 	 24 
Parameters 	 389 
Goodness-of-fit on FA2 	 1.0405 
Conventional R [F>4sigma(F)] 	RI = 0.0434 [7690 data] 
Rw 
Absolute structure parameter 
	
0.04(5) 




	 Sheidrick Weights 
Largest diff. peak and hole 
	0.44 and -0.29 e.A''-3 
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Table 1. Atomic coordinates (x 10^4) and equivalent isotropic 
displacement parameters (A112 x 10,13) for 167e. U(eq) is defined 
as one third of the trace of the orthogonalized Uij tensor. 
x 	y 	z 	U(eq) 
S(1) 4256(1) 4648(1) 5860(1) 28 
C(2) 3599(3) 3549(1) 5594(1) 26 
0(3) 2000(2) 3276(1) 5546(1) 33 
C(4) 5337(3) 2986(1) 5444(1) 30 
C(5) 6224(3) 2342(1) 5773(1) 32 
0(6) 7958(2) 1942(1) 5636(1) 47 
C(7) 4976(3) 1486(1) 5901(1) 31 
C(8) 5138(3) 557(1) 5722(1) 36 
C(9) 4020(3) -235(2) 5848(1) 42 
C(10) 2729(4) -104(2) 6145(1) 48 
C(11) 2547(4) 825(2) 6323(1) 51 
C(12) 3670(3) 1612(2) 6202(1) 43 
0(13) 6748(2) 3681(1) 5330(1) 37 
 6379(4) 4124(2) 4952(1) 47 
 1983(2) 4950(1) 6087(1) 22 
 1500(3) 4205(1) 6404(1) 27 
 -62(3) 3588(1) 6357(1) 38 
C(18) -508(4) 2886(2) 6643(1) 53 
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C(19) 567(4) 2809(2) 6977(1) 57 
C(20) 2107(4) 3420(2) 7029(1) 47 
C(21) 2600(4) 4122(2) 6741(1) 42 
C(22) 2044(2) 6041(1) 6242(1) 21 
C(23) 2746(3) 6795(1) 5936(1) 27 
N(24) 170(2) 6276(1) 6411(1) 22 
C(25) -1551(3) 6201(1) 6165(1) 29 
C(26) -1666(2) 6926(2) 5824(1) 29 
C(27) -1975(3) 6583(2) 5444(1) 41 
C(28) -2047(4) 7246(2) 5129(1) 55 
C(29) -1802(4) 8257(2) 5189(1) 50 
C(30) -1508(3) 8605(2) 5565(1) 42 
C(31) -1466(3) 7945(2) 5881(1) 36 
S(32) 148(1) 7020(1) 6797(1) 24 
0(33) -1790(2) 7250(1) 6875(1) 34 
0(34) 1397(2) 7846(1) 6731(1) 31 
C(35) 1030(3) 6297(1) 7198(1) 23 
 -147(3) 5539(1) 7354(1) 26 
 421(3) 5068(1) 7700(1) 32 
C(38) 2095(3) 5297(2) 7889(1) 35 
 3247(3) 6015(2) 7721(1) 34 
 2759(3) 6536(1) 7376(1) 27 
 -1971(3) 5199(2) 7167(1) 32 
 2643(4) 4782(2) 8270(1) 54 
 4142(3) 7321(2) 7238(1) 37 
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C(4)-C(5)-1-I(5 1) 108.1 
0(6)-C(5)-H(5 1) 108.9 







C(9)-C(8)-H(8 1) 121.3 
C(8)-C(9)-C(1 0) 120.5(2) 
C(8)-C(9)-H(91) 118.7 
C(10)-C(9)-H(91) 120.8 
C(9)-C(10)-C(1 1) 119.6(2) 
C(9)-C(10)-H(101) 119.7 
C(11)-C(10)-H(101) 120.7 
C(10)-C(1 1)-C(12) 120.2(2) 
C(10)-C(11)-H(111) 120.3 
C(12)-C(11)-H(111) 119.5 


































C(20)-C(21)-H(21 1) 120.3 







C(22)-C(23)-}-I(23 1) 108.2 
C(22)-C(23)-H(232) 110.4 





























C(30)-C(3 1)-C(26) 121.14(19) 
C(30)-C(3 I)-H(31 1) 119.0 



































H(42 I)-C(42)-H(422) 107.0 
C(38)-C(42)-H(423) 112.8 
H(42 1)-C(42)-H(423) 109.5 
H(422)-C(42)-H(423) 111.4 
C(40)-C(43)-H(43 1) 110.0 
C(40)-C(43)-H(432) 110.3 





Symmetry transformations used to generate equivalent atoms: 
Table 3. Anisotropic displacement parameters (A'2 x l0'3) for 167e. 
The anisotropic displacement factor exponent takes the form: 
2piA2[hr\2a*\2U11 + ... +2hka*b*U12] 
Ull U22 U33 U23 U13 U12 
S(1) 27(1) 24(1) 34(1) -9(1) 9(1) -5(1) 
C(2) 35(1) 20(1) 22(1) 0(1) 4(1) -3(1) 
0(3) 35(1) 28(1) 36(1) -7(1) -2(1) -3(1) 
C(4) 36(1) 23(1) 32(1) -5(1) 8(1) -3(1) 
C(S) 29(1) 27(1) 40(1) -5(1) 2(1) 2(1) 
0(6) 36(1) 37(1) 66(1) -6(1) 7(1) 5(1) 
 33(1) 23(1) 37(1) 2(1) -5(1) 4(1) 
 42(1) 28(1) 36(1) 0(1) -6(1) 5(1) 
 56(1) 23(1) 47(1) -1(1) -14(1) 2(1) 
 50(1) 29(1) 65(2) 12(1) -6(1) -6(1) 
 54(2) 34(1) 66(2) 9(1) 18(1) 1(1) 
 50(1) 24(1) 56(1) 3(1) 13(1) 6(1) 
0(13) 41(1) 29(1) 41(1) -5(1) 14(1) -6(1) 
 69(2) 35(1) 37(1) -3(1) 22(1) -10(1) 
 23(1) 21(1) 23(1) -1(1) 3(1) -4(1) 
 36(1) 19(1) 25(1) 2(1) 9(1) 3(1) 
 42(1) 27(1) 45(1) 5(1) 13(1) -4(1) 
 61(2) 32(1) 66(2) 13(1) 26(1) -3(1) 
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C(1,9) 89(2) 33(1) 49(1) 14(1) 31(1) 12(1) 
 74(1) 37(1) 29(1) 2(1) 1(1) 21(1) 
 68(1) 32(1) 26(1) 1(1) 1(1) 18(1) 
 22(1) 21(1) 22(1) 0(1) 2(1) -2(1) 
 29(1) 23(1) 30(1) 2(1) 9(1) -1(1) 
N(24) 21(1) 24(1) 21(1) 0(1) 2(1) 0(1) 
 22(1) 30(1) 34(1) -2(1) -2(1) -3(1) 
 21(1) 39(1) 29(1) -2(1) -3(1) 4(1) 
 42(1) 48(1) 33(1) -6(1) -5(1) -8(1) 
 64(2) 72(2) 28(1) 0(1) -13(1) -11(1) 
 57(1) 58(1) 33(1) 9(1) -9(1) 0(1) 
 49(1) 36(1) 40(1) 6(1) -5(1) 11(1) 
 48(1) 36(1) 25(1) -2(1) -2(1) 13(1) 
S(32) 28(1) 20(1) 23(1) 0(1) 5(1) 2(1) 
0(33) 32(1) 34(1) 34(1) 1(1) 6(1) 10(1) 
0(34) 43(1) 22(1) 29(1) -1(1) 3(1) -3(1) 
 28(1) 21(1) 19(1) -2(1) 5(1) 1(1) 
 31(1) 23(1) 24(1) -4(1) 6(1) 1(1) 
 48(1) 23(1) 25(1) -1(1) 6(1) -4(1) 
 53(1) 25(1) 27(1) -1(1) -4(1) 3(1) 
 40(1) 29(1) 33(1) -6(1) -6(1) 2(1) 
 30(1) 24(1) 28(1) -5(1) 4(1) 1(1) 
 31(1) 31(1) 35(1) 2(1) 4(1) -7(1) 
 85(2) 41(1) 37(1) 10(1) -18(1) -5(1) 
 29(1) 38(1) 44(1) 0(1) 1(1) -7(1) 
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Table 4. Hydrogen coordinates (x 10^4) and isotropic 
displacement parameters (AA2 x 10^3) for 167e. 
x 	y 	z 	U(eq) 
H(41) 5000 2562 5217 39 
H(51) 6475 2778 6003 42 
H(81) 6057 474 5515 46 
H(91) 4171 -868 5724 53 
H(101) 1969 -645 6226 61 
H(111) 1652 926 6524 65 
H(121) 3555 2247 6323 54 
H(141) 7402 4578 4900 72 
H(142) 6360 3612 4750 71 
H(143) 5158 4481 4966 72 
H(151) 1039 4915 5878 29 
H(171) -806 3640 6117 50 
H(181) -1570 2452 6611 68 
H(191) 263 2335 7175 75 
H(201) 2837 3363 7250 68 
H(211) 3692 4511 6770 48 
H(221) 2966 6046 6459 28 
H(231) 2573 7452 6041 43 
232 
H(232) 2041 6732 5692 43 
H(233) 4089 6688 5888 42 
 -1573 5524 6056 36 
 -2651 6300 6341 36 
H(271) -2134 5887 5398 52 
H(281) -2291 7004 4878 69 
H(291) -1821 8700 4973 61 
H(301) -1347 9284 5609 53 
H(311) -1278 8198 6139 45 
H(371) -371 4575 7807 41 
H(391) 4430 6154 7843 44 
 -2447 4610 7299 53 
 -1797 5064 6891 52 
 -2874 5722 7197 54 
H(421) 3919 4935 8320 85 
H(422) 2571 4088 8230 85 
H(423) 1892 4988 8489 86 
 5353 7226 7368 59 
 4344 7265 6957 59 
 3675 7995 7289 58 
H(42) 8632 2440 5592 73 
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1 	SOMes  
Synthesis of a new thiol auxiliary (1) is readily achieved (in five or six steps, >74% overall yield from norephedrine) and is shown to give high 
diastereoselectivity in boron-mediated anti-aldol reactions with a range of aldehydes. This new thiol auxiliary may be directly displaced by a 
range of nucleophiles under very mild conditions, to give the corresponding phosphonate esters, alcohols, acids, SNAC thiolesters, and 
methyl esters. 
Despite recent advances in the catalytic aldol and organo-
catalytic aldol reactions,' auxiliary-controlled aldol reactions 
have maintained their place as one of the principle means 
through which the aldol reaction finds application in 
synthesis .2  This is primarily due to the high yields and high 
diastereoselectivities which may be attained in auxiliary-
controlled reactions and the facile separation of diastereo-
meric aldol adducts which allows the subsequent isolation 
of enantiopure species. Two auxiliaries currently have 
predominance in the field :2  the Evans' oxazolidinone3 and 
its oxazolidinethione and thiazolidinethione counterparts for 
For recent reviews, see: (a) Sodeoka, M.; Hamashima, Y. Bull. Chem. 
Soc. Jpn. 2005, 78, 941-956. (b) Denmark. S. E.; Heemstra, J. R., Jr.; 
Beutner, G. L. Angew. Chem., mt. Ed. 2005, 44,4682-4698. (c) Kazmaier, 
U. Angew. Chem., In!. Ed. 2005, 44, 2186-2188. (d) Seayad. J.; List, B. 
Org. Biomol. Chem. 2005. 3, 719-724. (e) Saito, S.; Yamamoto, H. Acc. 
Chem. Res. 2004, 37, 570-579. (f) Alcaide, B.; Almendros, P. Angew. 
Chem., In!. Ed. 2003, 42. 858-860. 
(a) Palomo, C.; Oiarbide, M.; Garcia, J. M. Chem. Soc. Rev. 2004, 
33, 65-75. (b) Arya, P.; Qin, H. Tetrahedron 2000, 56, 917-947. 
(3)(a) Evans, D. A.; Bartroli, J. A.; Shih, T. Li. Am. Chem. Soc. 1981, 
103, 2127-2129. (b) Gage, J. R.; Evans, D. A. Org. Svnth. 1990, 68, 77-
91. (c) Evans, D. A.; Shaw, J. T. Actual. C/tim. 2003, 35-38. (d) Abiko, 
A.; Liu, J. F.; Masamune, S. J. Am. Chem. Soc. 1997, 119, 2586-2587. (e) 
Abiko, A. Acc. Chem. Res. 2004, 37, 387-395. 
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syn-aldol reactions and the Abiko—Masamune norephedrine-
derived auxiliary for a range of anti-aldol reactions .31,,  
However, for an auxiliary-based strategy to be truly useful, 
the auxiliary must be removable under a range of conditions.' 
Although this has clearly been demonstrated for the Evans' 
oxazolidinone, and to a lesser extent for the Abiko—
Masamune auxiliary, there are still some nucleophilic 
displacement reactions which (though highly desirable 
synthetically) are unachieveable, or very low yielding, with 
either of these auxiliaries because of competitive retro-aldol 
or elimination reactions. In the course of synthetic studies 
directed toward the synthesis of the marine natural product 
octalactin A,5 we have encountered these problems first 
hand .6 Direct displacement by a phosphonate anion of the 
norephedrine-derived auxiliary in an anti-aldol adduct re-
sulted in extensive decomposition of the aldol adduct through 
a retro-aldol mechanism, such that the acylated auxiliary was 
For a recent review of auxiliary-mediated reactions, see: Gnas, Y.; 
Glorius, F. Synthesis 2006, 1899-1930. 
Tapiolas, D. M.; Roman, M.; Fenical, W.; Stout, T. J.; Clardy, J. 2. 
Am. Chem. Soc. 1991, 113, 4682-4683. 
Hulme, A. N.; Howells, G. E. Tetrahedron Let!. 1997, 38, 8245-
8248. 
the major recovered product at the end of the reaction.7 
Following our earlier success in the achiral manifold with 
the use of thiolesters to address this displacement problem,5 
we therefore set out to develop a high-yielding route to a 
thiol alternative of the Abiko—Masamune auxiliary (Scheme 
1). 
Scheme 1. Synthesis of the Thiol Analogue of the 
Abiko—Masamune Auxiliary 
Ph 	1. MesS02CI, 	Ph 
Ho'( Et
3N, CH2Cb 'BuOK DMF Ph,,.# 
I NH2 2. SOCl2 	HN
SO2Mes 	 S02Mes 
2 (92% overall) 3(92%) 
PhCOSI-t, 
0 	Ph 	BnBr, NaH, 	0 	Ph 	 PBu3 (cat), 
DMF 	Ph)LS)..( 	IMecNI1-120 
BnN, 	 HN 
S02Mes 	 S02Mes 
6(99%) 4(93%) 






BnN, S021VIes BaN 'SQM es 
1(95%) 6(91%) 
(IS,2R)-(+)-Norephedrine was converted into its mesity-
lene sulfonamide,Od,c  and subsequent treatment with thionyl 
chloride gave alkyl chloride 2 with net retention of stereo-
chemistty.9 The chloride was converted into aziridine 3,10 
which was opened regio- and stereoselectively (>95:5) with 
thiolbenzoic acid in the presence of catalytic P13113.' Treat-
ment of thiolbenzoate 4 with benzyl bromide and sodium 
hydride gave benzyl sulfonamide S exclusively. 12  Reduction 
of the benzoate using LiAIH4 gave the thiol auxiliary I in 
excellent yield. Thiol 1 could also be accessed through 
saponification with NaOMe, thus avoiding the need for 
tedious purification from aluminum salts (five or six steps 
from norephedrine, >74% overall yield). The thiol was 
converted into its propionate derivative 6, to allow the 
determination of the levels of diastereoselectivity that it could 
confer in a range of aldol reactions. The X-ray crystal 
structure of 6 has confirmed the overall net retention of 
stereochemistry of this synthetic sequence (Figure 1). 
It has been reported by Abiko and Masamune that selective 
enolization may be achieved in the boron-mediated aldol 
Howells, G. E.; Hulme, A. N.; White, J. W. Unpublished results. 
Hulme, A. N.; Howells, G. E.; Walker, R. E. Synlef t 1998, 828-
830. 
Flores-Parra, A.; Suarez-Moreno, P.; Sanchez-Ruiz, S. A.; Tiahuexti, 
M.; Jaen-Gaspar, J.; Tlahuext, H.; Salas-Coronado, R.; Cruz, A.; Noth, H.; 
Contreras, R. Tetrahedron: Asymmetry 1998, 9, 1661-1672. 
On a small scale, direct conversion of the sulfonamido alcohol to 
aziridine 3 was achieved through in situ generation of the mesylate (MsCI, 
Et3N, 87%). 
(II) Fan, R.-H.; Hou, X.-L. .1. Org. Chem, 2003, 68, 726-730. 
(12) Significant levels of benzoate migration and concomitant thiol 
benzylation were observed when benzylation was attempted in the presence 
of other bases. 
Figure 1. Crystal structure of thiopropionate 6. 
reaction of the norephedrine-derived auxiliary through the 
appropriate choice of reagents, thus leading to either anti-
or syn-aldol adducts. Id., With the classical oxygenated 
auxiliary, the formation of anti-aldol adducts is controlled 
by the presence of bulky ligands on the boron [(cHex)2B0Tf] 
and the addition of Et3N at low temperatures to form the 
kinetic E(0)-enolate. We therefore set out by using these 
Table 1. anti-Aldol Reaction of Thiopropionate 6 
o 	Ph 	 (I) (CHex)BOTf,  Et3N, OH 0 	Ph 
CH2Cl2, -78 C RLS..( 
BnN S02Mes (ii) RCHO 	 S02Mes  
yield (%)a 
product 	 drb 
7a 	 92 (93:7) 
7b 	90(92:8) 
7c 	 94 (92:8) 
7d 	 94 (94:6) 
7e 	 85 (91:9) 
7f 	 91(97:3) 
Isolated yield of the major diastereomer. b  Diastereomeric ratio deter-
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optimized conditions with thiol auxiliary 1. Gratifyingly, we 
found that we could obtain anti-aldol adducts with a range 
of aldehydes (vinyl, alkyl, and aromatic) in high yield and 
with high selectivity using the thiol auxiliary I (Table 1).' 
In all cases, our yields were comparable to that of the 
established Abiko—Masamune auxiliary, and only a minor 
erosion of diastereoselectivity was observed. As with the 
classic auxiliary, the minor diastereomer is thought to be 
the other anti diastereomer, rather than the syn diastereomer. 3 c 
This confirms the high selectivity of enolate formation in 
these reactions but suggests a minor erosion of facial 
selectivity of the resultant enolate in switching from the ester 
to the thiolester. 
The main focus for the synthesis of the thiol auxiliary 1 
was its potentially facile displacement with a range of 
nucleophiles. Of most immediate synthetic relevance to us 
was the displacement of the auxiliary by phosphonate 
nucleophiles (Table 2), which might then allow direct 
extension of the aldol adduct using a Homer—Wadsworth—
Emmons (HWE) reaction. 4 Treatment of protected aldol 
adducts 8 with the lithium anion of diethyl ethane phospho-
nate was shown to give the desired phosphonate esters 9 in 
high yield (78-91%) and with varying diastereoselectivity 
Table 2. Phosphonate Displacement of Auxiliary 1 








SOMes 	 8(91-95%) S02Mes 




TBSO 0 0 	 Ph 
R Et)2 + HS'" 
BflNSOM es 
R 	phosphonate 	yield 9 (%) 	yield I (%) 
9a 	 90 	 91 
9b 	 81 	 85 
adjacent to the phosphonate (3:2 to 4:1 ratio of diastereo-
mers). However, the diastereomeric phosphonate esters were 
not separated, as previous studies have shown that both give 
equal selectivity in the HWE reaction.6 In all cases, the 
auxiliary 1 was also recovered in excellent yield (79-91%). 
After the successful displacement of auxiliary 1 was 
achieved with a phosphonate anion, we decided to investigate 
the displacement reaction with other mild nucleophiles 
(Scheme 2). Initially, we examined reduction of the aldol 
Scheme 2. Nucleophilic Displacement Reactions of anti-AldoI 
Adducts 7 
OH 0 Ph 	
NaBH4, 	
OH 
THF (aq) OH 
BnN 
7c 	 10 (99%) + 1(84%) 






7c 11(99%) + 1(99%) 








S02Mes 12 (88%) + 1(93%) 
OH 0 Ph 	 OH 0
NaOMe, SY 
MeOH 	 oMe 
0 )P 	BnN S02Mes 	0 
if 	 Oo) + 1(99%) .—o 13(94/ 
adducts to give the diol, a reaction which is typically 
achieved with rather harsh conditions (LiA1H4, DIBALH) 
with the classic Abiko—Masamune auxiliary.'5 In contrast, 
we found that upon treatment of 7c with NaB H4 diol 10 was 
obtained in high yield in only 1 h (99%). We then decided 
to investigate the hydrolysis reactions of aldol adducts 7, 
the counterparts of which have been shown to be quite 
sluggish with the classic auxiliary. LiOH-mediated hydrolysis 
of the thiolester 7c was complete in only 30 mm (as opposed 
to the typical 24-48 h reaction times required for hydrolysis 
of the Abiko—Masamune auxiliary) 16  and gave an excellent 
yield of the corresponding acid 11 (99%, Scheme 2).' 
89 	 85 
Optimum conditions for aldol coupling with thiol auxiliary I were 
found to be: 	3.0 equiv of Et3N [cf. 2.4 equiv reported in ref 3e] and 2.0 
equiv of (°Hex)2BOTf [cf. 2.0 equiv reported in ref 3e]. When conducting 
milligram scale reactions, an excess of aldehyde (3.0+ equiv) was used. 
Matyanoff, B. E.; Reitz, A. B. Chem. Rev. 1989, 89, 863-927. 
9d 	 91 	 79 
For recent synthetic examples, see: (a) Fraunhoffer, K. J.; Bacho- 
vchin, D. A.; White, M. C. Org. Lett. 2005, 7,223-226. (b) Lafontaine. J. 
A.; Provencal, D. P.; Gardelli, C.; Leahy, J. W. J. Org. Chem. 2003, 68, 
4215-4234. (c) Maleczka, R. E., Jr.; Terrell, L. R.; Geng, F.; Ward, J. S., 
III. Org. Left. 2002, 4, 2841-2844. (d) Amarasinghe, K. K. D.; Montgom- 
9f 	 78 	 80 op cry, J. J. Am. Chem. Soc. 2002, 124, 9366-9367. 
—0 
For recent synthetic examples, see: 	(a) Kiho, T.; Nakayama, M.; 
Kogen, H. Tetrahedron 2003, 59, 1685-1697. (b) Andrus, M. B.; Meredith, 
E. L.; Simmons, B. L.; Sekhar, B. B. V. S.; Hicken, E. J. Org. Lett. 2002, 
4, 3549-3552. 
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Similarly, transthiolesterification of 7c was achieved under 
the extremely mild conditions reported by Raines et al. (N-
acetylcysteamine, 'Pr2NEt)18 in only 1 h, to give an excellent 
yield of the SNAC thiolester 12 (88%). This latter procedure 
is notable because it avoids the need for a two-step 
hydrolysis/thiolesterification process which is typically used 
in the case of polyketide starter units derived from the Evans 
oxazolidinone.'9 [The use of trimethylaluminum in these 
transthiolesterification reactions as reported by Willis et al. 
(N-acetylcysteamine, Me3AI, THF, 0 °C)21 was not viable.2 t1 
Finally, transesterification of aldol adduct 7f was very readily 
achieved by treatment with sodium methoxide, giving methyl 
(17) If the hydrolysis reactions were left for extended time periods, partial 
degradation of the thiol auxiliary I was observed. 
(18) Nilsson, B. L.; Kiessling, L. L.; Raines, R. T. Org. Lett. 2000, 2, 
1939-1941. 
(19) For recent examples of the two-step synthesis of SNAC thiolesters, 
see: (a) Wu, J.; Zaleski, T. J.; Valenzano, C.; K.hosla, C.; Cane, D. F. I. 
Am. Chem. Soc. 2005, 127, 17393-17404. (b) Aldrich, C. C.; Venkatraman, 
L.; Sherman, D. H.; Fecik, R. A. I. Am. Chem. Soc. 2005, 127, 8910-
8911. (c) Hartung. I. V.; Rude, M. A.; Schnarr, N. A.; Hunziker, D.; Khosla, 
C. J. Am. Chem. Soc. 2005, 127, 11202-11203. 
(20) Le Sann, C.; Muftoz, D. M.; Saunders, N.; Simpson, T. J.; Smith, 
D. 1.; Soulas, F.; Watts, P.; Willis. C. L. Org. Biomol. Chem. 2005,3,1719-
1728. 
(21) Complex mixtures were obtained under these conditions including 
the products of elimination and retroaldol reactions. 
ester 13 in 94% yield in only 30 mm. In all of the successful 
displacement reactions, auxiliary I was recovered in high 
yield (84-99%). 
In conclusion, we have developed an auxiliary which 
promotes highly selective anti-aldol adduct formation, while 
also offering facile displacement with a range of nucleophiles. 
The high yields associated with these reactions, relative ease 
of synthesis of the thiol auxiliary 1, and its excellent bench 
stability make it an attractive alternative for use in synthesis. 
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